Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

137660341 159616 None 0 Human Functional pEC50 = 11 11.0 141 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1031 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2CCCCC2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4102192 159616 None 0 Human Functional pEC50 = 11 11.0 141 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1031 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC2CCCCC2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
2042 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
2174 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
2176 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
439302 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
439302.0 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
CHEMBL395429 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
DB00107 2983 None 40 Human Functional pEC50 = 11 11.0 1 5
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
90680085 111564 None 0 Human Functional pEC50 = 10.9 10.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 951 18 12 14 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3277916 111564 None 0 Human Functional pEC50 = 10.9 10.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 951 18 12 14 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137654006 158846 None 0 Human Functional pEC50 = 10.9 10.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 986 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4093931 158846 None 0 Human Functional pEC50 = 10.9 10.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 986 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137653847 159044 None 0 Human Functional pEC50 = 10.9 10.9 309 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCCC2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4095930 159044 None 0 Human Functional pEC50 = 10.9 10.9 309 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCCC2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137645401 157990 None 0 Human Functional pEC50 = 10.9 10.9 181 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 977 16 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4084223 157990 None 0 Human Functional pEC50 = 10.9 10.9 181 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 977 16 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)NCC(N)=O)C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137650792 157529 None 0 Human Functional pEC50 = 10.8 10.8 97 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 18 11 14 -2.4 CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4078856 157529 None 0 Human Functional pEC50 = 10.8 10.8 97 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 18 11 14 -2.4 CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
137653639 159135 None 0 Human Functional pEC50 = 10.7 10.7 40 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4096848 159135 None 0 Human Functional pEC50 = 10.7 10.7 40 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
76073634 115920 None 5 Human Functional pEC50 = 10.6 10.6 3981 4
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354594 115920 None 5 Human Functional pEC50 = 10.6 10.6 3981 4
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
137632034 156375 None 0 Human Functional pEC50 = 10.6 10.6 48 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4065273 156375 None 0 Human Functional pEC50 = 10.6 10.6 48 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
137661047 159585 None 0 Human Functional pEC50 = 10.6 10.6 48 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4101771 159585 None 0 Human Functional pEC50 = 10.6 10.6 48 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 20 11 14 -1.6 CCCCCCC(NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
155536940 172351 None 0 Human Functional pEC50 = 10.6 10.6 17 3
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4474284 172351 None 0 Human Functional pEC50 = 10.6 10.6 17 3
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
137652597 158904 None 0 Human Functional pEC50 = 10.5 10.5 2 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1034 19 14 15 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4094454 158904 None 0 Human Functional pEC50 = 10.5 10.5 2 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1034 19 14 15 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137654217 158770 None 0 Human Functional pEC50 = 10.5 10.5 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 987 15 14 14 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NNC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4092971 158770 None 0 Human Functional pEC50 = 10.5 10.5 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 987 15 14 14 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NNC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
155565903 175847 None 0 Human Functional pEC50 = 10.5 10.5 - 1
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4583231 175847 None 0 Human Functional pEC50 = 10.5 10.5 - 1
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
2042 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
2174 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
2176 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
439302 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
439302.0 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
CHEMBL395429 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
DB00107 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmcl.2017.12.027
449224 169078 None 10 Human Functional pEC50 = 10.4 10.4 54 4
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL439044 169078 None 10 Human Functional pEC50 = 10.4 10.4 54 4
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
2042 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
2174 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
2176 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
439302 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
439302.0 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
CHEMBL395429 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
DB00107 2983 None 40 Human Functional pEC50 = 10.4 10.4 1 5
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
449224 169078 None 10 Human Functional pEC50 = 10.4 10.4 54 4
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL439044 169078 None 10 Human Functional pEC50 = 10.4 10.4 54 4
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137647351 157647 None 0 Human Functional pEC50 = 10.4 10.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 995 19 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4080341 157647 None 0 Human Functional pEC50 = 10.4 10.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 995 19 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137648677 158057 None 0 Human Functional pEC50 = 10.3 10.3 44 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4084795 158057 None 0 Human Functional pEC50 = 10.3 10.3 44 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2ccccc2)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137634607 156198 None 0 Human Functional pEC50 = 10.3 10.3 11 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4063150 156198 None 0 Human Functional pEC50 = 10.3 10.3 11 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
90680084 111563 None 0 Human Functional pEC50 = 10.2 10.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 18 12 14 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3277915 111563 None 0 Human Functional pEC50 = 10.2 10.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 18 12 14 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137661245 159567 None 0 Human Functional pEC50 = 10.1 10.1 123 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 950 15 11 14 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4101586 159567 None 0 Human Functional pEC50 = 10.1 10.1 123 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 950 15 11 14 -2.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC1=O 10.1016/j.bmcl.2017.04.030
90285421 115046 None 0 Human Functional pEC50 = 10.1 10.1 -9 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342789 115046 None 0 Human Functional pEC50 = 10.1 10.1 -9 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
3601935 162457 None 0 Human Functional pEC50 = 10.1 10.1 1 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 271 3 1 4 1.9 Cn1nccc1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL4165132 162457 None 0 Human Functional pEC50 = 10.1 10.1 1 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 271 3 1 4 1.9 Cn1nccc1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
137634089 156389 None 0 Human Functional pEC50 = 10.1 10.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 981 19 13 15 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4065416 156389 None 0 Human Functional pEC50 = 10.1 10.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 981 19 13 15 -4.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
155527198 171281 None 0 Human Functional pEC50 = 10.1 10.1 8 3
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4458988 171281 None 0 Human Functional pEC50 = 10.1 10.1 8 3
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
2168 3976 None 29 Human Functional pEC50 = 10 10.0 -97 6
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
2810 3976 None 29 Human Functional pEC50 = 10 10.0 -97 6
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
644077 3976 None 29 Human Functional pEC50 = 10 10.0 -97 6
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
644077.0 3976 None 29 Human Functional pEC50 = 10 10.0 -97 6
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
CHEMBL373742 3976 None 29 Human Functional pEC50 = 10 10.0 -97 6
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
DB00067 3976 None 29 Human Functional pEC50 = 10 10.0 -97 6
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
76685194 115047 None 0 Human Functional pEC50 = 10 10.0 -5 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342790 115047 None 0 Human Functional pEC50 = 10 10.0 -5 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
5014150 162950 None 0 Human Functional pEC50 = 10 10.0 1 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 305 3 1 4 2.2 Cn1nccc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL4173036 162950 None 0 Human Functional pEC50 = 10 10.0 1 2
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced increase in Ca2+ flux preincubated for 5 mins followed by OT addition measured after 5 mins for every 2 secs by Ca5 dye based FLIPR assay
ChEMBL 305 3 1 4 2.2 Cn1nccc1NS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
137631348 156525 None 0 Human Functional pEC50 = 10.0 10.0 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 979 18 11 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4066923 156525 None 0 Human Functional pEC50 = 10.0 10.0 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 979 18 11 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(C)[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137639236 156841 None 0 Human Functional pEC50 = 10.0 10.0 3 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4070577 156841 None 0 Human Functional pEC50 = 10.0 10.0 3 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1025 17 11 14 -2.3 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
18779926 14442 None 33 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
402 14442 None 33 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
CHEMBL1200739 14442 None 33 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
CHEMBL4103942 14442 None 33 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 34 0 0 0 0.1 S 10.1016/j.bmcl.2017.04.030
137649234 157228 None 0 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4075102 157228 None 0 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137654919 158780 None 0 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1041 20 12 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4093088 158780 None 0 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1041 20 12 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
126705667 159080 None 0 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4096331 159080 None 0 Human Functional pEC50 = 9.9 9.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
155532160 171829 None 0 Human Functional pEC50 = 9.8 9.8 - 1
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 21 13 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4467042 171829 None 0 Human Functional pEC50 = 9.8 9.8 - 1
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1006 21 13 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
137648427 157939 None 0 Human Functional pEC50 = 9.7 9.7 20 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4083700 157939 None 0 Human Functional pEC50 = 9.7 9.7 20 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 991 17 11 14 -2.5 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137652984 158721 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 975 17 10 13 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4092407 158721 None 0 Human Functional pEC50 = 9.7 9.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 975 17 10 13 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137659822 159477 None 0 Human Functional pEC50 = 9.6 9.6 288 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 934 14 10 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4100627 159477 None 0 Human Functional pEC50 = 9.6 9.6 288 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 934 14 10 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC1=O 10.1016/j.bmcl.2017.04.030
137641012 157138 None 0 Human Functional pEC50 = 9.6 9.6 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 18 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4073891 157138 None 0 Human Functional pEC50 = 9.6 9.6 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 18 12 15 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137639340 156995 None 0 Human Functional pEC50 = 9.6 9.6 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 985 16 12 13 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4072207 156995 None 0 Human Functional pEC50 = 9.6 9.6 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 985 16 12 13 -4.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
118720268 115905 None 0 Human Functional pEC50 = 9.6 9.6 151 4
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354579 115905 None 0 Human Functional pEC50 = 9.6 9.6 151 4
Agonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at recombinant human OTR expressed in HEK293 cells assessed as increase in intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
127051498 140684 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813771 140684 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1005 17 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2174 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2176 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
439302 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
439302.0 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
CHEMBL395429 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
DB00107 2983 None 40 Human Functional pEC50 = 9.5 9.5 1 5
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
137654665 158707 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1023 21 13 15 -3.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4092242 158707 None 0 Human Functional pEC50 = 9.5 9.5 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1023 21 13 15 -3.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
145964703 164146 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 822 12 8 12 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4208981 164146 None 0 Human Functional pEC50 = 9.4 9.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 822 12 8 12 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COC)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3814633 214749 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
145975112 163765 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 778 10 8 11 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4204637 163765 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 778 10 8 11 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3814744 214750 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137659747 159344 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1091 21 14 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4099102 159344 None 0 Human Functional pEC50 = 9.3 9.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1091 21 14 15 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
127049296 140764 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3815099 140764 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
145978563 163904 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 860 11 8 14 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2nnc(C)o2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4206141 163904 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 860 11 8 14 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2nnc(C)o2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
145966784 164543 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 792 10 8 11 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@@H]2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4213896 164543 None 0 Human Functional pEC50 = 9.2 9.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 792 10 8 11 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@@H]2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
2042 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2174 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2176 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302.0 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
CHEMBL395429 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
DB00107 2983 None 40 Human Functional pEC50 = 9.2 9.2 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
145966470 164420 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 883 13 9 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CNc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4212399 164420 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 883 13 9 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CNc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
137654009 158857 None 0 Human Functional pEC50 = 9.1 9.1 29 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 976 16 10 13 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4094019 158857 None 0 Human Functional pEC50 = 9.1 9.1 29 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 976 16 10 13 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1016/j.bmcl.2017.04.030
145974697 164767 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 855 11 8 12 0.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4216826 164767 None 0 Human Functional pEC50 = 9.1 9.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 855 11 8 12 0.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2c2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3813894 214742 None 0 Human Functional pEC50 = 9 9.0 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137635522 156228 None 0 Human Functional pEC50 = 8.9 8.9 7 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 18 13 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4063521 156228 None 0 Human Functional pEC50 = 8.9 8.9 7 2
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1019 18 13 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC1=O 10.1016/j.bmcl.2017.04.030
145976821 163757 None 0 Human Functional pEC50 = 8.9 8.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 821 11 9 12 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4204502 163757 None 0 Human Functional pEC50 = 8.9 8.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 821 11 9 12 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
137643372 158199 None 0 Human Functional pEC50 = 8.9 8.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4086714 158199 None 0 Human Functional pEC50 = 8.9 8.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1005 17 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137638040 156847 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1050 22 15 15 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4070617 156847 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1050 22 15 15 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137635922 156060 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1047 19 11 14 -1.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4061446 156060 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1047 19 11 14 -1.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137647481 157900 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 19 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4083280 157900 None 0 Human Functional pEC50 = 8.8 8.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 19 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
145978698 163706 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 905 14 8 12 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)CCC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4203673 163706 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 905 14 8 12 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)CCC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
145977344 163819 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 934 15 10 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4205163 163819 None 0 Human Functional pEC50 = 8.7 8.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 934 15 10 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
11169 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
131676677 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555.0 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432.0 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
495 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3301668 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
DB01282 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3814120 214743 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
2174 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
2176 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
439302 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
439302.0 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
CHEMBL395429 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
DB00107 2983 None 40 Human Functional pEC50 = 8.0 8.0 1 5
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
CHEMBL1817752 211451 None 0 Human Functional pEC50 = 7.0 7.0 -77 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819550 211484 None 0 Human Functional pEC50 = 7.0 7.0 -47 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819550 211484 None 0 Human Functional pEC50 = 7.0 7.0 -47 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
145960494 161655 None 0 Human Functional pEC50 = 7.0 7.0 20 4
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4128839 161655 None 0 Human Functional pEC50 = 7.0 7.0 20 4
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1081 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccc(cc2)SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL1817761 211460 None 0 Human Functional pEC50 = 7.0 7.0 -338 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817752 211451 None 0 Human Functional pEC50 = 7.0 7.0 -77 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817761 211460 None 0 Human Functional pEC50 = 7.0 7.0 -338 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
11454 3577 None 12 Human Functional pEC50 = 6.0 6.0 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
53330936 3577 None 12 Human Functional pEC50 = 6.0 6.0 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817709 3577 None 12 Human Functional pEC50 = 6.0 6.0 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB12495 3577 None 12 Human Functional pEC50 = 6.0 6.0 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
5329098 98628 None 55 Human Functional pEC50 = 4.9 4.9 1 3
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1 nan
CHEMBL276711 98628 None 55 Human Functional pEC50 = 4.9 4.9 1 3
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 238 1 2 1 3.1 Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1 nan
137658241 159701 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 964 16 11 14 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4103260 159701 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 964 16 11 14 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL1819547 211481 None 0 Human Functional pEC50 = 5.9 5.9 -63 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cscn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819547 211481 None 0 Human Functional pEC50 = 5.9 5.9 -63 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cscn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
90672737 110523 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCNC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3246917 110523 None 0 Human Functional pEC50 = 7.9 7.9 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 970 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCNC(=O)C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
172444756 197044 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5437397 197044 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
172455058 196471 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N\c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5424615 196471 None 0 Human Functional pEC50 = 6.9 6.9 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N\c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL3814126 214744 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1C 10.1016/j.bmc.2016.05.062
1112934 56110 None 5 Human Functional pEC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL1587205 56110 None 5 Human Functional pEC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
CHEMBL1625302 56110 None 5 Human Functional pEC50 = 4.8 4.8 -1 3
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 425 5 1 5 4.7 N=c1n(CC(=O)c2ccc(Br)s2)c2ccccc2n1Cc1ccccc1 nan
2168 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2810 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077.0 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL373742 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB00067 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2168 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
2810 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
644077.0 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL373742 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB00067 3976 None 29 Human Functional pEC50 = 7.8 7.8 -97 6
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817705 211446 None 0 Human Functional pEC50 = 7.8 7.8 -61 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL3813858 214740 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135506374 137987 None 19 Human Functional pEC50 = 6.8 6.8 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 6.8 6.8 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
25161471 55055 None 12 Human Functional pEC50 = 4.8 4.8 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
CHEMBL1356933 55055 None 12 Human Functional pEC50 = 4.8 4.8 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
CHEMBL1616435 55055 None 12 Human Functional pEC50 = 4.8 4.8 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 265 4 2 2 3.5 Oc1ccc(Cl)cc1CNCc1ccc(F)cc1 nan
118716666 115053 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 437 4 1 6 3.5 O=S(=O)(Nc1ccnn1-c1ncc(C(F)(F)F)cn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342796 115053 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 437 4 1 6 3.5 O=S(=O)(Nc1ccnn1-c1ncc(C(F)(F)F)cn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
90286664 115055 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 375 6 1 7 3.0 CCc1ccc(S(=O)(=O)Nc2ccnn2-c2nc(C3CC3)ns2)cc1 10.1021/ml5004348
CHEMBL3342798 115055 None 0 Human Functional pEC50 = 5.8 5.8 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 375 6 1 7 3.0 CCc1ccc(S(=O)(=O)Nc2ccnn2-c2nc(C3CC3)ns2)cc1 10.1021/ml5004348
CHEMBL1817705 211446 None 0 Human Functional pEC50 = 7.8 7.8 -61 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2369069 179390 None 3 Human Functional pEC50 = 4.8 4.8 -2 3
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 346 3 0 5 4.0 CCN1C(=S)SC(=O)C1=C1C=C(C)N(Cc2ccco2)C(C)=C1 nan
CHEMBL473106 179390 None 3 Human Functional pEC50 = 4.8 4.8 -2 3
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 346 3 0 5 4.0 CCN1C(=S)SC(=O)C1=C1C=C(C)N(Cc2ccco2)C(C)=C1 nan
137658004 159770 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 948 15 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4104022 159770 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 948 15 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
90286007 115051 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 382 4 1 5 3.4 Cc1ccnc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1 10.1021/ml5004348
CHEMBL3342794 115051 None 0 Human Functional pEC50 = 7.8 7.8 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 382 4 1 5 3.4 Cc1ccnc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1 10.1021/ml5004348
53363016 64821 None 0 Human Functional pEC50 = 6.8 6.8 -28 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL1819557 64821 None 0 Human Functional pEC50 = 6.8 6.8 -28 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL 1005 18 12 15 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NC)NC1=O 10.1021/jm200278m
CHEMBL3814232 214746 None 0 Human Functional pEC50 = 6.8 6.8 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
10444 2326 None 17 Mouse Functional pEC50 = 7.8 7.8 2 4
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2326 None 17 Mouse Functional pEC50 = 7.8 7.8 2 4
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2326 None 17 Mouse Functional pEC50 = 7.8 7.8 2 4
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2326 None 17 Mouse Functional pEC50 = 7.8 7.8 2 4
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL1819556 211489 None 0 Human Functional pEC50 = 6.8 6.8 -190 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)C2(CCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2919564 30210 None 14 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 404 9 2 5 4.0 COc1ccc(CCNCC(O)Cn2c3ccccc3c3ccccc32)cc1OC nan
CHEMBL1390471 30210 None 14 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 404 9 2 5 4.0 COc1ccc(CCNCC(O)Cn2c3ccccc3c3ccccc32)cc1OC nan
90285421 115046 None 0 Human Functional pEC50 = 7.7 7.7 -9 2
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342789 115046 None 0 Human Functional pEC50 = 7.7 7.7 -9 2
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1016/j.ejmech.2017.05.013
90285421 115046 None 0 Human Functional pEC50 = 7.7 7.7 -9 2
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1021/ml5004348
CHEMBL3342789 115046 None 0 Human Functional pEC50 = 7.7 7.7 -9 2
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 334 4 1 5 2.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1 10.1021/ml5004348
90285984 115050 None 5 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 352 4 1 5 2.9 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1F 10.1021/ml5004348
CHEMBL3342793 115050 None 5 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 352 4 1 5 2.9 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(Cl)cc1F 10.1021/ml5004348
145974945 164811 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 884 13 8 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4217353 164811 None 0 Human Functional pEC50 = 6.7 6.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 884 13 8 12 0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2COc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
42601352 35412 None 0 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
CHEMBL1437791 35412 None 0 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
CHEMBL3211384 35412 None 0 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 282 4 2 3 3.4 Oc1ccc(Cl)cc1CNCc1ccc(Cl)nc1 nan
2042 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2174 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2176 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302.0 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
CHEMBL395429 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
DB00107 2983 None 40 Mouse Functional pEC50 = 8.7 8.7 -1 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
11454 3577 None 12 Human Functional pEC50 = 8.6 8.6 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
53330936 3577 None 12 Human Functional pEC50 = 8.6 8.6 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
CHEMBL1817709 3577 None 12 Human Functional pEC50 = 8.6 8.6 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
DB12495 3577 None 12 Human Functional pEC50 = 8.6 8.6 -93 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm200278m
127049997 140676 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813707 140676 None 0 Human Functional pEC50 = 8.6 8.6 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2042 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
2174 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
2176 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
439302 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
439302.0 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
CHEMBL395429 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
DB00107 2983 None 40 Human Functional pEC50 = 8.6 8.6 1 5
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL None None None None 10.1021/acs.jmedchem.3c01415
155555127 174439 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1485 46 11 17 7.5 CCCCCCCCCCCCCCCC(=O)N[C@H]1CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(OC(=O)OCCCCCCCCCCCCCC)cc2)NC1=O 10.1016/j.bmc.2019.06.018
CHEMBL4550879 174439 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric methodAgonist activity at human OTR receptor expressed in HEK293 cells assessed as intracellular calcium level measured at 3 secs interval for 5 mins by fura-2/AM dye based micro spectrofluorometric method
ChEMBL 1485 46 11 17 7.5 CCCCCCCCCCCCCCCC(=O)N[C@H]1CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(OC(=O)OCCCCCCCCCCCCCC)cc2)NC1=O 10.1016/j.bmc.2019.06.018
6174589 107642 None 5 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 379 6 2 6 2.0 CCN(CC)c1ccc2cc(C(N)=O)/c(=N\NC(=O)c3ccncc3)oc2c1 nan
CHEMBL3189462 107642 None 5 Human Functional pEC50 = 4.7 4.7 -1 2
PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]PUBCHEM_BIOASSAY: Counterscreen for vasopressin 1 receptor (V1R) agonists: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434964 (Confirmation screen (V1R agonists in triplicate)), 434969 (Counterscreen (OXTR agonists in triplicate)), 2797 (Counterscreen (V1R agonists in singlicate))]
ChEMBL 379 6 2 6 2.0 CCN(CC)c1ccc2cc(C(N)=O)/c(=N\NC(=O)c3ccncc3)oc2c1 nan
137651797 157211 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1010 16 10 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4074898 157211 None 0 Human Functional pEC50 = 7.7 7.7 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1010 16 10 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL3814165 214745 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135506374 137987 None 19 Human Functional pEC50 = 7.6 7.6 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 7.6 7.6 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
90285817 115048 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 351 4 1 4 3.5 O=S(=O)(Nc1ccnn1-c1ccc(F)cc1)c1ccc(Cl)cc1 10.1021/ml5004348
CHEMBL3342791 115048 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 351 4 1 4 3.5 O=S(=O)(Nc1ccnn1-c1ccc(F)cc1)c1ccc(Cl)cc1 10.1021/ml5004348
10444 2326 None 17 Human Functional pEC50 = 7.6 7.6 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2326 None 17 Human Functional pEC50 = 7.6 7.6 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2326 None 17 Human Functional pEC50 = 7.6 7.6 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2326 None 17 Human Functional pEC50 = 7.6 7.6 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL3814617 214748 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)N(C)C(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL1817756 211455 None 0 Human Functional pEC50 = 6.6 6.6 -426 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
2042 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2174 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
2176 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
439302.0 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
CHEMBL395429 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
DB00107 2983 None 40 Human Functional pEC50 = 7.6 7.6 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL None None None None 10.1021/acs.jmedchem.8b00697
CHEMBL1817756 211455 None 0 Human Functional pEC50 = 6.6 6.6 -426 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
172444756 195015 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5395020 195015 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1146 21 13 17 -0.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
23983726 48861 None 3 Human Functional pEC50 = 5.6 5.6 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 472 1 3 3 6.2 CC1(C)CC[C@@]2(C(=O)O)C(C1)C1=CCC3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)C[C@H]2O nan
CHEMBL1559201 48861 None 3 Human Functional pEC50 = 5.6 5.6 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 472 1 3 3 6.2 CC1(C)CC[C@@]2(C(=O)O)C(C1)C1=CCC3[C@@]4(C)CC[C@H](O)C(C)(C)C4CC[C@@]3(C)[C@]1(C)C[C@H]2O nan
3650228 56001 None 6 Human Functional pEC50 = 4.6 4.6 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
CHEMBL1549574 56001 None 6 Human Functional pEC50 = 4.6 4.6 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
CHEMBL1624349 56001 None 6 Human Functional pEC50 = 4.6 4.6 -1 2
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 402 5 2 3 5.1 COc1ccc(C2NCCc3c2[nH]c2ccccc32)cc1COc1ccc(F)cc1 nan
921775 42032 None 5 Human Functional pEC50 = 4.6 4.6 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 304 4 2 4 3.7 COc1ccc(CNc2[nH]cnc3c4ccccc4nc2-3)cc1 nan
CHEMBL1495292 42032 None 5 Human Functional pEC50 = 4.6 4.6 - 1
PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for agonists of the Oxytocin Receptor (OXTR). (Class of assay: confirmatory) [Related pubchem assays: 2435 (Primary screen (OXTR agonists in singlicate)), 434991 (Counterscreen (V1R agonists in triplicate)), 2482 (Summary (OXTR agonists)), 434963 (Confirmation screen (OXTR agonists in triplicate))]
ChEMBL 304 4 2 4 3.7 COc1ccc(CNc2[nH]cnc3c4ccccc4nc2-3)cc1 nan
145973088 164797 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 681 9 8 10 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4217226 164797 None 0 Human Functional pEC50 = 7.6 7.6 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 681 9 8 10 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
135413563 122996 None 20 Human Functional pEC50 = 7.6 7.6 -3 3
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 122996 None 20 Human Functional pEC50 = 7.6 7.6 -3 3
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3813879 214741 None 0 Human Functional pEC50 = 6.6 6.6 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N(C)[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1C 10.1016/j.bmc.2016.05.062
CHEMBL1819548 211482 None 0 Human Functional pEC50 = 7.5 7.5 -53 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
135506374 137987 None 19 Mouse Functional pEC50 = 7.5 7.5 1 4
Agonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL3763342 137987 None 19 Mouse Functional pEC50 = 7.5 7.5 1 4
Agonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant mouse OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL1819548 211482 None 0 Human Functional pEC50 = 7.5 7.5 -53 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819549 211483 None 0 Human Functional pEC50 = 7.5 7.5 -47 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
145963213 161575 None 0 Human Functional pEC50 = 6.5 6.5 -8 4
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4127791 161575 None 0 Human Functional pEC50 = 6.5 6.5 -8 4
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
135506374 137987 None 19 Human Functional pEC50 = 8.5 8.5 -2 4
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 8.5 8.5 -2 4
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
2042 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
2174 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
2176 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
439302 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
439302.0 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
CHEMBL395429 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
DB00107 2983 None 40 Human Functional pEC50 = 8.5 8.5 1 5
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
CHEMBL1819541 211475 None 0 Human Functional pEC50 = 8.5 8.5 -14 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819541 211475 None 0 Human Functional pEC50 = 8.5 8.5 -14 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
137640630 157152 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 20 12 14 -2.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4074033 157152 None 0 Human Functional pEC50 = 8.5 8.5 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1007 20 12 14 -2.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
137656718 159647 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 941 17 10 13 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4102595 159647 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 941 17 10 13 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
145975622 163850 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 918 11 8 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCCN(C)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4205509 163850 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 918 11 8 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCCN(C)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL1819549 211483 None 0 Human Functional pEC50 = 7.5 7.5 -47 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccsc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
172442093 195186 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5398356 195186 None 0 Human Functional pEC50 = 7.5 7.5 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N\c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
145972114 164722 None 0 Human Functional pEC50 = 6.5 6.5 -3 2
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 515 4 2 6 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4216174 164722 None 0 Human Functional pEC50 = 6.5 6.5 -3 2
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 515 4 2 6 3.4 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL1817707 211448 None 0 Human Functional pEC50 = 7.5 7.5 -194 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 211447 None 0 Human Functional pEC50 = 7.5 7.5 -309 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817707 211448 None 0 Human Functional pEC50 = 7.5 7.5 -194 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817706 211447 None 0 Human Functional pEC50 = 7.5 7.5 -309 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CCCNCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1817704 211445 None 0 Human Functional pEC50 = 7.5 7.5 -257 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
135413563 122996 None 20 Human Functional pEC50 = 7.5 7.5 -3 3
Agonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assayAgonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL360648 122996 None 20 Human Functional pEC50 = 7.5 7.5 -3 3
Agonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assayAgonist activity at human OTR receptor expressed in CHO cells co-expressing NFAT-luciferase incubated for 5 hrs by luciferase reporter gene assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL1817704 211445 None 0 Human Functional pEC50 = 7.5 7.5 -257 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
145962220 161671 None 0 Human Functional pEC50 = 7.5 7.5 87 4
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4129142 161671 None 0 Human Functional pEC50 = 7.5 7.5 87 4
Agonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1095 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2cccc(c2)CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
172455058 195723 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5409527 195723 None 0 Human Functional pEC50 = 6.5 6.5 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1160 22 13 17 -0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](Cc2ccc(/N=N/c3ccccc3)cc2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
172449652 195862 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N\c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5412177 195862 None 0 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N\c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
127049996 140694 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813883 140694 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137637782 156094 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4061946 156094 None 0 Human Functional pEC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 949 15 11 14 -3.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL3814395 214747 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
137654636 158627 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
CHEMBL4091483 158627 None 0 Human Functional pEC50 = 7.4 7.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 965 16 12 15 -4.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.bmcl.2017.04.030
11169 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
131676677 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555.0 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432.0 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
495 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3301668 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
DB01282 797 None 33 Human Functional pEC50 = 7.4 7.4 1 5
Agonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at human OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
135506374 137987 None 19 Human Functional pEC50 = 6.4 6.4 -2 4
Agonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assayAgonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 6.4 6.4 -2 4
Agonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assayAgonist activity at human OTR expressed in HEK293 cells assessed as induction of IP1 accumulation after 1 hr by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2017.10.059
135506374 137987 None 19 Human Functional pEC50 = 6.4 6.4 -2 4
Agonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assayAgonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 6.4 6.4 -2 4
Agonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assayAgonist activity at human oxytocin receptor expressed in HEK293 cells assessed as increase in IP1 accumulation preincubated for 1 hr followed by addition of Ab-Cryptate and IP1-d2 by HTRF assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL1817708 211449 None 0 Human Functional pEC50 = 7.4 7.4 -53 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNCCC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817708 211449 None 0 Human Functional pEC50 = 7.4 7.4 -53 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNCCC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
172449652 195789 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5410810 195789 None 0 Human Functional pEC50 = 5.4 5.4 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1094 19 11 16 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(/N=N/c3ccccc3)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
90285722 115052 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 400 5 1 6 3.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(SC(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342795 115052 None 0 Human Functional pEC50 = 7.3 7.3 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 400 5 1 6 3.7 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(SC(F)(F)F)cc1 10.1021/ml5004348
2042 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
2174 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
2176 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
439302 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
439302.0 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
CHEMBL395429 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
DB00107 2983 None 40 Human Functional pEC50 = 8.3 8.3 1 5
Agonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at wild type OTR (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
137648249 158080 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 992 17 11 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4085152 158080 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 992 17 11 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O 10.1016/j.bmcl.2017.04.030
145975847 163817 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 882 13 8 11 1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4205128 163817 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 882 13 8 11 1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2CCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
145977939 164042 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 724 10 9 11 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4207691 164042 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 724 10 9 11 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3813722 214738 None 0 Human Functional pEC50 = 8.3 8.3 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
90285477 115049 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 388 4 1 6 3.5 Cc1csc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1 10.1021/ml5004348
CHEMBL3342792 115049 None 0 Human Functional pEC50 = 6.3 6.3 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 388 4 1 6 3.5 Cc1csc(-n2nccc2NS(=O)(=O)c2ccc(C(F)(F)F)cc2)n1 10.1021/ml5004348
10444 2326 None 17 Human Functional pEC50 = 7.3 7.3 -2 4
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2326 None 17 Human Functional pEC50 = 7.3 7.3 -2 4
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2326 None 17 Human Functional pEC50 = 7.3 7.3 -2 4
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2326 None 17 Human Functional pEC50 = 7.3 7.3 -2 4
Agonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAgonist activity at human OTR expressed in HEK cells assessed as increase in intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145964151 164402 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 958 12 8 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCC(N3CCCC3)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL4212247 164402 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as increase in calcium flux after 60 to 120 mins by fluo-4 dye based FLIPR assay
ChEMBL 958 12 8 13 -0.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N2CCC(N3CCCC3)CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.12.027
CHEMBL3813729 214739 None 0 Human Functional pEC50 = 8.2 8.2 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135506374 137987 None 19 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assayAgonist activity at recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells assessed as change in intracellular calcium level by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.ejmech.2015.11.050
135506374 137987 None 19 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-DUKX-A2 cells assessed as stimulation of intracellular calcium concentration by calcium 3 dye based FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
135506374 137987 None 19 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assayAgonist activity at recombinant human OTR expressed in CHO-K1 cells assessed as induction of Ca2+ mobilization after overnight incubation by FLIPR assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.7b00965
10444 2326 None 17 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
139030525 2326 None 17 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
145711714 2326 None 17 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4204210 2326 None 17 Human Functional pEC50 = 7.2 7.2 -2 4
Agonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assayAgonist activity at human OTR receptor expressed in HEK293FT cells incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 531 4 2 6 4.2 Cc1c(ccc(c1)C(=O)N1Cc2c(Nc3ccccc13)n(nc2)C)CNC(=O)N1CCC[C@H]1C(=S)N(C)C 10.1021/acs.jmedchem.8b00697
11169 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
131676677 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
165708555.0 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
16681432.0 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
495 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
CHEMBL3301668 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
DB01282 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b00697
127051499 140698 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL3813982 140698 None 0 Human Functional pEC50 = 8.1 8.1 - 1
Agonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assayAgonist activity at human oxytocin receptor expressed in CHO cells assessed as increase in intracellular calcium flux measured for 90 sec by fluo-4 dye based FLIPR assay
ChEMBL 1019 17 9 14 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL1819440 211472 None 20 Human Functional pEC50 = 7.2 7.2 -204 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
CHEMBL1819440 211472 None 20 Human Functional pEC50 = 7.2 7.2 -204 5
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm200278m
90285806 115054 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 432 5 1 7 2.4 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(S(=O)(=O)C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342797 115054 None 0 Human Functional pEC50 = 6.1 6.1 - 1
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 432 5 1 7 2.4 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(S(=O)(=O)C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL1817759 211458 None 0 Human Functional pEC50 = 6.1 6.1 -53 3
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
135506374 137987 None 19 Mouse Functional pEC50 = 7.1 7.1 1 4
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137987 None 19 Mouse Functional pEC50 = 7.1 7.1 1 4
Agonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assayAgonist activity at mouse OTR receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL1817759 211458 None 0 Human Functional pEC50 = 6.1 6.1 -53 3
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
2042 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
2174 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
2176 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
439302 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
439302.0 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
CHEMBL395429 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
DB00107 2983 None 40 Human Functional pEC50 = 8.1 8.1 1 5
Agonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assayAgonist activity at SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells assessed as intracellular calcium flux after 3 mins by fluorescence assay
ChEMBL None None None None 10.1021/jm501395b
76685194 115047 None 0 Human Functional pEC50 = 8.1 8.1 -5 2
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
CHEMBL3342790 115047 None 0 Human Functional pEC50 = 8.1 8.1 -5 2
Agonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assayAgonist activity at human OTR expressed in HEK293 cell membranes induction of IP1 accumulation at 0.1 to 10 uM measured after 1 hr by fluorescence assay
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2017.05.013
76685194 115047 None 0 Human Functional pEC50 = 8.1 8.1 -5 2
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
CHEMBL3342790 115047 None 0 Human Functional pEC50 = 8.1 8.1 -5 2
Agonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR methodAgonist activity at human oxytocin receptor expressed CHO cells assessed as calcium flux by FLIPR method
ChEMBL 368 4 1 5 3.1 O=S(=O)(Nc1ccnn1-c1ccccn1)c1ccc(C(F)(F)F)cc1 10.1021/ml5004348
2168 3976 None 29 Human Functional pEC50 = 8.1 8.1 -97 6
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
2810 3976 None 29 Human Functional pEC50 = 8.1 8.1 -97 6
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
644077 3976 None 29 Human Functional pEC50 = 8.1 8.1 -97 6
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
644077.0 3976 None 29 Human Functional pEC50 = 8.1 8.1 -97 6
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
CHEMBL373742 3976 None 29 Human Functional pEC50 = 8.1 8.1 -97 6
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
DB00067 3976 None 29 Human Functional pEC50 = 8.1 8.1 -97 6
Agonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assayAgonist activity at human oxytocin receptor expressed CHO cells assessed as induction of phospholipase C activity after 15 mins by inositol phosphate accumulation assay
ChEMBL None None None None 10.1021/jm1016208
CHEMBL1817763 211462 None 0 Human Functional pEC50 = 6.1 6.1 -63 3
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817763 211462 None 0 Human Functional pEC50 = 6.1 6.1 -63 3
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
135506374 137987 None 19 Human Functional pEC50 = 6.1 6.1 -2 4
Agonist activity at human OTR stably expressed in HEK cells by calcium flux assayAgonist activity at human OTR stably expressed in HEK cells by calcium flux assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
CHEMBL3763342 137987 None 19 Human Functional pEC50 = 6.1 6.1 -2 4
Agonist activity at human OTR stably expressed in HEK cells by calcium flux assayAgonist activity at human OTR stably expressed in HEK cells by calcium flux assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1021/acs.jmedchem.8b00697
137652261 157224 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 18 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4075079 157224 None 0 Human Functional pEC50 = 7.1 7.1 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1006 18 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL1819543 211477 None 0 Human Functional pEC50 = 8.0 8.0 -18 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1819543 211477 None 0 Human Functional pEC50 = 8.0 8.0 -18 4
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm200278m
137653770 158856 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1063 20 12 15 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
CHEMBL4094014 158856 None 0 Human Functional pEC50 = 8.0 8.0 - 1
Agonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as calcium mobilization measured after 30 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1063 20 12 15 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmcl.2017.04.030
172442093 195621 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL5407278 195621 None 0 Human Functional pEC50 = 7.0 7.0 - 1
Agonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assayAgonist activity at human Oxytocin receptor transfected in HEK293 cells incubated for 1 hr by IP-one HTRF assay
ChEMBL 1033 17 12 16 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCc2ccc(/N=N/c3ccc(C(=O)NCC(N)=O)cc3)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.3c01415
CHEMBL1817758 211457 None 0 Human Functional pEC50 = 6.0 6.0 -63 3
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
CHEMBL1817758 211457 None 0 Human Functional pEC50 = 6.0 6.0 -63 3
Agonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assayAgonist activity at human OT receptor expressed in CHO-K1 cells by luciferase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccco2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm200278m
90663156 106662 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Ability to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptorAbility to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142545 106662 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Ability to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptorAbility to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142790 106662 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Ability to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptorAbility to inhibit OT-induced inositol phosphate accumulation was determined in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
44459839 99890 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 573 12 3 7 2.3 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2cccs2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
CHEMBL285608 99890 None 0 Human Functional pIC50 = 9 9.0 - 1
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 573 12 3 7 2.3 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2cccs2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
155520603 170606 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 431 6 0 7 4.0 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4449435 170606 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 431 6 0 7 4.0 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
10411308 203691 None 0 Human Functional pIC50 = 7.0 7.0 -39 3
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL603708 203691 None 0 Human Functional pIC50 = 7.0 7.0 -39 3
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
2213 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
3008 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
5311010 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
5311010.0 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
68613 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
68613.0 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
CHEMBL378642 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
CHEMBL382301 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
DB09059 518 None 30 Rat Functional pIC50 = 7.9 7.9 1 4
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL None None None None 10.1016/j.bmcl.2005.10.107
155517601 170291 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)C3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4444840 170291 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)C3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
155516256 170141 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 4.2 COCc1nnc(N2C3CCC2CC(Oc2ccc(F)cc2Cl)C3)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4442843 170141 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 4.2 COCc1nnc(N2C3CCC2CC(Oc2ccc(F)cc2Cl)C3)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
9824954 73886 None 0 Rat Functional pIC50 = 5.9 5.9 -43 3
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 449 2 1 5 5.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2005.10.107
CHEMBL201889 73886 None 0 Rat Functional pIC50 = 5.9 5.9 -43 3
Antagonism of OT-induced response at OT receptor in rat uterine stripsAntagonism of OT-induced response at OT receptor in rat uterine strips
ChEMBL 449 2 1 5 5.5 Cc1ccn(-c2ccc(C(=O)N3Cc4cccnc4Nc4ccccc43)c(C(F)(F)F)c2)n1 10.1016/j.bmcl.2005.10.107
44458614 99145 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 571 7 2 5 3.7 C[C@@H](O)CN1CCC[C@@H](C(=O)NC2CC3CCC2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1 10.1021/jm970342o
CHEMBL280678 99145 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 571 7 2 5 3.7 C[C@@H](O)CN1CCC[C@@H](C(=O)NC2CC3CCC2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1 10.1021/jm970342o
142391767 169745 None 0 Human Functional pIC50 = 6.9 6.9 6 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 442 5 0 7 3.7 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc2c(c1)OCO2 10.1021/acsmedchemlett.9b00186
CHEMBL4437214 169745 None 0 Human Functional pIC50 = 6.9 6.9 6 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 442 5 0 7 3.7 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc2c(c1)OCO2 10.1021/acsmedchemlett.9b00186
155542139 173182 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 3.9 COCc1nnc(N2C[C@H]3C[C@@H](Oc4ccc(F)cc4Cl)C[C@H]3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4519861 173182 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 473 7 0 8 3.9 COCc1nnc(N2C[C@H]3C[C@@H](Oc4ccc(F)cc4Cl)C[C@H]3C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
135413562 2205 None 13 Human Functional pIC50 = 7.9 7.9 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 2205 None 13 Human Functional pIC50 = 7.9 7.9 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 2205 None 13 Human Functional pIC50 = 7.9 7.9 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
135493119 79100 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113201 79100 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135192983 176222 None 16 Human Functional pIC50 = 7.8 7.8 190 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4591825 176222 None 16 Human Functional pIC50 = 7.8 7.8 190 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
135399831 79093 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113189 79093 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145961670 161458 None 0 Human Functional pIC50 = 5.8 5.8 -123 4
Antagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
CHEMBL4126100 161458 None 0 Human Functional pIC50 = 5.8 5.8 -123 4
Antagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assayAntagonist activity at human mammary gland oxytocin receptor expressed in CHO cells assessed as inhibition of agonist-induced intracellular calcium flux preincubated for 20 mins followed by oxytocin addition measured for 5 mins by Fluo-4-AM dye based FLIPR assay
ChEMBL 1139 19 14 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCc2ccccc2CSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2018.03.019
135192979 175942 None 0 Human Functional pIC50 = 6.7 6.7 41 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4585239 175942 None 0 Human Functional pIC50 = 6.7 6.7 41 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135192895 174090 None 0 Human Functional pIC50 = 6.7 6.7 8 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4542267 174090 None 0 Human Functional pIC50 = 6.7 6.7 8 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 485 7 0 8 3.5 COc1ccc(-n2c(CO[C@@H]3CCOC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135192936 173099 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2CC3CC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4518063 173099 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2CC3CC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11683187 202388 None 41 Human Functional pIC50 = 7.6 7.6 20 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL594828 202388 None 41 Human Functional pIC50 = 7.6 7.6 20 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
135193003 175488 None 0 Human Functional pIC50 = 6.6 6.6 3 3
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 424 5 0 7 3.3 COc1ccc(-n2c(CC#N)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4575160 175488 None 0 Human Functional pIC50 = 6.6 6.6 3 3
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 424 5 0 7 3.3 COc1ccc(-n2c(CC#N)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
155558305 174845 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 459 6 0 8 3.0 COCc1nnc(N2CC3COCC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4560499 174845 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 459 6 0 8 3.0 COCc1nnc(N2CC3COCC3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
146238444 171773 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 417 6 0 7 3.6 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4466263 171773 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 417 6 0 7 3.6 COCc1nnc(N2CCC(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
155554422 174703 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 445 7 0 7 4.0 COCc1nnc(C2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4557241 174703 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 445 7 0 7 4.0 COCc1nnc(C2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11465834 138509 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 138509 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Agonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assayAgonist activity at human OTR expressed in CHO cells assessed as inhibition of oxytocin-induced calcium mobilization by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
135192928 175008 None 0 Human Functional pIC50 = 7.5 7.5 125 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3cccc(F)c3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4564411 175008 None 0 Human Functional pIC50 = 7.5 7.5 125 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@@H]3C[C@]3(c3cccc(F)c3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
1103817 17011 None 9 Human Functional pIC50 = 7.5 7.5 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
CHEMBL1254117 17011 None 9 Human Functional pIC50 = 7.5 7.5 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm050645f
135530014 79090 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113179 79090 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 526 9 3 6 2.9 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(CCCO)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
145976595 163810 None 0 Human Functional pIC50 = 7.4 7.4 -5 3
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
CHEMBL4205046 163810 None 0 Human Functional pIC50 = 7.4 7.4 -5 3
Antagonist activity at OXR receptor (unknown origin)Antagonist activity at OXR receptor (unknown origin)
ChEMBL 408 2 1 4 4.9 Cc1ccn(C(=O)Nc2ccc(C(=O)N3CCCCc4ccccc43)c(Cl)c2)n1 10.1021/acs.jmedchem.8b00697
2213 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
3008 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
5311010 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
5311010.0 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
68613 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
68613.0 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
CHEMBL378642 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
CHEMBL382301 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
DB09059 518 None 30 Human Functional pIC50 = 6.4 6.4 -12 4
Antagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assayAntagonist activity at human OTR expressed in HEK293 cell membranes assessed as inhibition of OT-induced IP1 accumulation measured after 1 hr by fluorescence assay
ChEMBL None None None None 10.1016/j.ejmech.2017.05.013
155564470 175529 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 411 5 0 8 2.5 COCc1nnc(N2CC3(CCc4cc(F)ccc4O3)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4576147 175529 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 411 5 0 8 2.5 COCc1nnc(N2CC3(CCc4cc(F)ccc4O3)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
137212772 138027 None 0 Human Functional pIC50 = 5.4 5.4 -3 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assayAntagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
CHEMBL3763951 138027 None 0 Human Functional pIC50 = 5.4 5.4 -3 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assayAntagonist activity at human OTR expressed in HEK293 cells assessed as inhibition of agonist-induced IP1 accumulation preincubated for 30 mins followed by agonist addition measured after 1 hr by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2017.10.059
137212772 138027 None 0 Human Functional pIC50 = 5.4 5.4 -3 2
Antagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
CHEMBL3763951 138027 None 0 Human Functional pIC50 = 5.4 5.4 -3 2
Antagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assayAntagonist activity at human oxytocin receptor expressed in HEK293 cells assessed as inhibition of oxytocin induced IP1 accumulation pretreated for 30 mins measured 1 hr post Ab-Cryptate and IP1-d2 addition by HTRF assay
ChEMBL 609 7 2 8 4.7 COc1cc(CN2CCN(C(=O)NCc3ccc(C(=O)N4Cc5cnn(C)c5Nc5ccccc54)cc3C)CC2)cc(OC)c1 10.1016/j.ejmech.2015.11.050
135192889 174153 None 0 Human Functional pIC50 = 6.4 6.4 25 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 425 5 0 6 4.1 COc1ccc(-n2c(C3CC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4543809 174153 None 0 Human Functional pIC50 = 6.4 6.4 25 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 425 5 0 6 4.1 COc1ccc(-n2c(C3CC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135192997 173934 None 0 Human Functional pIC50 = 7.4 7.4 18 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 461 8 0 7 3.7 COc1ccc(-n2c(COCCF)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4538696 173934 None 0 Human Functional pIC50 = 7.4 7.4 18 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 461 8 0 7 3.7 COc1ccc(-n2c(COCCF)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135508167 79089 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113177 79089 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 596 10 3 8 2.8 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(NCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
44459838 99676 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 635 12 3 6 3.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
CHEMBL284120 99676 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Inhibitory concentration required for antagonist activity against oxytocin receptorInhibitory concentration required for antagonist activity against oxytocin receptor
ChEMBL 635 12 3 6 3.6 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)N[C@@H](Cc2ccc(Cl)c(Cl)c2)C(N)=O)C1=O 10.1016/s0960-894x(01)00201-3
142391805 174081 None 0 Human Functional pIC50 = 7.3 7.3 35 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 435 5 0 6 4.2 COc1ccc(-n2c(C(F)F)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4541860 174081 None 0 Human Functional pIC50 = 7.3 7.3 35 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 435 5 0 6 4.2 COc1ccc(-n2c(C(F)F)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
145952624 162479 None 0 Human Functional pIC50 = 5.3 5.3 -1 4
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 889 21 2 10 3.3 CC[C@H](C)[C@@H](OC(=O)CCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
CHEMBL4165525 162479 None 0 Human Functional pIC50 = 5.3 5.3 -1 4
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 889 21 2 10 3.3 CC[C@H](C)[C@@H](OC(=O)CCc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
3537 4004 None 22 Rat Functional pIC50 = 7.3 7.3 -3 4
Antagonist activity at OXR receptor in rat uterusAntagonist activity at OXR receptor in rat uterus
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 4004 None 22 Rat Functional pIC50 = 7.3 7.3 -3 4
Antagonist activity at OXR receptor in rat uterusAntagonist activity at OXR receptor in rat uterus
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 4004 None 22 Rat Functional pIC50 = 7.3 7.3 -3 4
Antagonist activity at OXR receptor in rat uterusAntagonist activity at OXR receptor in rat uterus
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
145957924 162187 None 0 Human Functional pIC50 = 5.2 5.2 -2 4
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C\c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
CHEMBL4161021 162187 None 0 Human Functional pIC50 = 5.2 5.2 -2 4
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C\c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
2213 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
3008 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
5311010 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
5311010.0 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
68613 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
68613.0 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
CHEMBL378642 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
CHEMBL382301 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
DB09059 518 None 30 Human Functional pIC50 = 7.2 7.2 -12 4
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL None None None None 10.1021/jm050645f
135469700 79102 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113203 79102 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 555 10 2 7 2.9 CN(C)CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145974527 164855 None 0 Human Functional pIC50 = 6.2 6.2 -67 2
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4217872 164855 None 0 Human Functional pIC50 = 6.2 6.2 -67 2
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 491 5 3 6 3.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=S)N(C)C 10.1021/acs.jmedchem.8b00697
11683187 202388 None 41 Human Functional pIC50 = 6.2 6.2 20 2
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
CHEMBL594828 202388 None 41 Human Functional pIC50 = 6.2 6.2 20 2
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced calcium release by Aequorin based assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
135192930 170879 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@H]3C[C@@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4452863 170879 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 429 6 0 7 3.4 COCc1nnc(N2C[C@H]3C[C@@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11683187 202388 None 41 Human Functional pIC50 = 7.2 7.2 20 2
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
CHEMBL594828 202388 None 41 Human Functional pIC50 = 7.2 7.2 20 2
Antagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assayAntagonist activity at human OTR receptor expressed in HEK293FT cells assessed as inhibition of LIT-001-induced response incubated for 30 mins by beta-arrestin recruitment assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acs.jmedchem.8b00697
2252 2230 None 35 Rat Functional pIC50 = 6.2 6.2 -141 4
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
6918320 2230 None 35 Rat Functional pIC50 = 6.2 6.2 -141 4
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
CHEMBL24781 2230 None 35 Rat Functional pIC50 = 6.2 6.2 -141 4
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00160-9
155537980 172437 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 397 5 0 8 2.2 COCc1nnc(N2CC3(C2)OCc2cc(F)ccc23)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4475530 172437 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 397 5 0 8 2.2 COCc1nnc(N2CC3(C2)OCc2cc(F)ccc23)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
145953024 162685 None 0 Human Functional pIC50 = 5.2 5.2 -15 5
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C/c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
CHEMBL4168948 162685 None 0 Human Functional pIC50 = 5.2 5.2 -15 5
Antagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence methodAntagonist activity at human OXTR expressed in CHOK1 cells assessed as oxytocin-induced beta-arrestin recruitment pre-incubated for 30 mins before oxytocin stimulation for 90 or 180 mins by chemiluminescence method
ChEMBL 886 20 2 10 3.4 CC[C@H](C)[C@@H](OC(=O)/C=C/c1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)OC 10.1021/acs.jmedchem.8b00885
9871105 98721 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 513 5 2 4 3.6 CC1(C)C2CCC1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(NC(=O)C1CCCNC1)C2 10.1021/jm970342o
CHEMBL277400 98721 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonistic activity against Oxytocin receptorAntagonistic activity against Oxytocin receptor
ChEMBL 513 5 2 4 3.6 CC1(C)C2CCC1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(NC(=O)C1CCCNC1)C2 10.1021/jm970342o
135476004 79092 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113185 79092 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
135414531 79107 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113208 79107 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
145970269 163677 None 0 Human Functional pIC50 = 6.1 6.1 -15 2
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
CHEMBL4203314 163677 None 0 Human Functional pIC50 = 6.1 6.1 -15 2
Antagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assayAntagonist activity at human OTR expressed in HEK cells assessed as inhibition of OT-induced intracellular calcium flux incubated for 45 mins by Indo1-AM dye based fluorescence assay
ChEMBL 475 5 3 6 2.5 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)NCC(=O)N(C)C 10.1021/acs.jmedchem.8b00697
135469685 79110 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113211 79110 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 542 10 2 7 3.0 COCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
135192948 175719 None 0 Human Functional pIC50 = 6.1 6.1 5 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 499 7 0 8 3.9 COc1ccc(-n2c(COC3CCOCC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
CHEMBL4580413 175719 None 0 Human Functional pIC50 = 6.1 6.1 5 2
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 499 7 0 8 3.9 COc1ccc(-n2c(COC3CCOCC3)nnc2N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)cn1 10.1021/acsmedchemlett.9b00186
135530164 79099 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113200 79099 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Inhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cellsInhibitory activity against human Oxytocin induced intracellular Calcium mobilization in human Oxytocin receptor transfected HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
155568614 176229 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)CC32)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4591943 176229 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 444 6 0 8 2.9 COCc1nnc(N2CC3CN(c4ccc(F)cc4Cl)CC32)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
11634973 75365 None 15 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/acsmedchemlett.9b00186
CHEMBL2037511 75365 None 15 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/acsmedchemlett.9b00186
135192932 171631 None 0 Human Functional pIC50 = 8.0 8.0 190 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 443 7 0 7 3.8 CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4464246 171631 None 0 Human Functional pIC50 = 8.0 8.0 190 4
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 443 7 0 7 3.8 CCOCc1nnc(N2C[C@@H]3C[C@]3(c3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
155565553 175711 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 446 7 0 8 2.9 COCc1nnc(N2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
CHEMBL4580192 175711 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assayAntagonist activity at human OTR expressed in HEK293 cells assessed as decrease in calcium flux measured after 10 mins in presence of vasopressin by Fluo-4 dye based microplate reader based assay
ChEMBL 446 7 0 8 2.9 COCc1nnc(N2CCN(Cc3ccc(F)cc3Cl)CC2)n1-c1ccc(OC)nc1 10.1021/acsmedchemlett.9b00186
14981575 78903 None 0 Rat Functional pKd = 9 9.0 58 3
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 valueIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112896 78903 None 0 Rat Functional pKd = 9 9.0 58 3
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 valueIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
10437668 78911 None 1 Rat Functional pKd = 8.9 8.9 41 3
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentrationIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentration
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112903 78911 None 1 Rat Functional pKd = 8.9 8.9 41 3
In vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentrationIn vitro antagonism of OT-induced uterine contractions, against rat uterus by measuring pA2 value which refers to the negative logarithm of the molar concentration
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL1790200 211345 None 0 Rat Functional pKd = 8.7 8.7 - 0
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm00087a009
16737618 96935 None 0 Rat Functional pKd = 8 8.0 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL265630 96935 None 0 Rat Functional pKd = 8 8.0 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL539918 218203 None 0 Rat Functional pKd = 7 7.0 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL435159 216123 None 0 Rat Functional pKd = 7 7.0 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL261938 212981 None 0 Rat Functional pKd = 7 7.0 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
44429299 169353 None 0 Rat Functional pKd = 7.9 7.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL441128 169353 None 0 Rat Functional pKd = 7.9 7.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429298 147542 None 0 Rat Functional pKd = 7.9 7.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393020 147542 None 0 Rat Functional pKd = 7.9 7.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736614 149125 None 0 Rat Functional pKd = 6.9 6.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL394268 149125 None 0 Rat Functional pKd = 6.9 6.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44429304 87299 None 0 Rat Functional pKd = 7.9 7.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233080 87299 None 0 Rat Functional pKd = 7.9 7.9 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL1790192 211343 None 0 Rat Functional pKd = 6.9 6.9 - 0
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm00087a009
CHEMBL2021547 211588 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL None None None C=C(C)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
45270786 198346 None 0 Rat Functional pKd = 6.8 6.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1168 18 12 13 0.8 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL558950 198346 None 0 Rat Functional pKd = 6.8 6.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1168 18 12 13 0.8 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL2367696 212044 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL None None None C=C(C)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42645836 194918 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL538934 194918 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
2192 2358 None 26 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
9690136 2358 None 26 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
CHEMBL1254024 2358 None 26 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 471 7 2 5 3.7 CO/N=C/1\CN([C@@H](C1)C(=O)NC[C@H](c1ccccc1)O)C(=O)c1ccc(cc1)c1ccccc1C 10.1021/jm901812z
44429288 88043 None 0 Rat Functional pKd = 7.8 7.8 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL234377 88043 None 0 Rat Functional pKd = 7.8 7.8 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429307 149123 None 0 Rat Functional pKd = 6.8 6.8 - 0
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394266 149123 None 0 Rat Functional pKd = 6.8 6.8 - 0
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44408817 138047 None 0 Rat Functional pKd = 6.8 6.8 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1050 17 9 14 -2.7 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC[C@@H](N)C(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL376412 138047 None 0 Rat Functional pKd = 6.8 6.8 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1050 17 9 14 -2.7 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC[C@@H](N)C(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL1790202 211346 None 0 Rat Functional pKd = 5.8 5.8 - 0
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)O)NC1=O 10.1021/jm00087a009
42645362 195878 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL541246 195878 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
42646319 195628 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1099 18 12 13 -0.9 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL540754 195628 None 0 Rat Functional pKd = 7.8 7.8 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1099 18 12 13 -0.9 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL1790198 211344 None 0 Rat Functional pKd = 7.8 7.8 - 0
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm00087a009
44429303 147543 None 0 Rat Functional pKd = 7.8 7.8 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393021 147543 None 0 Rat Functional pKd = 7.8 7.8 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44408952 156381 None 0 Rat Functional pKd = 6.7 6.7 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1103 17 8 13 0.1 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL406533 156381 None 0 Rat Functional pKd = 6.7 6.7 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1103 17 8 13 0.1 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSC2(CCCCC2)CC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL558740 218231 None 0 Rat Functional pKd = 5.6 5.6 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL None None None CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)C2(CCCCC2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL397407 214963 None 0 Rat Functional pKd = 5.6 5.6 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
16109438 96630 None 0 Human Functional pKd = 6.6 6.6 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL263090 96630 None 0 Human Functional pKd = 6.6 6.6 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1051 17 11 14 -1.0 NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
10461270 3678 None 12 Rat Functional pKd = 8.5 8.5 - 0
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 3678 None 12 Rat Functional pKd = 8.5 8.5 - 0
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 3678 None 12 Rat Functional pKd = 8.5 8.5 - 0
Antagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contractionAntagonist activity at oxytocin receptor in rat uterine strips assessed as inhibition of oxytocin-induced contraction
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
16736613 87381 None 0 Rat Functional pKd = 6.5 6.5 - 0
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233281 87381 None 0 Rat Functional pKd = 6.5 6.5 - 0
Antagonist activity in phenoxybenzamine-treated rat by Pressor assayAntagonist activity in phenoxybenzamine-treated rat by Pressor assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44408951 155323 None 0 Rat Functional pKd = 6.5 6.5 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1035 17 8 13 -1.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
CHEMBL402693 155323 None 0 Rat Functional pKd = 6.5 6.5 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1035 17 8 13 -1.6 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CSSCCC(=O)N2CCN(C(=O)[C@@H]2Cc2ccccc2)[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm058038f
16109437 84338 None 0 Human Functional pKd = 6.5 6.5 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL221485 84338 None 0 Human Functional pKd = 6.5 6.5 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1065 18 11 14 -0.6 NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
16737617 162027 None 0 Rat Functional pKd = 7.5 7.5 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL415418 162027 None 0 Rat Functional pKd = 7.5 7.5 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44429300 87053 None 0 Rat Functional pKd = 6.5 6.5 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL232501 87053 None 0 Rat Functional pKd = 6.5 6.5 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16736414 149124 None 0 Rat Functional pKd = 7.4 7.4 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394267 149124 None 0 Rat Functional pKd = 7.4 7.4 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL267214 213174 None 0 Rat Functional pKd = 6.4 6.4 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@](N)(CO)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
44429295 169053 None 0 Rat Functional pKd = 8.3 8.3 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL438849 169053 None 0 Rat Functional pKd = 8.3 8.3 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394411 214933 None 0 Rat Functional pKd = 7.4 7.4 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None CCOc1ccc(C[C@H]2NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16109444 161543 None 0 Human Functional pKd = 6.4 6.4 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL412742 161543 None 0 Human Functional pKd = 6.4 6.4 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1037 16 11 14 -1.3 NCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
16109439 137329 None 0 Human Functional pKd = 6.3 6.3 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375187 137329 None 0 Human Functional pKd = 6.3 6.3 - 0
Activity at OT receptor assessed as oxytocic activity in absence of magnesiumActivity at OT receptor assessed as oxytocic activity in absence of magnesium
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
16736613 87381 None 0 Rat Functional pKd = 8.3 8.3 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233281 87381 None 0 Rat Functional pKd = 8.3 8.3 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 991 19 11 13 -1.8 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
2213 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
3008 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
5311010 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
5311010.0 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
68613 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
68613.0 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
CHEMBL378642 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
CHEMBL382301 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
DB09059 518 None 30 Rat Functional pKd = 8.3 8.3 1 4
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
CHEMBL563952 218241 None 0 Rat Functional pKd = 7.3 7.3 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL None None None N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)NC2(Cc3ccccc3C2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
44409014 166204 None 0 Rat Functional pKd = 7.2 7.2 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1144 20 13 15 -2.8 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
CHEMBL425991 166204 None 0 Rat Functional pKd = 7.2 7.2 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1144 20 13 15 -2.8 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
45270785 197936 None 0 Rat Functional pKd = 6.2 6.2 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1197 20 13 14 -0.5 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL552946 197936 None 0 Rat Functional pKd = 6.2 6.2 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1197 20 13 14 -0.5 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
44429290 87403 None 0 Rat Functional pKd = 8.2 8.2 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233328 87403 None 0 Rat Functional pKd = 8.2 8.2 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
56668141 63208 None 0 Rat Functional pKd = 8.2 8.2 - 0
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 989 9 11 14 -2.8 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm00087a009
CHEMBL1790201 63208 None 0 Rat Functional pKd = 8.2 8.2 - 0
In vitro Oxytocin receptor antagonistic activity against rat uterine stripsIn vitro Oxytocin receptor antagonistic activity against rat uterine strips
ChEMBL 989 9 11 14 -2.8 CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm00087a009
42645836 194918 None 0 Rat Functional pKd = 7.2 7.2 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
CHEMBL538934 194918 None 0 Rat Functional pKd = 7.2 7.2 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1128 20 13 14 -2.2 N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](C(c2ccccc2)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1016/j.ejmech.2008.12.010
45267363 197973 None 0 Rat Functional pKd = 8.2 8.2 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1107 17 12 14 -1.2 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL553710 197973 None 0 Rat Functional pKd = 8.2 8.2 - 0
Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+Antagonist activity at oxytocin receptor in Wistar rat uterus assessed as inhibition of oxytocin-induced uterotonic activity treated 1 min prior to oxytocin challenge in absence of Mg2+
ChEMBL 1107 17 12 14 -1.2 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1016/j.ejmech.2008.12.010
CHEMBL415417 215648 None 0 Rat Functional pKd = 6.1 6.1 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(C)(C)C)C(=O)NCC(N)=O 10.1016/j.ejmech.2006.12.016
44408750 156704 None 0 Rat Functional pKd = 6.1 6.1 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1213 20 13 15 -1.0 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
CHEMBL406896 156704 None 0 Rat Functional pKd = 6.1 6.1 - 0
Uterotonic activity against OT receptor in Wistar rat in absence of magnesiumUterotonic activity against OT receptor in Wistar rat in absence of magnesium
ChEMBL 1213 20 13 15 -1.0 NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(c2ccccc2)c2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm058038f
44429294 168422 None 0 Rat Functional pKd = 8.1 8.1 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL434193 168422 None 0 Rat Functional pKd = 8.1 8.1 - 1
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44429307 149123 None 0 Rat Functional pKd = 8.1 8.1 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL394266 149123 None 0 Rat Functional pKd = 8.1 8.1 - 0
Antagonist activity in rat uterus by uterotonic assayAntagonist activity in rat uterus by uterotonic assay
ChEMBL 1003 18 10 13 -1.7 CCc1ccc(C[C@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
46225048 204270 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 415 5 0 7 3.6 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cc(F)cc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL606976 204270 None 0 Human Functional pKi = 9.4 9.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 415 5 0 7 3.6 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cc(F)cc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
42611262 180665 None 0 Human Functional pKi = 9.1 9.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL475395 180665 None 0 Human Functional pKi = 9.1 9.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
11848692 178635 None 1 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 396 4 0 7 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(-c3cccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL466762 178635 None 1 Human Functional pKi = 9 9.0 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 396 4 0 7 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(-c3cccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
2202 2761 None 30 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
9895468 2761 None 30 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
CHEMBL582857 2761 None 30 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
DB12643 2761 None 30 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 629 8 1 9 2.9 COc1cc(OC)ccc1S(=O)(=O)N1c2ccc(cc2[C@@](C1=O)(N1C[C@@H](C[C@H]1C(=O)N(C)C)O)c1ccccc1OC)Cl 10.1016/j.bmcl.2010.11.061
11465834 138509 None 0 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 138509 None 0 Human Functional pKi = 8.8 8.8 - 1
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
44581242 175991 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458635 175991 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 475 8 0 6 4.9 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44571488 183928 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 396 6 0 3 5.0 N#Cc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL480584 183928 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 396 6 0 3 5.0 N#Cc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571389 184171 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL482322 184171 None 0 Human Functional pKi = 6 6.0 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
71452693 78694 None 0 Human Functional pKi = 6 6.0 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 711 8 6 7 2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL2112376 78694 None 0 Human Functional pKi = 6 6.0 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 711 8 6 7 2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
44579401 187203 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 354 7 0 7 3.2 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL491422 187203 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 354 7 0 7 3.2 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46830094 8436 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 392 7 0 6 3.5 COCCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093599 8436 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 392 7 0 6 3.5 COCCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46881861 8274 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092499 8274 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
46225023 201999 None 1 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592250 201999 None 1 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3)CC2)cn1 10.1016/j.bmcl.2009.11.097
46884439 8405 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 378 7 0 6 3.1 COCCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093365 8405 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 378 7 0 6 3.1 COCCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
45271574 199032 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 374 5 0 8 3.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL563905 199032 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 374 5 0 8 3.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
44572048 189623 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(-c2ccccc2)ccc1C(=O)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL514031 189623 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 349 6 0 2 4.7 Cc1cc(-c2ccccc2)ccc1C(=O)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
46884437 7741 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 348 5 0 5 3.5 CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1089025 7741 None 0 Human Functional pKi = 6.9 6.9 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 348 5 0 5 3.5 CCN(C(=O)c1cnc(-c2ccccc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46844643 5605 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2cccc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1077300 5605 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2cccc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
46830095 8265 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 376 5 0 5 4.2 COc1ccc(N(C(=O)c2cnc(-c3cccc(C)c3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1092459 8265 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 376 5 0 5 4.2 COc1ccc(N(C(=O)c2cnc(-c3cccc(C)c3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
11475469 178899 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 413 6 0 9 3.1 COCc1nnc(-c2cnc(-c3ccc(C#N)cc3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL469005 178899 None 0 Human Functional pKi = 7.9 7.9 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 413 6 0 9 3.1 COCc1nnc(-c2cnc(-c3ccc(C#N)cc3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
45271580 197299 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3cccc(F)c3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL549494 197299 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3cccc(F)c3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
4353841 189383 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 341 4 0 4 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2008.06.098
CHEMBL511908 189383 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 341 4 0 4 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3)cc2)cc1 10.1016/j.bmcl.2008.06.098
44579400 187202 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 324 5 0 6 3.4 CCOc1ccc(-c2nnc(C)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL491421 187202 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 324 5 0 6 3.4 CCOc1ccc(-c2nnc(C)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
44579441 186933 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 374 7 0 7 3.5 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1Cl 10.1016/j.bmcl.2008.08.066
CHEMBL489386 186933 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 374 7 0 7 3.5 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1Cl 10.1016/j.bmcl.2008.08.066
44571386 184172 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 403 6 0 2 5.6 Cc1cc(F)ccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL482323 184172 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 403 6 0 2 5.6 Cc1cc(F)ccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
46884438 7742 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.9 COc1ccc(N(C(=O)c2cnc(-c3ccccc3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1089026 7742 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.9 COc1ccc(N(C(=O)c2cnc(-c3ccccc3C)cn2)C(C)C)cn1 10.1016/j.bmcl.2010.02.018
46881859 8272 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092497 8272 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 345 4 0 4 2.9 COc1ccc(N(C)C(=O)N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
44577937 178687 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 7 0 7 4.2 COCc1nnc(-c2ccc(-c3ccccc3OC)cc2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL467185 178687 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 7 0 7 4.2 COCc1nnc(-c2ccc(-c3ccccc3OC)cc2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
44577939 189299 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 406 6 0 8 3.4 COCc1nnc(-c2cnc(-c3ccc(F)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511265 189299 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 406 6 0 8 3.4 COCc1nnc(-c2cnc(-c3ccc(F)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
11667812 202343 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL594591 202343 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
11667812 202343 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL594591 202343 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2010.01.143
46225080 202070 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 413 7 0 8 2.9 COCc1nnc(N2CC[C@@H](Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592732 202070 None 0 Human Functional pKi = 7.8 7.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 413 7 0 8 2.9 COCc1nnc(N2CC[C@@H](Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46225049 203601 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 351 5 0 7 2.6 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL603205 203601 None 0 Human Functional pKi = 6.8 6.8 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 351 5 0 7 2.6 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
46225153 201567 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 399 7 0 8 2.5 COCc1nnc(N2CC(Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL589128 201567 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 399 7 0 8 2.5 COCc1nnc(N2CC(Oc3ccc(F)cc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
11486351 193086 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 398 10 0 8 3.2 CCOc1ccc(-c2nnc(COCCOC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL522255 193086 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 398 10 0 8 3.2 CCOc1ccc(-c2nnc(COCCOC)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46881932 7788 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1089391 7788 None 0 Human Functional pKi = 7.7 7.7 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cccc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
44579402 192761 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 408 7 0 7 3.9 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C(F)(F)F 10.1016/j.bmcl.2008.08.066
CHEMBL521789 192761 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 408 7 0 7 3.9 CCOc1ccc(-c2nnc(COC)n2-c2ccc(OC)nc2)cc1C(F)(F)F 10.1016/j.bmcl.2008.08.066
45268188 198668 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 406 6 0 9 4.0 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3SC)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL561520 198668 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 406 6 0 9 4.0 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3SC)cn2)cn1 10.1016/j.bmcl.2009.03.160
44571492 184074 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL481730 184074 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ncccc2C(F)(F)F)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
5002508 176165 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 460 6 0 5 4.4 COc1ccc(N(Cc2cc3cccc4c3n(c2=O)CCC4)S(=O)(=O)c2ccccc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL459073 176165 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 460 6 0 5 4.4 COc1ccc(N(Cc2cc3cccc4c3n(c2=O)CCC4)S(=O)(=O)c2ccccc2)cc1 10.1016/j.bmcl.2008.11.018
44572047 180813 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 360 6 0 3 4.3 N#Cc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL475561 180813 None 0 Human Functional pKi = 5.7 5.7 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 360 6 0 3 4.3 N#Cc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
53325929 56787 None 0 Human Functional pKi = 4.7 4.7 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 537 11 1 7 5.8 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCc4ccoc4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643590 56787 None 0 Human Functional pKi = 4.7 4.7 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 537 11 1 7 5.8 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCc4ccoc4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
44577982 178743 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 378 4 0 7 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL467545 178743 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 378 4 0 7 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2008.06.098
11502419 202030 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 409 7 0 8 3.2 COCc1nnc(N2CCC(Oc3ccccc3C)CC2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592495 202030 None 0 Human Functional pKi = 8.7 8.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 409 7 0 8 3.2 COCc1nnc(N2CCC(Oc3ccccc3C)CC2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
11618185 203504 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cccc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL602545 203504 None 0 Human Functional pKi = 8.6 8.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3cccc(F)c3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
15548578 78696 None 0 Human Functional pKi = 8.6 8.6 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 742 12 8 8 1.8 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL2112378 78696 None 0 Human Functional pKi = 8.6 8.6 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 742 12 8 8 1.8 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
2252 2230 None 35 Human Functional pKi = 7.7 7.7 141 4
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/j.bmcl.2008.06.098
6918320 2230 None 35 Human Functional pKi = 7.7 7.7 141 4
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/j.bmcl.2008.06.098
CHEMBL24781 2230 None 35 Human Functional pKi = 7.7 7.7 141 4
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/j.bmcl.2008.06.098
44578010 189288 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3ccc(C)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511215 189288 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3ccc(C)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46225082 202071 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL592733 202071 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884440 8406 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 352 4 0 5 3.3 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1093366 8406 None 0 Human Functional pKi = 6.7 6.7 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 352 4 0 5 3.3 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
45272485 198885 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 394 5 0 8 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL562946 198885 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 394 5 0 8 3.9 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
46883884 8402 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 312 4 0 5 3.1 COc1ccc2oc(C(=O)N(C)c3ccc(OC)nc3)cc2c1 10.1016/j.bmcl.2010.02.018
CHEMBL1093340 8402 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 312 4 0 5 3.1 COc1ccc2oc(C(=O)N(C)c3ccc(OC)nc3)cc2c1 10.1016/j.bmcl.2010.02.018
44577983 178744 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 6 0 8 4.5 CCSc1ccc(-c2cnc(-c3nnc(C)n3-c3ccc(OC)nc3)cn2)c(C)c1 10.1016/j.bmcl.2008.06.098
CHEMBL467546 178744 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 6 0 8 4.5 CCSc1ccc(-c2cnc(-c3nnc(C)n3-c3ccc(OC)nc3)cn2)c(C)c1 10.1016/j.bmcl.2008.06.098
46881860 8273 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 363 4 0 4 3.0 COc1ccc(N(C)C(=O)N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1092498 8273 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 363 4 0 4 3.0 COc1ccc(N(C)C(=O)N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
46830096 7998 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.8 CCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1090654 7998 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 362 5 0 5 3.8 CCN(C(=O)c1cnc(-c2cccc(C)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46883886 8404 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 328 7 0 4 3.6 CCN(C(=O)COc1ccc(C(C)C)cc1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093342 8404 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 328 7 0 4 3.6 CCN(C(=O)COc1ccc(C(C)C)cc1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
53316694 56782 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 1 6 5.7 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643585 56782 None 0 Human Functional pKi = 5.6 5.6 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 1 6 5.7 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
53316695 56784 None 0 Human Functional pKi = 4.6 4.6 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 527 10 1 6 6.1 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643587 56784 None 0 Human Functional pKi = 4.6 4.6 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 527 10 1 6 6.1 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC(C)(C)C)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
45270760 197324 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 390 6 0 9 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3OC)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL549633 197324 None 0 Human Functional pKi = 6.6 6.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 390 6 0 9 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3OC)cn2)cn1 10.1016/j.bmcl.2009.03.160
15548579 111671 None 0 Human Functional pKi = 7.6 7.6 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL328348 111671 None 0 Human Functional pKi = 7.6 7.6 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
44579399 187268 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.08.066
CHEMBL492029 187268 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 368 8 0 7 3.6 CCOCc1nnc(-c2ccc(OCC)c(C)c2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.08.066
11574636 201566 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL589125 201566 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
11574636 201566 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL589125 201566 None 0 Human Functional pKi = 7.6 7.6 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 389 5 0 7 3.0 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
46225079 201708 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL590097 201708 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 395 7 0 8 2.8 COCc1nnc(N2CC[C@@H](Oc3ccccc3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884480 8264 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 5 0 5 3.7 CCN(C(=O)c1cnc(-c2cccc(F)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1092458 8264 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 5 0 5 3.7 CCN(C(=O)c1cnc(-c2cccc(F)c2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44577873 189554 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 494 6 1 6 2.0 Cc1nc(C(C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2008.06.098
CHEMBL513488 189554 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 494 6 1 6 2.0 Cc1nc(C(C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2008.06.098
44571491 184053 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 367 6 0 2 4.8 Cc1cc(F)ccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL481569 184053 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 367 6 0 2 4.8 Cc1cc(F)ccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44572003 189744 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccccc2Cl)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL514975 189744 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccccc2Cl)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44581241 175990 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458634 175990 None 0 Human Functional pKi = 8.5 8.5 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
11488952 77613 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
CHEMBL208787 77613 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assayAntagonist activity against human OTR expressed in CHO cells measured as calcium influx by FLIPR assay
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
46225083 202303 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 337 5 0 7 2.2 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL594361 202303 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 337 5 0 7 2.2 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3)C2)cn1 10.1016/j.bmcl.2009.11.097
44215484 178685 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1016/j.bmcl.2008.06.098
CHEMBL467154 178685 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 440 7 0 6 4.6 Cc1nnc(-c2ccc(-c3ccccc3)cc2)n1-c1ccccc1OCCN1CCOCC1 10.1016/j.bmcl.2008.06.098
46225051 201892 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 383 5 0 7 3.1 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL591310 201892 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 383 5 0 7 3.1 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccc(F)cc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
44571529 189809 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL515447 189809 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 404 6 0 3 4.8 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
45483204 200343 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL1204126 200343 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL1204403 200343 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
CHEMBL572709 200343 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 619 11 1 7 4.6 COc1ccc(S(=O)(=O)N2c3ccccc3CCC2CCS(=O)(=O)N2CCC(NCC3CCCCC3)CC2)c(OC)c1 10.1016/j.bmcl.2010.11.061
44572105 172550 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 336 6 0 3 3.8 O=C(c1ccc(-c2ccccc2)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL447916 172550 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 336 6 0 3 3.8 O=C(c1ccc(-c2ccccc2)nc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571489 192393 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 372 6 0 3 4.6 O=C(c1ccc(-c2ccccc2)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL520595 192393 None 0 Human Functional pKi = 5.5 5.5 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 372 6 0 3 4.6 O=C(c1ccc(-c2ccccc2)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
46225117 201749 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 401 7 0 8 2.7 COCc1nnc(N2CC(Oc3ccccc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL590349 201749 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 401 7 0 8 2.7 COCc1nnc(N2CC(Oc3ccccc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46225050 202069 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592731 202069 None 0 Human Functional pKi = 7.5 7.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 365 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC[C@@H](Oc3ccccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
16062053 195098 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL539665 195098 None 0 Human Functional pKi = 6.5 6.5 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 360 5 0 8 3.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccccc3)cn2)cn1 10.1016/j.bmcl.2009.03.160
46881890 8451 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 377 5 0 4 3.4 CCN(C(=O)N1CC(Oc2cc(F)cc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1093744 8451 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 377 5 0 4 3.4 CCN(C(=O)N1CC(Oc2cc(F)cc(F)c2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
45272491 198981 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 428 5 0 8 4.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(Cl)cc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL563613 198981 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 428 5 0 8 4.5 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(Cl)cc3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
44572107 180036 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(C(=O)N(Cc2ccccc2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL474621 180036 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(C(=O)N(Cc2ccccc2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
46884478 8492 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 373 5 0 6 3.4 CCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1094002 8492 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 373 5 0 6 3.4 CCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
53317994 56783 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 0 6 5.8 CCN(CC)Cc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643586 56783 None 0 Human Functional pKi = 5.4 5.4 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 11 0 6 5.8 CCN(CC)Cc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
11384094 178688 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3cccc(C)c3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL467186 178688 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 402 6 0 8 3.6 COCc1nnc(-c2cnc(-c3cccc(C)c3C)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
15548579 111671 None 0 Human Functional pKi = 8.4 8.4 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
CHEMBL328348 111671 None 0 Human Functional pKi = 8.4 8.4 - 0
In vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell lineIn vivo antagonistic activity against cloned human oxytocin receptor over-expressed in a stable HEK293 cell line
ChEMBL 728 11 8 8 1.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCCSC[C@H](CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O 10.1016/s0960-894x(99)00478-3
11538526 202029 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccc(F)cc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592494 202029 None 0 Human Functional pKi = 8.4 8.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 397 5 0 7 3.5 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccc(F)cc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
46225118 203509 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)ccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL602641 203509 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 369 5 0 7 2.7 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)ccc3C)C2)cn1 10.1016/j.bmcl.2009.11.097
46883829 8455 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 1 4 3.5 CCN(C(=O)c1cc(-c2ccc(C)cc2)n[nH]1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093776 8455 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 1 4 3.5 CCN(C(=O)c1cc(-c2ccc(C)cc2)n[nH]1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46881892 8157 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 387 5 0 7 2.8 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1091817 8157 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 387 5 0 7 2.8 COc1ccc(-n2c(C)nnc2N2CC(Oc3cc(F)cc(F)c3C)C2)cn1 10.1016/j.bmcl.2010.01.143
44577938 189415 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 374 6 0 8 2.9 COCc1nnc(-c2cnc(-c3ccccc3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL512257 189415 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 374 6 0 8 2.9 COCc1nnc(-c2cnc(-c3ccccc3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46844644 8500 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2ccc(F)cc2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1094050 8500 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 359 5 0 4 3.2 CCN(C(=O)N1CC(Oc2ccc(F)cc2C)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
46884479 8263 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 403 7 0 7 3.0 COCCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1092457 8263 None 0 Human Functional pKi = 6.4 6.4 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 403 7 0 7 3.0 COCCN(C(=O)c1cnc(-c2ccc(C#N)cc2C)cn1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44579442 186934 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 391 7 0 9 2.7 CCOc1ccc(-c2nnc(Cn3nccn3)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
CHEMBL489387 186934 None 0 Human Functional pKi = 7.4 7.4 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 391 7 0 9 2.7 CCOc1ccc(-c2nnc(Cn3nccn3)n2-c2ccc(OC)nc2)cc1C 10.1016/j.bmcl.2008.08.066
46883887 7773 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 6 0 4 3.7 CCN(C(=O)COc1ccc2ccccc2c1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1089272 7773 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 6 0 4 3.7 CCN(C(=O)COc1ccc2ccccc2c1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46881891 8498 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 379 5 0 4 3.6 CCN(C(=O)N1CC(Oc2ccc(F)cc2Cl)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
CHEMBL1094049 8498 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 379 5 0 4 3.6 CCN(C(=O)N1CC(Oc2ccc(F)cc2Cl)C1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.01.143
11625088 202028 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 379 5 0 7 3.3 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL592493 202028 None 0 Human Functional pKi = 8.3 8.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 379 5 0 7 3.3 COc1ccc(-n2c(C)nnc2N2CCC(Oc3ccccc3C)CC2)cn1 10.1016/j.bmcl.2009.11.097
46225081 204686 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 431 7 0 8 3.1 COCc1nnc(N2CC[C@@H](Oc3cc(F)cc(F)c3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL609848 204686 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 431 7 0 8 3.1 COCc1nnc(N2CC[C@@H](Oc3cc(F)cc(F)c3C)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
44186995 197605 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 5 0 8 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(C)cccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL550244 197605 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 5 0 8 3.8 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(C)cccc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
44577874 178684 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 6 3.6 CO/N=C1/C[C@H](c2ncno2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1016/j.bmcl.2008.06.098
CHEMBL467153 178684 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 6 3.6 CO/N=C1/C[C@H](c2ncno2)N(C(=O)c2ccc(-c3ccccc3C)cc2)C1 10.1016/j.bmcl.2008.06.098
4017619 180509 None 18 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 335 6 0 2 4.4 O=C(c1ccc(-c2ccccc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL475207 180509 None 18 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 335 6 0 2 4.4 O=C(c1ccc(-c2ccccc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
50941635 56781 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 12 1 6 5.8 CCCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643584 56781 None 0 Human Functional pKi = 5.3 5.3 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 513 12 1 6 5.8 CCCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
53324622 56788 None 0 Human Functional pKi = 4.3 4.3 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 577 12 1 7 6.3 COc1ccc(CNCc2ccc(-c3nc(CN(C4CCCC4)S(=O)(=O)c4ccc(OC)cc4)cs3)cc2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643591 56788 None 0 Human Functional pKi = 4.3 4.3 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 577 12 1 7 6.3 COc1ccc(CNCc2ccc(-c3nc(CN(C4CCCC4)S(=O)(=O)c4ccc(OC)cc4)cs3)cc2)cc1 10.1016/j.bmcl.2010.11.061
45269934 197752 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 6 0 8 3.8 CCc1ccccc1Oc1cnc(-c2nnc(C)n2-c2ccc(OC)nc2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL551395 197752 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 388 6 0 8 3.8 CCc1ccccc1Oc1cnc(-c2nnc(C)n2-c2ccc(OC)nc2)cn1 10.1016/j.bmcl.2009.03.160
44577984 189384 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 7 0 9 3.3 COCc1nnc(-c2cnc(-c3ccc(OC)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
CHEMBL511917 189384 None 0 Human Functional pKi = 6.3 6.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 418 7 0 9 3.3 COCc1nnc(-c2cnc(-c3ccc(OC)c(C)c3)cn2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2008.06.098
46225116 201709 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 371 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL590099 201709 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 371 5 0 7 2.9 COc1ccc(-n2c(C)nnc2N2CC(Oc3ccccc3Cl)C2)cn1 10.1016/j.bmcl.2009.11.097
44577936 178686 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 371 5 0 5 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cc1 10.1016/j.bmcl.2008.06.098
CHEMBL467184 178686 None 0 Human Functional pKi = 7.3 7.3 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 371 5 0 5 4.9 COc1ccc(-n2c(C)nnc2-c2ccc(-c3ccccc3OC)cc2)cc1 10.1016/j.bmcl.2008.06.098
11257380 178719 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.11.097
CHEMBL467378 178719 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.11.097
11257380 178719 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2008.06.098
CHEMBL467378 178719 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2008.06.098
11257380 178719 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL467378 178719 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 376 4 0 7 3.6 COc1ccc(-n2c(C)nnc2-c2cnc(-c3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
135461089 187173 None 4 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 478 8 2 6 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccccc2)cc1 10.1016/j.bmcl.2008.08.066
CHEMBL491224 187173 None 4 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human oxytocin receptor by cell based beta-lactamase reporter gene assay
ChEMBL 478 8 2 6 2.8 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccccc2)cc1 10.1016/j.bmcl.2008.08.066
44581240 189833 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL515660 189833 None 0 Human Functional pKi = 8.2 8.2 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
46884441 8407 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 359 4 0 6 3.0 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(C#N)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1093367 8407 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 359 4 0 6 3.0 COc1ccc(N(C)C(=O)c2cnc(-c3ccc(C#N)cc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
44571387 184170 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 401 7 0 3 5.2 COc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL482321 184170 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 401 7 0 3 5.2 COc1ccccc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44572045 189760 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 365 7 0 3 4.4 COc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL515111 189760 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 365 7 0 3 4.4 COc1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44572046 179701 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 413 7 0 4 3.8 CS(=O)(=O)c1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL474219 179701 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 413 7 0 4 3.8 CS(=O)(=O)c1ccccc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571388 192698 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(-c2ccccc2)ccc1C(=O)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL521444 192698 None 0 Human Functional pKi = 6.2 6.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 385 6 0 2 5.5 Cc1cc(-c2ccccc2)ccc1C(=O)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571530 180022 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 379 7 0 3 4.7 COc1ccc(C)cc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL474609 180022 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 379 7 0 3 4.7 COc1ccc(C)cc1-c1ccc(C(=O)N(CC2CC2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
44571490 184052 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 415 7 0 3 5.5 COc1ccc(C)cc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
CHEMBL481568 184052 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 415 7 0 3 5.5 COc1ccc(C)cc1-c1ccc(C(=O)N(Cc2ccccc2)CC2CCCO2)cc1 10.1016/j.bmcl.2008.11.064
53323297 56785 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 499 11 1 6 5.5 CCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643588 56785 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 499 11 1 6 5.5 CCCNCc1ccc(-c2nc(CN(C3CCCC3)S(=O)(=O)c3ccc(OC)cc3)cs2)cc1 10.1016/j.bmcl.2010.11.061
53323298 56786 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 553 11 1 6 6.6 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC4CCCCC4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
CHEMBL1643589 56786 None 0 Human Functional pKi = 5.2 5.2 - 0
Antagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM stainingAntagonist activity at recombinant oxytocin receptor expressed in CHO cells assessed as inhibition of vasopressin-induced calcium release after 10 mins by Fluo4-AM staining
ChEMBL 553 11 1 6 6.6 COc1ccc(S(=O)(=O)N(Cc2csc(-c3ccc(CNCC4CCCCC4)cc3)n2)C2CCCC2)cc1 10.1016/j.bmcl.2010.11.061
46881862 7940 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 365 4 0 4 3.2 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
CHEMBL1090417 7940 None 0 Human Functional pKi = 7.2 7.2 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assayAntagonist activity at human oxytocin receptor expressed in CHO cells by beta lactamase assay
ChEMBL 365 4 0 4 3.2 COc1ccc(N(C)C(=O)N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1016/j.bmcl.2010.01.143
44572103 179431 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2cccc(Cl)c2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL473442 179431 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2cccc(Cl)c2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44581266 175499 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL457544 175499 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human recombinant oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 479 8 0 6 4.7 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3F)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44572104 179432 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccc(Cl)cc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL473443 179432 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 369 6 0 2 5.0 O=C(c1ccc(-c2ccc(Cl)cc2)cc1)N(CC1CC1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
44571429 183921 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
CHEMBL480546 183921 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assayAntagonist activity at human oxytocin receptor expressed in CHO cells by FLIPR assay
ChEMBL 440 6 0 3 5.6 O=C(c1ccc(-c2ccccc2C(F)(F)F)nc1)N(Cc1ccccc1)CC1CCCO1 10.1016/j.bmcl.2008.11.064
10437668 78911 None 1 Human Functional pKi = 8.1 8.1 - 3
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmcl.2008.06.098
CHEMBL2112903 78911 None 1 Human Functional pKi = 8.1 8.1 - 3
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmcl.2008.06.098
45268191 199203 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 430 5 0 8 4.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(F)ccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL565189 199203 None 0 Human Functional pKi = 8.1 8.1 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 430 5 0 8 4.2 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3c(F)ccc(F)c3Cl)cn2)cn1 10.1016/j.bmcl.2009.03.160
46883925 8447 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 379 6 1 5 3.1 CCN(C(=O)c1ccc(-c2ccc(OC)cc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093709 8447 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 379 6 1 5 3.1 CCN(C(=O)c1ccc(-c2ccc(OC)cc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
44577981 189400 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 369 5 0 8 2.8 COCc1nnc(-c2cnc(-c3cccc(C#N)c3)cn2)n1-c1cccnc1 10.1016/j.bmcl.2008.06.098
CHEMBL512105 189400 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase reporter assay
ChEMBL 369 5 0 8 2.8 COCc1nnc(-c2cnc(-c3cccc(C#N)c3)cn2)n1-c1cccnc1 10.1016/j.bmcl.2008.06.098
46883830 7694 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 0 5 3.3 CCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1088765 7694 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 336 5 0 5 3.3 CCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46883885 8403 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 326 5 0 5 3.5 CCN(C(=O)c1cc2cc(OC)ccc2o1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1093341 8403 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 326 5 0 5 3.5 CCN(C(=O)c1cc2cc(OC)ccc2o1)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
45273367 199008 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
CHEMBL563771 199008 None 0 Human Functional pKi = 8.0 8.0 - 0
Antagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta-lactamase assay
ChEMBL 392 5 0 8 3.7 COc1ccc(-n2c(C)nnc2-c2cnc(Oc3ccc(F)cc3C)cn2)cn1 10.1016/j.bmcl.2009.03.160
11683187 202388 None 41 Human Functional pKi = 8.0 8.0 20 2
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
CHEMBL594828 202388 None 41 Human Functional pKi = 8.0 8.0 20 2
Antagonist activity at human cloned oxytocin receptor by cell based beta lactamase assayAntagonist activity at human cloned oxytocin receptor by cell based beta lactamase assay
ChEMBL 419 7 0 8 2.9 COCc1nnc(N2CC(Oc3ccc(F)cc3Cl)C2)n1-c1ccc(OC)nc1 10.1016/j.bmcl.2009.11.097
46884413 8198 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 318 4 0 3 4.0 COc1ccc(N(C)C(=O)c2ccc(-c3ccccc3)cc2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1092098 8198 None 0 Human Functional pKi = 7.1 7.1 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 318 4 0 3 4.0 COc1ccc(N(C)C(=O)c2ccc(-c3ccccc3)cc2)cn1 10.1016/j.bmcl.2010.02.018
46883832 7696 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 6 0 6 3.3 CCN(C(=O)c1cnn(-c2ccc(OC)cc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1088767 7696 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 6 0 6 3.3 CCN(C(=O)c1cnn(-c2ccc(OC)cc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46884414 7840 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 334 4 0 5 3.1 COc1ccc(N(C)C(=O)c2cnc(-c3ccccc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
CHEMBL1089682 7840 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 334 4 0 5 3.1 COc1ccc(N(C)C(=O)c2cnc(-c3ccccc3C)cn2)cn1 10.1016/j.bmcl.2010.02.018
46883888 8141 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 349 5 1 4 3.1 CCN(C(=O)c1ccc(-c2ccccc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1091770 8141 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 349 5 1 4 3.1 CCN(C(=O)c1ccc(-c2ccccc2)[nH]c1=O)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
46883831 7695 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 7 0 6 2.9 COCCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
CHEMBL1088766 7695 None 0 Human Functional pKi = 7.0 7.0 - 0
Antagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assayAntagonist activity at human cloned OT receptor by cell based beta-lactamase reporter gene assay
ChEMBL 366 7 0 6 2.9 COCCN(C(=O)c1cnn(-c2ccccc2)c1C)c1ccc(OC)nc1 10.1016/j.bmcl.2010.02.018
11169 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
131676677 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
165708555 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
165708555.0 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
16681432 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
16681432.0 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
495 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
CHEMBL3301668 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
DB01282 797 None 33 Mouse Functional pEC50 = 7.2 7.2 -10 5
Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.Agonist activity at MmOT receptor expressed in HEK293FT cells assessed as stimulation of calcium release by Aequorin based assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
11169 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
131676677 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
165708555 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
165708555.0 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
16681432 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
16681432.0 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
495 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
CHEMBL3301668 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
DB01282 797 None 33 Human Functional pEC50 = 8 8.0 1 5
Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.Agonist activity at hOT receptor receptor expressed in HEK293FT cells by beta-arrestin recruitment assay.
Guide to Pharmacology None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 30199637
2255 2608 None 0 Human Functional pIC50 None 7.1 7.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17316912
2256 2609 None 0 Human Functional pIC50 None 7.3 7.3 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17316912
2254 2610 None 0 Human Functional pIC50 None 7.6 7.6 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 17316912




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

118719819 115807 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 20 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353930 115807 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 20 11 14 -2.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719821 115809 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 19 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353932 115809 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1005 19 11 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719828 115816 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1019 19 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353939 115816 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1019 19 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719829 115817 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 23 11 14 -1.1 CCCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353940 115817 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 23 11 14 -1.1 CCCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719835 115823 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353946 115823 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719837 115825 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1059 20 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353948 115825 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1059 20 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719845 115833 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1047 20 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353956 115833 None 0 Human Binding pEC50 = 11 11.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1047 20 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720268 115905 None 0 Human Binding pEC50 = 11 11.0 - 1
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354579 115905 None 0 Human Binding pEC50 = 11 11.0 - 1
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155560248 175150 None 0 Human Binding pEC50 = 11.0 11.0 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 175150 None 0 Human Binding pEC50 = 11.0 11.0 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542264 173197 None 0 Human Binding pEC50 = 10.9 10.9 - 0
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 173197 None 0 Human Binding pEC50 = 10.9 10.9 - 0
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118719844 115832 None 0 Human Binding pEC50 = 10.7 10.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccncc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353955 115832 None 0 Human Binding pEC50 = 10.7 10.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccncc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720260 115897 None 0 Human Binding pEC50 = 10.7 10.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1061 21 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2cccs2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354571 115897 None 0 Human Binding pEC50 = 10.7 10.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1061 21 11 15 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2cccs2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720282 115918 None 0 Human Binding pEC50 = 10.7 10.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354592 115918 None 0 Human Binding pEC50 = 10.7 10.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719831 115819 None 0 Human Binding pEC50 = 10.5 10.5 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 11 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353942 115819 None 0 Human Binding pEC50 = 10.5 10.5 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 11 15 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720278 115914 None 0 Human Binding pEC50 = 10.4 10.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354588 115914 None 0 Human Binding pEC50 = 10.4 10.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720284 115921 None 0 Human Binding pEC50 = 10.4 10.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354595 115921 None 0 Human Binding pEC50 = 10.4 10.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
44232512 115923 None 0 Human Binding pEC50 = 10.4 10.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354597 115923 None 0 Human Binding pEC50 = 10.4 10.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719818 115806 None 0 Human Binding pEC50 = 10.3 10.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 19 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353929 115806 None 0 Human Binding pEC50 = 10.3 10.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 19 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720279 115915 None 0 Human Binding pEC50 = 10.3 10.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354589 115915 None 0 Human Binding pEC50 = 10.3 10.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1023 20 11 13 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720286 115924 None 0 Human Binding pEC50 = 10.3 10.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354598 115924 None 0 Human Binding pEC50 = 10.3 10.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 21 11 13 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
171345673 194441 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1221 21 18 21 -9.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5286119 194441 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1221 21 18 21 -9.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
118719820 115808 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 21 11 14 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353931 115808 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 21 11 14 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719824 115812 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 11 14 -3.1 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
CHEMBL3353935 115812 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 11 14 -3.1 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](O)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
118719838 115826 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1071 21 11 15 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(OC)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353949 115826 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1071 21 11 15 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(OC)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720261 115898 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 20 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CCCO2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354572 115898 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1035 20 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CC2CCCO2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720277 115913 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 988 22 10 12 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354587 115913 None 0 Human Binding pEC50 = 10.2 10.2 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 988 22 10 12 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720281 115917 None 0 Human Binding pEC50 = 10.1 10.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354591 115917 None 0 Human Binding pEC50 = 10.1 10.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1038 20 11 13 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
76073634 115920 None 5 Human Binding pEC50 = 10.1 10.1 - 1
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354594 115920 None 5 Human Binding pEC50 = 10.1 10.1 - 1
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720274 115910 None 0 Human Binding pEC50 = 10.1 10.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354584 115910 None 0 Human Binding pEC50 = 10.1 10.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720288 115926 None 0 Human Binding pEC50 = 10.1 10.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354600 115926 None 0 Human Binding pEC50 = 10.1 10.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
449224 169078 None 10 Human Binding pEC50 = 10 10.0 - 1
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL439044 169078 None 10 Human Binding pEC50 = 10 10.0 - 1
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719833 115821 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353944 115821 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1041 20 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720259 115896 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1031 20 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccco2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354570 115896 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1031 20 11 15 -1.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccco2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720264 115901 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354575 115901 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720275 115911 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354585 115911 None 0 Human Binding pEC50 = 10.0 10.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719834 115822 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353945 115822 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719842 115830 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 21 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353953 115830 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 21 11 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719843 115831 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccn2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353954 115831 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1056 21 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCc2ccccn2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720271 115907 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354581 115907 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118719827 115815 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1021 22 11 14 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3353938 115815 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1021 22 11 14 -1.5 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720269 115906 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354580 115906 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720272 115908 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354582 115908 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 990 21 11 13 -2.2 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720289 115927 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354601 115927 None 0 Human Binding pEC50 = 9.9 9.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1029 20 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719836 115824 None 0 Human Binding pEC50 = 9.8 9.8 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(C)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353947 115824 None 0 Human Binding pEC50 = 9.8 9.8 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1055 20 11 14 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(C)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720265 115902 None 0 Human Binding pEC50 = 9.8 9.8 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354576 115902 None 0 Human Binding pEC50 = 9.8 9.8 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 991 21 11 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719825 115813 None 0 Human Binding pEC50 = 9.7 9.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1032 20 10 14 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](OC)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
CHEMBL3353936 115813 None 0 Human Binding pEC50 = 9.7 9.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1032 20 10 14 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CCCSC[C@@H](C(=O)N3C[C@@H](OC)C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm500365s
118720273 115909 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354583 115909 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 974 21 10 12 -1.9 CCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
118720285 115922 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1025 20 10 12 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354596 115922 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1025 20 10 12 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720276 115912 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
CHEMBL3354586 115912 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1004 22 11 13 -1.8 CCCCCN(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(=O)[C@@H]1CCSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm500365s
155559767 174997 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Agonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor high affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
171357037 194157 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1150 19 17 20 -8.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5280014 194157 None 0 Human Binding pEC50 = 9.6 9.6 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1150 19 17 20 -8.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
118720290 115928 None 0 Human Binding pEC50 = 9.5 9.5 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1013 20 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354602 115928 None 0 Human Binding pEC50 = 9.5 9.5 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1013 20 10 13 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccs2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719826 115814 None 0 Human Binding pEC50 = 9.4 9.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 947 19 11 13 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353937 115814 None 0 Human Binding pEC50 = 9.4 9.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 947 19 11 13 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719832 115820 None 0 Human Binding pEC50 = 9.4 9.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353943 115820 None 0 Human Binding pEC50 = 9.4 9.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1009 21 12 15 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720280 115916 None 0 Human Binding pEC50 = 9.4 9.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 20 10 12 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354590 115916 None 0 Human Binding pEC50 = 9.4 9.4 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1007 20 10 12 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719841 115829 None 0 Human Binding pEC50 = 9.3 9.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccncc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353952 115829 None 0 Human Binding pEC50 = 9.3 9.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccncc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
171347098 193870 None 0 Human Binding pEC50 = 9.3 9.3 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1340 24 20 25 -10.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5273426 193870 None 0 Human Binding pEC50 = 9.3 9.3 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1340 24 20 25 -10.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
118720283 115919 None 0 Human Binding pEC50 = 9.3 9.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 20 10 12 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354593 115919 None 0 Human Binding pEC50 = 9.3 9.3 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 20 10 12 -1.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccc(C)c2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
11169 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
131676677 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
165708555 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
165708555.0 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
16681432 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
16681432.0 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
495 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
CHEMBL3301668 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
DB01282 797 None 33 Human Binding pEC50 = 9.2 9.2 1 2
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/jm500365s
171352228 193969 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1192 21 17 20 -7.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5275543 193969 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1192 21 17 20 -7.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
155559767 174997 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118720287 115925 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 21 10 12 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354599 115925 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1022 21 10 12 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCc2ccccc2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719823 115811 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](SC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353934 115811 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 10 14 -2.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](SC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720267 115904 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354578 115904 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720270 115578 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 11 13 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3352839 115578 None 0 Human Binding pEC50 = 9.1 9.1 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 11 13 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSCC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155559767 174997 None 0 Human Binding pEC50 = 9.0 9.0 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 9.0 9.0 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118720266 115903 None 0 Human Binding pEC50 = 9.0 9.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354577 115903 None 0 Human Binding pEC50 = 9.0 9.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 975 21 10 13 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCSC[C@@H](C(=O)N(CCOC)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719822 115810 None 0 Human Binding pEC50 = 9.0 9.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 10 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](OC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353933 115810 None 0 Human Binding pEC50 = 9.0 9.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1017 19 10 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCCSC[C@@H](C(=O)N2C[C@H](OC)C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
2042 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
2174 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
2176 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
439302 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
439302.0 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
CHEMBL395429 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
DB00107 2983 None 40 Human Binding pEC50 = 8.9 8.9 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
118719830 115818 None 0 Human Binding pEC50 = 8.9 8.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353941 115818 None 0 Human Binding pEC50 = 8.9 8.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1033 19 11 14 -1.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C2CCCCC2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719839 115827 None 0 Human Binding pEC50 = 8.9 8.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353950 115827 None 0 Human Binding pEC50 = 8.9 8.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccccn2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118719840 115828 None 0 Human Binding pEC50 = 8.9 8.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccnc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3353951 115828 None 0 Human Binding pEC50 = 8.9 8.9 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1042 20 11 15 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2cccnc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
118720263 115900 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1064 21 11 16 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCN2CCOCC2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354574 115900 None 0 Human Binding pEC50 = 8 8.0 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1064 21 11 16 -3.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCN2CCOCC2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155515303 170094 None 0 Human Binding pEC50 = 8.0 8.0 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4442222 170094 None 0 Human Binding pEC50 = 8.0 8.0 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
155551252 174047 None 0 Human Binding pEC50 = 8.0 8.0 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 174047 None 0 Human Binding pEC50 = 8.0 8.0 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155553462 174235 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4546103 174235 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
2181 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
2182 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
27991 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
27991.0 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
CHEMBL1429 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
CHEMBL264448 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
DB00035 1331 None 29 Human Binding pEC50 = 7.0 7.0 -15 8
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b00132
155542264 173197 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 173197 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
3537 4004 None 22 Human Binding pEC50 = 6.9 6.9 -3 3
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
5311500 4004 None 22 Human Binding pEC50 = 6.9 6.9 -3 3
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
CHEMBL363910 4004 None 22 Human Binding pEC50 = 6.9 6.9 -3 3
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/jm901084f
155551252 174047 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 174047 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542151 173199 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 173199 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542151 173199 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 173199 None 0 Human Binding pEC50 = 7.9 7.9 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155555256 174435 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1005 18 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4550811 174435 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1005 18 11 14 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CSCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
118476348 173626 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1096 17 11 13 0.6 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CSC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL4531053 173626 None 0 Human Binding pEC50 = 6.9 6.9 - 0
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1096 17 11 13 0.6 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CSC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCc2ccccc2)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
2042 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
2174 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
2176 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
439302 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
439302.0 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
CHEMBL395429 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
DB00107 2983 None 40 Human Binding pEC50 = 7.8 7.8 1 8
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
155560248 175150 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 175150 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
44393941 170951 None 0 Human Binding pEC50 = 5.8 5.8 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 595 8 2 6 4.4 CO[C@@H]1C[C@@H](C(=O)NCCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL445393 170951 None 0 Human Binding pEC50 = 5.8 5.8 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 595 8 2 6 4.4 CO[C@@H]1C[C@@H](C(=O)NCCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
53317550 56355 None 0 Human Binding pEC50 = 6.8 6.8 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630523 56355 None 0 Human Binding pEC50 = 6.8 6.8 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
171357008 194141 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1397 26 21 26 -11.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5279634 194141 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1397 26 21 26 -11.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
155523986 171013 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL4454891 171013 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
155551252 174047 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 174047 None 0 Human Binding pEC50 = 7.8 7.8 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155552392 174256 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546597 174256 None 0 Human Binding pEC50 = 6.8 6.8 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
53320505 56356 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630524 56356 None 0 Human Binding pEC50 = 7.8 7.8 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
155553492 174236 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546106 174236 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
155542151 173199 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 173199 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
118720262 115899 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1048 21 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCC2CCCN2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
CHEMBL3354573 115899 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL 1048 21 12 15 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N(CCC2CCCN2)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm500365s
155542264 173197 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 173197 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155548766 173869 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4537162 173869 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
2042 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
2174 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
2176 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
439302 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
439302.0 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
CHEMBL395429 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
DB00107 2983 None 40 Human Binding pEC50 = 8.7 8.7 1 8
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b00564
2042 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
2174 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
2176 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
439302 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
439302.0 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
CHEMBL395429 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
DB00107 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None None 10.1021/acs.jmedchem.9b01862
2042 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
2174 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
2176 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
439302 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
439302.0 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
CHEMBL395429 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
DB00107 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL None None None None 10.1021/acsmedchemlett.2c00455
2042 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2174 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2176 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
439302 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
439302.0 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
CHEMBL395429 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
DB00107 2983 None 40 Human Binding pEC50 = 8.6 8.6 1 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
155548766 173869 None 0 Human Binding pEC50 = 8.6 8.6 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4537162 173869 None 0 Human Binding pEC50 = 8.6 8.6 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1724 62 18 24 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
53316559 56354 None 0 Human Binding pEC50 = 8.6 8.6 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630522 56354 None 0 Human Binding pEC50 = 8.6 8.6 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
155559767 174997 None 0 Human Binding pEC50 = 8.6 8.6 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 8.6 8.6 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
11169 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
131676677 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
165708555 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
165708555.0 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
16681432 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
16681432.0 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
495 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
CHEMBL3301668 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
DB01282 797 None 33 Human Binding pEC50 = 8.5 8.5 1 2
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.9b01862
155542151 173199 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 173199 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155551252 174047 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 174047 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155553462 174235 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4546103 174235 None 0 Human Binding pEC50 = 7.7 7.7 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
2168 3976 None 29 Human Binding pEC50 = 7.7 7.7 -18 9
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2810 3976 None 29 Human Binding pEC50 = 7.7 7.7 -18 9
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
644077 3976 None 29 Human Binding pEC50 = 7.7 7.7 -18 9
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
644077.0 3976 None 29 Human Binding pEC50 = 7.7 7.7 -18 9
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
CHEMBL373742 3976 None 29 Human Binding pEC50 = 7.7 7.7 -18 9
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
DB00067 3976 None 29 Human Binding pEC50 = 7.7 7.7 -18 9
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
171344442 193781 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1164 19 17 20 -8.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5271164 193781 None 0 Human Binding pEC50 = 6.7 6.7 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1164 19 17 20 -8.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)NC(C)(C)C(=O)N[C@@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
44394045 169606 None 0 Human Binding pEC50 = 5.7 5.7 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 641 6 1 6 5.2 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL443300 169606 None 0 Human Binding pEC50 = 5.7 5.7 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 641 6 1 6 5.2 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
118476338 173495 None 0 Human Binding pEC50 = 6.6 6.6 - 0
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL4528032 173495 None 0 Human Binding pEC50 = 6.6 6.6 - 0
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 957 15 12 13 -1.5 CC(C)[C@@H]1NC(=O)[C@H](Cc2cccs2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CO)CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
10282736 123882 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 627 6 1 6 4.8 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL362382 123882 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 627 6 1 6 4.8 CO[C@@H]1C[C@@H](C(=O)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155553462 174235 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4546103 174235 None 0 Human Binding pEC50 = 7.6 7.6 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2123 45 24 30 -6.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
53319051 56357 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1174 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630525 56357 None 0 Human Binding pEC50 = 7.6 7.6 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 1174 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Te][Te]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44393965 126270 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 587 5 1 6 3.8 CO[C@@H]1C[C@@H](C(=O)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL364994 126270 None 0 Human Binding pEC50 = 5.6 5.6 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 587 5 1 6 3.8 CO[C@@H]1C[C@@H](C(=O)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155560248 175150 None 0 Human Binding pEC50 = 7.5 7.5 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 175150 None 0 Human Binding pEC50 = 7.5 7.5 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155552392 174256 None 0 Human Binding pEC50 = 8.5 8.5 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546597 174256 None 0 Human Binding pEC50 = 8.5 8.5 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1452 49 15 20 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155560248 175150 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 175150 None 0 Human Binding pEC50 = 6.5 6.5 - 0
Agonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
73346893 89388 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL2369425 89388 None 0 Human Binding pEC50 = 7.5 7.5 - 1
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
135413563 122996 None 20 Human Binding pEC50 = 7.5 7.5 1 8
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
CHEMBL360648 122996 None 20 Human Binding pEC50 = 7.5 7.5 1 8
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1021/jm901084f
135413563 122996 None 20 Human Binding pEC50 = 7.5 7.5 1 8
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
CHEMBL360648 122996 None 20 Human Binding pEC50 = 7.5 7.5 1 8
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 600 4 2 7 4.3 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
155559767 174997 None 0 Human Binding pEC50 = 7.5 7.5 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 7.5 7.5 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155542264 173197 None 0 Human Binding pEC50 = 7.5 7.5 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 173197 None 0 Human Binding pEC50 = 7.5 7.5 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
44419026 168602 None 15 Human Binding pEC50 = 6.5 6.5 - 2
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
CHEMBL435323 168602 None 15 Human Binding pEC50 = 6.5 6.5 - 2
Agonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assayAgonist activity at human OTR stably expressed in CHOK1 cells by NFAT-luciferase reporter gene assay
ChEMBL 1039 17 13 14 -2.7 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/acs.jmedchem.9b00132
155542151 173199 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520203 173199 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH1-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2207 51 24 30 -3.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
171355737 194245 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 985 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5281925 194245 None 0 Human Binding pEC50 = 5.4 5.4 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 985 17 13 14 -5.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
155559767 174997 None 0 Human Binding pEC50 = 8.4 8.4 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 8.4 8.4 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155547725 173671 None 0 Human Binding pEC50 = 8.4 8.4 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1133 26 12 15 -0.9 CCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.6b00564
CHEMBL4532537 173671 None 0 Human Binding pEC50 = 8.4 8.4 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1133 26 12 15 -0.9 CCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.6b00564
2252 2230 None 35 Human Binding pEC50 = 8.3 8.3 -1 5
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
6918320 2230 None 35 Human Binding pEC50 = 8.3 8.3 -1 5
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
CHEMBL24781 2230 None 35 Human Binding pEC50 = 8.3 8.3 -1 5
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1021/jm901084f
155527834 171392 None 0 Human Binding pEC50 = 8.3 8.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1020 19 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CSCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4460622 171392 None 0 Human Binding pEC50 = 8.3 8.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1020 19 12 15 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CSCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155542264 173197 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 173197 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor C47A mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
155551252 174047 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4541104 174047 None 0 Human Binding pEC50 = 7.4 7.4 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2179 49 24 30 -4.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
2168 3976 None 29 Human Binding pEC50 = 7.4 7.4 -18 9
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
2810 3976 None 29 Human Binding pEC50 = 7.4 7.4 -18 9
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
644077 3976 None 29 Human Binding pEC50 = 7.4 7.4 -18 9
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
644077.0 3976 None 29 Human Binding pEC50 = 7.4 7.4 -18 9
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
CHEMBL373742 3976 None 29 Human Binding pEC50 = 7.4 7.4 -18 9
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
DB00067 3976 None 29 Human Binding pEC50 = 7.4 7.4 -18 9
Activity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assayActivity at oxytocin receptor expressed in COS1 cells assessed as IP-one generation by HTRF assay
ChEMBL None None None None 10.1021/jm100989w
44394044 123902 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 603 5 1 6 4.6 CO[C@@H]1C[C@@H](C(=S)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL362483 123902 None 0 Human Binding pEC50 = 6.4 6.4 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 603 5 1 6 4.6 CO[C@@H]1C[C@@H](C(=S)N2CCCN(C)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155524463 171117 None 0 Human Binding pEC50 = 6.3 6.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4456573 171117 None 0 Human Binding pEC50 = 6.3 6.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
44393911 65247 None 0 Human Binding pEC50 = 6.3 6.3 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 611 8 2 6 5.7 CO[C@@H]1C[C@@H](/C(S)=N/CCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL182627 65247 None 0 Human Binding pEC50 = 6.3 6.3 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 611 8 2 6 5.7 CO[C@@H]1C[C@@H](/C(S)=N/CCc2ccccn2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
44393912 64576 None 0 Human Binding pEC50 = 6.3 6.3 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 643 6 1 6 5.6 CO[C@@H]1C[C@@H](C(=S)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
CHEMBL181487 64576 None 0 Human Binding pEC50 = 6.3 6.3 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 643 6 1 6 5.6 CO[C@@H]1C[C@@H](C(=S)N2CCC(N3CCCC3)CC2)N(C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)C1 10.1016/j.bmcl.2004.04.107
155553492 174236 None 0 Human Binding pEC50 = 8.3 8.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4546106 174236 None 0 Human Binding pEC50 = 8.3 8.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1322 41 14 18 -1.0 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
155529697 171546 None 0 Human Binding pEC50 = 8.3 8.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1362 40 13 18 -0.2 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4463103 171546 None 0 Human Binding pEC50 = 8.3 8.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1362 40 13 18 -0.2 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/acs.jmedchem.9b01862
155558494 174843 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4560445 174843 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155515303 170094 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
CHEMBL4442222 170094 None 0 Human Binding pEC50 = 7.3 7.3 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1336 41 13 18 -0.7 CCCCCCCCCCCCCC(=O)NCCOCCOCCNC(=O)CSC[C@H](NC(=O)CNC(=O)[C@@H]1CSCCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)N(C)CC(N)=O 10.1021/acs.jmedchem.9b01862
155560248 175150 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 175150 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins in presence of TMH5-TAT peptide by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
10411308 203691 None 0 Human Binding pEC50 = 7.2 7.2 -39 3
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL603708 203691 None 0 Human Binding pEC50 = 7.2 7.2 -39 3
Activity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assayActivity at human oxytocin receptor expressed in CHO cells by NFAT-luciferase gene reporter assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
10187625 127357 None 0 Human Binding pEC50 = 6.2 6.2 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 553 4 1 5 4.7 Cc1cc(C(=O)N2CCCCc3sccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
CHEMBL365862 127357 None 0 Human Binding pEC50 = 6.2 6.2 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 553 4 1 5 4.7 Cc1cc(C(=O)N2CCCCc3sccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1 10.1016/j.bmcl.2004.04.107
155524463 171117 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4456573 171117 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in absence of 10% FBS by pathhunter assay
ChEMBL 1738 62 17 24 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCC(=O)NCCOCCOCCC(=O)NCCCC[C@H](NC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155542264 173197 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4520170 173197 None 0 Human Binding pEC50 = 7.2 7.2 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2151 47 24 30 -5.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
171349253 193607 None 0 Human Binding pEC50 = 5.2 5.2 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1000 17 13 14 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
CHEMBL5266871 193607 None 0 Human Binding pEC50 = 5.2 5.2 - 0
Activation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assayActivation of human 3X-HA N-tagged OTR expressed in CHO-K1 cells incubated for 10 mins by cell Western assay
ChEMBL 1000 17 13 14 -5.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCC(=O)NC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acsmedchemlett.2c00455
2181 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
2182 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
27991 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
27991.0 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
CHEMBL1429 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
CHEMBL264448 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
DB00035 1331 None 29 Human Binding pEC50 = 7.1 7.1 -15 8
Agonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assayAgonist activity at human oxytocin receptor expressed in CHO-K1 cells after 5 hrs by firefly luciferase reporter gene assay
ChEMBL None None None None 10.1021/jm500365s
155559767 174997 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4564152 174997 None 0 Human Binding pEC50 = 7.1 7.1 - 0
Agonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 1006 19 12 15 -3.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
44394063 66382 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 573 4 1 5 5.0 CN1CCCN(C(=S)[C@@H]2CCCN2C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)CC1 10.1016/j.bmcl.2004.04.107
CHEMBL185152 66382 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Effective concentration for human Oxytocin receptorEffective concentration for human Oxytocin receptor
ChEMBL 573 4 1 5 5.0 CN1CCCN(C(=S)[C@@H]2CCCN2C(=O)NCc2ccc(C(=O)N3CCCCc4sccc43)cc2Cl)CC1 10.1016/j.bmcl.2004.04.107
155558494 174843 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
CHEMBL4560445 174843 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assayAgonist activity at recombinant human Gi/Go-coupled OTR expressed in CHOK1 cells assessed as induction of beta-arrestin recruitment measured after 90 mins in presence of 10% FBS by pathhunter assay
ChEMBL 1466 49 14 20 -0.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)NCC(=O)N[C@@H](CSCC(=O)NCCOCCOCCOCCNC(=O)CCCCCCCCCCCCCCCCC(=O)O)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.9b01862
155560248 175150 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
CHEMBL4567752 175150 None 0 Human Binding pEC50 = 6.1 6.1 - 0
Agonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assayAgonist activity at human oxytocin receptor V43A/C47A double mutant low affinity site expressed in HEK293 cells coexpressing Rluc8-tagged Galphaq, N-terminal GFP-tagged Ggamma2 and Gbeta1 protein incubated for 2 mins by Gq protein activation based BRET assay
ChEMBL 2235 53 24 30 -2.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSSCCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.6b00564
135506374 137987 None 19 Human Binding pEC50 = 6.1 6.1 -3 3
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.bmcl.2017.04.030
CHEMBL3763342 137987 None 19 Human Binding pEC50 = 6.1 6.1 -3 3
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL 581 5 4 8 4.1 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCN(Cc2cc(O)cc(O)c2)CC1 10.1016/j.bmcl.2017.04.030
2042 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
2174 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
2176 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
439302 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
439302.0 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
CHEMBL395429 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
DB00107 2983 None 40 Human Binding pEC50 = 8.1 8.1 1 8
Agonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assayAgonist activity at C-terminal GFP-tagged OTR (unknown origin) expressed in HEK293 cells measured after 18 hrs by luciferase reporter gene assay
ChEMBL None None None None 10.1016/j.bmcl.2017.04.030
44352184 117039 None 0 Rat Binding pIC50 = 9.2 9.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 687 11 2 8 2.5 Cn1cnc(CC(=O)NC(CCS(C)(=O)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL338711 117039 None 0 Rat Binding pIC50 = 9.2 9.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 687 11 2 8 2.5 Cn1cnc(CC(=O)NC(CCS(C)(=O)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
44352185 21412 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 673 11 3 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL131477 21412 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 673 11 3 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
14981580 78902 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 637 11 3 8 1.9 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCNCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112895 78902 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 637 11 3 8 1.9 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCNCC2)C3(C)C)CC1 10.1021/jm00031a004
14981581 78900 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 686 11 2 9 1.7 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCS(=O)(=O)CC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112893 78900 None 0 Rat Binding pIC50 = 8.9 8.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 686 11 2 9 1.7 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCS(=O)(=O)CC2)C3(C)C)CC1 10.1021/jm00031a004
10394512 117078 None 0 Rat Binding pIC50 = 8.8 8.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cnc(CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL338921 117078 None 0 Rat Binding pIC50 = 8.8 8.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cnc(CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL2112247 211693 None 0 Rat Binding pIC50 = 8 8.0 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cn(C)c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273425 98957 None 0 Rat Binding pIC50 = 8 8.0 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@@H](O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL279281 98957 None 0 Rat Binding pIC50 = 8 8.0 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@@H](O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44352453 18974 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1cccnc1)C2 10.1021/jm00077a002
CHEMBL128726 18974 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1cccnc1)C2 10.1021/jm00077a002
10073512 20547 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 471 4 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCNC1=O)C2 10.1021/jm00077a002
CHEMBL130768 20547 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 471 4 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCNC1=O)C2 10.1021/jm00077a002
10393719 22330 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 595 8 2 5 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)CC1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL132391 22330 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 595 8 2 5 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)CC1CN3CCC1CC3)C2 10.1021/jm00077a002
44352490 118016 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 577 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CC(S(C)(=O)=O)CN1)C2 10.1021/jm00077a002
CHEMBL340362 118016 None 0 Rat Binding pIC50 = 7 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 577 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CC(S(C)(=O)=O)CN1)C2 10.1021/jm00077a002
44433367 89881 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3C=CC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL237772 89881 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2CC3C=CC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433372 89960 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 426 5 3 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL237987 89960 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 426 5 3 3 5.0 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433375 90221 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 505 7 3 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2Cn2cccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL238206 90221 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 505 7 3 4 5.8 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)Nc2ccccc2Cn2cccc2C(=O)O)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44433363 146740 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C=C3CCC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
CHEMBL392363 146740 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 489 3 1 3 5.7 Cc1ccc(F)cc1C(=O)Nc1ccc(C(=O)N2C=C3CCC(=O)N3Cc3ccccc32)c(Cl)c1 10.1016/j.bmcl.2007.08.053
44350917 18087 None 0 Rat Binding pIC50 = 6 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL126709 18087 None 0 Rat Binding pIC50 = 6 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
10256140 21525 None 0 Rat Binding pIC50 = 6 6.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
CHEMBL131613 21525 None 0 Rat Binding pIC50 = 6 6.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
11755934 118183 None 0 Rat Binding pIC50 = 6 6.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 506 5 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccccc1)C2 10.1021/jm00077a002
CHEMBL340772 118183 None 0 Rat Binding pIC50 = 6 6.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 506 5 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccccc1)C2 10.1021/jm00077a002
44351224 118083 None 0 Rat Binding pIC50 = 5 5.0 - 0
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 351 3 0 2 4.0 O=S(=O)(/C=C/c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL340383 118083 None 0 Rat Binding pIC50 = 5 5.0 - 0
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 351 3 0 2 4.0 O=S(=O)(/C=C/c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10358978 16955 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 325 2 0 2 3.4 O=S(=O)(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL125358 16955 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 325 2 0 2 3.4 O=S(=O)(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
9996817 18104 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 331 2 0 3 3.5 O=S(=O)(c1cccs1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL126796 18104 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 331 2 0 3 3.5 O=S(=O)(c1cccs1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
19908315 18381 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 362 1 1 1 4.6 O=C(NC1C2CC3CC(C2)CC1C3)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL127119 18381 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 362 1 1 1 4.6 O=C(NC1C2CC3CC(C2)CC1C3)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
11778918 19424 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 289 1 0 1 3.9 O=C(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL129413 19424 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 289 1 0 1 3.9 O=C(c1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10402786 116893 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 304 1 1 1 4.3 O=C(Nc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL337976 116893 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 304 1 1 1 4.3 O=C(Nc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10404941 117014 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL338605 117014 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10403606 117786 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 318 1 1 1 4.6 Cc1ccc(NC(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL340149 117786 None 0 Rat Binding pIC50 = 5 5.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 318 1 1 1 4.6 Cc1ccc(NC(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
10432863 98369 None 0 Rat Binding pIC50 = 5 5.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](O)(CN)C2 10.1021/jm00077a002
CHEMBL274955 98369 None 0 Rat Binding pIC50 = 5 5.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](O)(CN)C2 10.1021/jm00077a002
10391626 116962 None 0 Rat Binding pIC50 = 5 5.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL338362 116962 None 0 Rat Binding pIC50 = 5 5.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
44429299 169353 None 0 Human Binding pIC50 = 6 6.0 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL441128 169353 None 0 Human Binding pIC50 = 6 6.0 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 20 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
16737617 162027 None 0 Human Binding pIC50 = 7.0 7.0 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL415418 162027 None 0 Human Binding pIC50 = 7.0 7.0 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10483940 117338 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 616 9 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)c1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL339497 117338 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 616 9 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)c1c[nH]cn1)C2 10.1021/jm00077a002
10368075 168554 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1=O)C2 10.1021/jm00077a002
CHEMBL435019 168554 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1=O)C2 10.1021/jm00077a002
44352360 18875 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CCC1=O)C2 10.1021/jm00077a002
CHEMBL128216 18875 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CCC1=O)C2 10.1021/jm00077a002
44352425 21029 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 6 2 4 3.6 CC(C)[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL131168 21029 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 6 2 4 3.6 CC(C)[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44352371 21332 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 3 7 1.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL131388 21332 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 3 7 1.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
44352438 115285 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 3 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CCCNC1)C2 10.1021/jm00077a002
CHEMBL334610 115285 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 3 5 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CCCNC1)C2 10.1021/jm00077a002
9985844 116712 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 588 6 2 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1[nH]cnc1Br)C2 10.1021/jm00077a002
CHEMBL336992 116712 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 588 6 2 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1[nH]cnc1Br)C2 10.1021/jm00077a002
10099421 164975 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 563 8 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
CHEMBL422080 164975 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 563 8 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
44350931 18088 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 0 3 4.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL126717 18088 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 0 3 4.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
44351066 19397 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 0 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL129268 19397 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 0 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
132072820 181039 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 610 8 0 7 5.4 COC(=O)[C@H]1[C@@H](OCc2cccc(OC)c2)CC[C@H]2CN3CC[C@@]4(C(=O)N(Cc5cccc(OC)c5)c5ccccc54)[C@@H]3C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4758081 181039 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 610 8 0 7 5.4 COC(=O)[C@H]1[C@@H](OCc2cccc(OC)c2)CC[C@H]2CN3CC[C@@]4(C(=O)N(Cc5cccc(OC)c5)c5ccccc54)[C@@H]3C[C@@H]21 10.1016/j.bmc.2020.115546
71458039 78906 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 530 8 3 5 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00031a004
CHEMBL2112899 78906 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 530 8 3 5 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00031a004
71449109 78910 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 565 8 2 6 2.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00031a004
CHEMBL2112902 78910 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 565 8 2 6 2.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00031a004
9805972 98668 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL276990 98668 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
10256467 20514 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL130742 20514 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCC(N)=O)C2 10.1021/jm00077a002
10257352 78813 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2112666 78813 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10370697 118451 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341049 118451 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
11756081 18906 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 1 5 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1ccnc1)C2 10.1021/jm00077a002
CHEMBL128398 18906 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 1 5 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1ccnc1)C2 10.1021/jm00077a002
10436744 21176 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
CHEMBL131269 21176 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
10415138 117022 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccn1)C2 10.1021/jm00077a002
CHEMBL338636 117022 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccn1)C2 10.1021/jm00077a002
CHEMBL339493 214085 None 0 Rat Binding pIC50 = 5.9 5.9 - 1
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10386478 117051 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 2 0 2 4.2 O=S(=O)(c1ccc(Br)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL338757 117051 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 2 0 2 4.2 O=S(=O)(c1ccc(Br)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
9983834 116807 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL337519 116807 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10026508 117987 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL340320 117987 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10031108 116622 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 578 6 1 3 6.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C[C@]13C[C@H]4C[C@H](C[C@H](C4)C1)C3)C2 10.1021/jm00077a002
CHEMBL336362 116622 None 0 Rat Binding pIC50 = 4.9 4.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 578 6 1 3 6.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C[C@]13C[C@H]4C[C@H](C[C@H](C4)C1)C3)C2 10.1021/jm00077a002
44273173 99079 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL280202 99079 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL338018 214061 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273080 98672 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 571 7 1 7 2.4 COC(=O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL277022 98672 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 571 7 1 7 2.4 COC(=O)CNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10031372 18883 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 592 7 2 6 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(N)(=O)=O)C1=O)C2 10.1021/jm00077a002
CHEMBL128258 18883 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 592 7 2 6 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(N)(=O)=O)C1=O)C2 10.1021/jm00077a002
10347928 118530 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341289 118530 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
10326385 155776 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 609 7 2 8 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL405016 155776 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 609 7 2 8 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL406351 215065 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL397407 214963 None 0 Human Binding pIC50 = 6.9 6.9 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10052640 21134 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 527 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC1CCCNC1)C2 10.1021/jm00077a002
CHEMBL131239 21134 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 527 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC1CCCNC1)C2 10.1021/jm00077a002
44352497 117121 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 472 5 2 4 3.1 CC(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339151 117121 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 472 5 2 4 3.1 CC(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44350953 18309 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL127063 18309 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
10455392 18856 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN)C2 10.1021/jm00077a002
CHEMBL128124 18856 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 430 4 2 4 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN)C2 10.1021/jm00077a002
CHEMBL234363 211996 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10458629 18970 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 4 3.4 CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL128712 18970 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 4 3.4 CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
10074681 117117 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 0 4 3.4 CN1CC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL339132 117117 None 0 Rat Binding pIC50 = 7.9 7.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 0 4 3.4 CN1CC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
10435004 18895 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 473 6 2 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCN)C2 10.1021/jm00077a002
CHEMBL128328 18895 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 473 6 2 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCN)C2 10.1021/jm00077a002
10075516 164305 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCn1ccnc1)C2 10.1021/jm00077a002
CHEMBL421090 164305 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCn1ccnc1)C2 10.1021/jm00077a002
10324129 168655 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 1 7 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1cnnn1)C2 10.1021/jm00077a002
CHEMBL435613 168655 None 0 Rat Binding pIC50 = 6.9 6.9 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 1 7 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cn1cnnn1)C2 10.1021/jm00077a002
44351212 163485 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 2 4 3.7 CC(C(=O)O)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL419422 163485 None 0 Rat Binding pIC50 = 5.9 5.9 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 2 4 3.7 CC(C(=O)O)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL1790937 211365 None 0 Rat Binding pIC50 = 7.8 7.8 2 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL2370623 212350 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL338308 214067 None 0 Rat Binding pIC50 = 7.8 7.8 4 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
14981577 78908 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 636 11 2 7 3.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCCCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112900 78908 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 636 11 2 7 3.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCCCC2)C3(C)C)CC1 10.1021/jm00031a004
44273368 98848 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 584 9 1 6 3.2 CN(C)CCCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL278377 98848 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 584 9 1 6 3.2 CN(C)CCCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10347928 118530 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341289 118530 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
121301508 176323 None 5 Human Binding pIC50 = 7.8 7.8 -8 3
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
CHEMBL4594444 176323 None 5 Human Binding pIC50 = 7.8 7.8 -8 3
Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)Inhibition of Oxytocin at 1 µM in the Eurofins-Panlabs radioligand binding assay (Eurofins_assay_260900)
ChEMBL 542 7 2 9 3.6 C[C@H](O)c1nc(Cn2nc(-c3ccc(Cl)cc3)n(C[C@H](O)C(F)(F)F)c2=O)nn1-c1cccc(Cl)c1 10.6019/CHEMBL5463729
44273417 99561 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL283317 99561 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 555 7 0 5 4.0 CCN(CC)[C@H]1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10029340 18894 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 5 2 4 4.0 Cc1[nH]cnc1C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL128327 18894 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 5 2 4 4.0 Cc1[nH]cnc1C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10052468 21129 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 522 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)/C=C/c1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL131235 21129 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 522 6 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)/C=C/c1c[nH]cn1)C2 10.1021/jm00077a002
10414877 21482 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 2 4 4.3 CC(C)(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
CHEMBL131564 21482 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 2 4 4.3 CC(C)(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
44352353 117208 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 500 5 1 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@](O)(CN1CCCC1=O)C2 10.1021/jm00077a002
CHEMBL339357 117208 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 500 5 1 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@](O)(CN1CCCC1=O)C2 10.1021/jm00077a002
9982888 168553 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 486 6 2 4 3.5 CC(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL435009 168553 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 486 6 2 4 3.5 CC(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339452 214083 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@@H](C)N(C)C1=O 10.1021/jm00099a019
CHEMBL436397 216141 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CC(=O)O)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10054982 117009 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 645 10 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCc1c[nH]cn1)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL338576 117009 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 645 10 2 6 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCc1c[nH]cn1)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10347928 118530 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL341289 118530 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3c[nH]cn3)C1=O)C2 10.1021/jm00077a002
CHEMBL2369135 212054 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H]([C@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL338294 214065 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10006805 165371 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 6 2 5 3.0 COC(=O)CNC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL423156 165371 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 6 2 5 3.0 COC(=O)CNC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10361799 18040 None 0 Rat Binding pIC50 = 4.8 4.8 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 370 3 0 4 3.3 O=[N+]([O-])c1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL126453 18040 None 0 Rat Binding pIC50 = 4.8 4.8 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 370 3 0 4 3.3 O=[N+]([O-])c1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
44273369 99598 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283524 99598 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
44352150 18872 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 5 2.8 CC(C(N)=O)[C@@H](N)C(=O)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL128194 18872 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 5 2.8 CC(C(N)=O)[C@@H](N)C(=O)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10098227 18964 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
CHEMBL128680 18964 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
10053091 20594 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 6 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1csc(N)n1)C2 10.1021/jm00077a002
CHEMBL130803 20594 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 6 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1csc(N)n1)C2 10.1021/jm00077a002
10098755 21493 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 2 4 4.5 CCC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
CHEMBL131581 21493 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 2 4 4.5 CCC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1c[nH]cn1 10.1021/jm00077a002
44352393 116929 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 555 6 3 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)NC1CCCCC1)C2 10.1021/jm00077a002
CHEMBL338177 116929 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 555 6 3 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)NC1CCCCC1)C2 10.1021/jm00077a002
44429288 88043 None 0 Human Binding pIC50 = 6.8 6.8 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL234377 88043 None 0 Human Binding pIC50 = 6.8 6.8 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
2241 2218 None 2 Rat Binding pIC50 = 7.8 7.8 -2 4
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None None 10.1021/jm00099a019
9810632 2218 None 2 Rat Binding pIC50 = 7.8 7.8 -2 4
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None None 10.1021/jm00099a019
CHEMBL127686 2218 None 2 Rat Binding pIC50 = 7.8 7.8 -2 4
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None None 10.1021/jm00099a019
CHEMBL1790938 211366 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
14981576 78901 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 610 12 1 7 2.9 CCN(CC)[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
CHEMBL2112894 78901 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 610 12 1 7 2.9 CCN(CC)[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
44273346 163042 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 570 8 1 6 2.8 CN(C)CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL417458 163042 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 570 8 1 6 2.8 CN(C)CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10051081 116967 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CNC1=O)C2 10.1021/jm00077a002
CHEMBL338383 116967 None 0 Rat Binding pIC50 = 7.8 7.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CNC1=O)C2 10.1021/jm00077a002
44352441 20697 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccccn1)C2 10.1021/jm00077a002
CHEMBL130887 20697 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccccn1)C2 10.1021/jm00077a002
44352440 116835 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL337667 116835 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 6 2 5 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1ccncc1)C2 10.1021/jm00077a002
10345259 117021 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 3 4.5 CC1CCC(=O)N1[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL338635 117021 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 484 4 0 3 4.5 CC1CCC(=O)N1[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10323684 117109 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 5 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(=O)C1=O)C2 10.1021/jm00077a002
CHEMBL339096 117109 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 4 1 5 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(=O)C1=O)C2 10.1021/jm00077a002
10347089 168547 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 7 1 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1cccnc1)C2 10.1021/jm00077a002
CHEMBL434993 168547 None 0 Rat Binding pIC50 = 6.8 6.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 535 7 1 4 4.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1cccnc1)C2 10.1021/jm00077a002
44351086 18165 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL126962 18165 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
10069537 163587 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00077a002
CHEMBL420144 163587 None 0 Rat Binding pIC50 = 5.8 5.8 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00077a002
10054203 118109 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 8 0 6 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CCCn3ccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL340388 118109 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 8 0 6 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CCCn3ccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL338020 214062 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC(C)C[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL340479 214092 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None C=CCN1C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H]1Cc1ccccc1 10.1021/jm00099a019
10436274 98555 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL276079 98555 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1ccncc1)C2 10.1021/jm00077a002
44351071 20038 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL130351 20038 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
44351053 118528 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL341274 118528 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL2370761 212378 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H]([C@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL2112249 211695 None 2 Rat Binding pIC50 = 8.7 8.7 8 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
11764710 116503 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL336082 116503 None 0 Rat Binding pIC50 = 8.7 8.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10078034 117536 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cncc1CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339929 117536 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 652 11 3 7 2.3 Cn1cncc1CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
14981578 78904 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 638 11 2 8 2.3 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCOCC2)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112897 78904 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 638 11 2 8 2.3 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)NC2CCOCC2)C3(C)C)CC1 10.1021/jm00031a004
10483586 20704 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 591 7 1 6 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(C)(=O)=O)C1=O)C2 10.1021/jm00077a002
CHEMBL130891 20704 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 591 7 1 6 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCS(C)(=O)=O)C1=O)C2 10.1021/jm00077a002
2042 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
2174 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
2176 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
439302 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
439302.0 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
CHEMBL395429 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
DB00107 2983 None 40 Human Binding pIC50 = 8.6 8.6 1 8
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None None 10.1016/j.ejmech.2006.12.016
71450903 78909 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 614 12 3 9 0.8 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(CO)CO)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112901 78909 None 0 Rat Binding pIC50 = 8.6 8.6 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 614 12 3 9 0.8 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(CO)CO)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112651 211701 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273259 73545 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 1 6 2.5 CN(CCO)C1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20171 73545 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 1 6 2.5 CN(CCO)C1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273355 74973 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 587 8 0 6 3.9 CN(C)CCSC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20319 74973 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 587 8 0 6 3.9 CN(C)CCSC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44273426 77135 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@H](CO)NC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20757 77135 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.6 C[C@H](CO)NC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44272990 99660 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283994 99660 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 500 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](O)C1=O)C2 10.1016/0960-894X(94)00469-V
44352164 18901 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 4 1 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CC(O)CN3C1=O)C2 10.1021/jm00077a002
CHEMBL128383 18901 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 4 1 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CC(O)CN3C1=O)C2 10.1021/jm00077a002
CHEMBL339118 214076 None 0 Rat Binding pIC50 = 6.7 6.7 19 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44273077 99238 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL281361 99238 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
44352165 118618 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 7 3 6 1.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CS(N)(=O)=O)C2 10.1021/jm00077a002
CHEMBL341507 118618 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 7 3 6 1.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CS(N)(=O)=O)C2 10.1021/jm00077a002
44350916 117696 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL340102 117696 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 1 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
44352496 19568 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 4 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CCC(=N)N3C1=O)C2 10.1021/jm00077a002
CHEMBL129983 19568 None 0 Rat Binding pIC50 = 7.7 7.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 4 1 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C3CCC(=N)N3C1=O)C2 10.1021/jm00077a002
10391259 18903 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 5 1 4 3.3 CNC1CCN([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL128388 18903 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 499 5 1 4 3.3 CNC1CCN([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
44342196 110924 None 0 Rat Binding pIC50 = 4.7 4.7 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 428 6 0 7 5.1 COc1cc(C)cc2c1Oc1ccc([C@H](CC(C)C)OC(C)=O)c(OC)c1C(=O)OC2 10.1016/S0960-894X(01)80905-7
CHEMBL326085 110924 None 0 Rat Binding pIC50 = 4.7 4.7 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 428 6 0 7 5.1 COc1cc(C)cc2c1Oc1ccc([C@H](CC(C)C)OC(C)=O)c(OC)c1C(=O)OC2 10.1016/S0960-894X(01)80905-7
CHEMBL339450 214082 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10007685 98653 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 7 2 4 4.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccc1)C2 10.1021/jm00077a002
CHEMBL276906 98653 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 7 2 4 4.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccccc1)C2 10.1021/jm00077a002
10052134 118000 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
CHEMBL340334 118000 None 0 Rat Binding pIC50 = 6.7 6.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 6 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
44350954 18380 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL127118 18380 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
44350850 117108 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 375 6 1 3 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)NCCC1CCc3ccccc31)C(=O)C2 10.1021/jm00099a020
CHEMBL339093 117108 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 375 6 1 3 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)NCCC1CCc3ccccc31)C(=O)C2 10.1021/jm00099a020
10386343 18924 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00077a002
CHEMBL128497 18924 None 0 Rat Binding pIC50 = 5.7 5.7 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00077a002
10315031 118406 None 0 Rat Binding pIC50 = 4.7 4.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 337 2 0 1 5.3 O=C(CC1CCCCCCC1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL341021 118406 None 0 Rat Binding pIC50 = 4.7 4.7 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 337 2 0 1 5.3 O=C(CC1CCCCCCC1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
10393977 168624 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 611 10 3 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCC(=O)O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL435409 168624 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 611 10 3 5 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)N(CCC(=O)O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
44351231 19443 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL129498 19443 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)C(=O)C2 10.1021/jm00099a020
44351156 116928 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL338170 116928 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 417 3 0 3 3.9 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
44273459 73953 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 482 4 0 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C=CC1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL20205 73953 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 482 4 0 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C=CC1=O)C2 10.1016/0960-894X(94)00469-V
10459672 117555 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 1 5 4.0 CCOC(=O)CCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL340016 117555 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 1 5 4.0 CCOC(=O)CCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44351226 118527 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL341267 118527 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 399 3 0 3 3.8 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL126765 211127 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCN)NC(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
44429294 168422 None 0 Human Binding pIC50 = 7.6 7.6 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL434193 168422 None 0 Human Binding pIC50 = 7.6 7.6 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1184 18 9 14 0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)N3Cc4ccccc4C[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44273473 72809 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 5 0 6 3.2 CC(=O)OC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20002 72809 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 5 0 6 3.2 CC(=O)OC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
10369423 168682 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
CHEMBL435815 168682 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 520 6 1 3 4.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccc1)C2 10.1021/jm00077a002
44351087 116956 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL338336 116956 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL338221 214064 None 0 Rat Binding pIC50 = 4.6 4.6 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@H]1C(=O)N2CCCC[C@@H]2C(=O)N2CCCC[C@H]2C(=O)N(C)[C@H](Cc2ccccc2)C(=O)N2CCC[C@H]2C(=O)N[C@H](Cc2ccccc2)C(=O)N1C 10.1021/jm00099a019
10391520 20551 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccnc1)C2 10.1021/jm00077a002
CHEMBL130770 20551 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 507 5 1 4 4.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccnc1)C2 10.1021/jm00077a002
44352363 116333 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 626 6 2 6 3.7 COC(=O)[N+]12CCC(CC1)C(C(=O)NC[C@@]1(O)C[C@H]3CC[C@]1(CS(=O)(=O)N1CCC4(C=Cc5ccccc54)CC1)C3(C)C)C2 10.1021/jm00077a002
CHEMBL335886 116333 None 0 Rat Binding pIC50 = 7.6 7.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 626 6 2 6 3.7 COC(=O)[N+]12CCC(CC1)C(C(=O)NC[C@@]1(O)C[C@H]3CC[C@]1(CS(=O)(=O)N1CCC4(C=Cc5ccccc54)CC1)C3(C)C)C2 10.1021/jm00077a002
11756226 21965 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 1 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1C(=O)O)C2 10.1021/jm00077a002
CHEMBL132064 21965 None 0 Rat Binding pIC50 = 6.6 6.6 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 1 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CCC1C(=O)O)C2 10.1021/jm00077a002
CHEMBL129414 211140 None 0 Rat Binding pIC50 = 5.6 5.6 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10459923 116406 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 5 1 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL335944 116406 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 5 1 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
10415322 168343 None 0 Rat Binding pIC50 = 8.5 8.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 2 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCC(N)=O)C1=O)C2 10.1021/jm00077a002
CHEMBL433662 168343 None 0 Rat Binding pIC50 = 8.5 8.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 2 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CCC(N)=O)C1=O)C2 10.1021/jm00077a002
10393965 22063 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 7 3 8 2.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL132157 22063 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 7 3 8 2.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)Nc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
10392579 116759 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 1 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL337221 116759 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 1 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
44352481 117085 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 621 11 1 6 3.8 CCN(CC)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL338951 117085 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 621 11 1 6 3.8 CCN(CC)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
9984805 117122 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 7 2 4 4.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC1CCCNC1)C2 10.1021/jm00077a002
CHEMBL339155 117122 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 7 2 4 4.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC1CCCNC1)C2 10.1021/jm00077a002
10053396 115178 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 8 3 7 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
CHEMBL334332 115178 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 8 3 7 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1nnn[nH]1)C2 10.1021/jm00077a002
10407141 17009 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 375 2 0 2 4.6 O=S(=O)(c1ccc2ccccc2c1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL125406 17009 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 375 2 0 2 4.6 O=S(=O)(c1ccc2ccccc2c1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
44351225 18026 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@](CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)(C2)C1O 10.1021/jm00099a020
CHEMBL126371 18026 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@](CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)(C2)C1O 10.1021/jm00099a020
10068542 18061 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 383 3 0 4 3.2 COC(=O)c1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL126565 18061 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 383 3 0 4 3.2 COC(=O)c1ccccc1S(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
44351265 118147 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 486 5 1 4 3.4 CC(C)C(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL340589 118147 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 486 5 1 4 3.4 CC(C)C(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL2112656 211704 None 0 Rat Binding pIC50 = 4.5 4.5 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10250542 115560 None 0 Rat Binding pIC50 = 4.5 4.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N)C2 10.1021/jm00077a002
CHEMBL335170 115560 None 0 Rat Binding pIC50 = 4.5 4.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N)C2 10.1021/jm00077a002
10416272 104795 None 5 Rat Binding pIC50 = 5.5 5.5 - 2
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL31065 104795 None 5 Rat Binding pIC50 = 5.5 5.5 - 2
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
9983763 19391 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 508 7 1 4 3.8 CCCS(=O)(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL129234 19391 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 508 7 1 4 3.8 CCCS(=O)(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44272960 73290 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 527 6 1 5 3.2 CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
CHEMBL20126 73290 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 527 6 1 5 3.2 CCNC1CC(=O)N([C@H]2CC3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1016/0960-894X(94)00469-V
44352311 18959 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL128652 18959 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](Cc1c[nH]cn1)NC(=O)CCC(N)=O)C2 10.1021/jm00077a002
10100280 96871 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 9 0 7 3.9 COC(=O)CCN(C(=O)Cc1cn(C)cn1)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL265073 96871 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 610 9 0 7 3.9 COC(=O)CCN(C(=O)Cc1cn(C)cn1)[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10392298 116877 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 532 8 2 6 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CC[N+](=O)[O-])C2 10.1021/jm00077a002
CHEMBL337888 116877 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 532 8 2 6 2.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CC[N+](=O)[O-])C2 10.1021/jm00077a002
CHEMBL129733 211141 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44350982 18208 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL126999 18208 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 403 3 1 3 3.5 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL52813 218195 None 0 Rat Binding pIC50 = 5.5 5.5 23 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C1=O 10.1021/jm00099a019
44268726 97423 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 427 3 0 3 4.4 CC1(C)C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL269624 97423 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 427 3 0 3 4.4 CC1(C)C(=O)[C@]2(CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
44351266 118297 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 458 4 1 4 2.8 CC(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
CHEMBL340920 118297 None 0 Rat Binding pIC50 = 5.5 5.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 458 4 1 4 2.8 CC(=O)NC1C(=O)[C@]2(CS(=O)(=O)N3CCC4(CCc5ccccc54)CC3)CCC1C2(C)C 10.1021/jm00099a020
10029477 20718 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 2 5 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CN)C1=O)C2 10.1021/jm00077a002
CHEMBL130905 20718 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 2 5 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CN)C1=O)C2 10.1021/jm00077a002
44352412 115563 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
CHEMBL335182 115563 None 0 Rat Binding pIC50 = 7.5 7.5 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccncc1)C2 10.1021/jm00077a002
44351232 20452 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 1 5 3.5 COC(=O)C[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL130695 20452 None 0 Rat Binding pIC50 = 6.5 6.5 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 473 5 1 5 3.5 COC(=O)C[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
3537 4004 None 22 Human Binding pIC50 = 6.5 6.5 -3 3
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
5311500 4004 None 22 Human Binding pIC50 = 6.5 6.5 -3 3
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
CHEMBL363910 4004 None 22 Human Binding pIC50 = 6.5 6.5 -3 3
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1016/j.bmcl.2007.08.053
10393379 20185 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 576 6 1 5 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3cccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL130476 20185 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 576 6 1 5 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(Cc3cccnc3)C1=O)C2 10.1021/jm00077a002
CHEMBL2370768 212379 None 0 Human Binding pIC50 = 4.4 4.4 - 0
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H]([C@@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
10030575 22126 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL132210 22126 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
44351052 17394 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1CN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CCC12C=Cc1ccccc12 10.1021/jm00099a020
CHEMBL125748 17394 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.0 CC1CN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CCC12C=Cc1ccccc12 10.1021/jm00099a020
44352123 118155 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 566 8 3 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCS(N)(=O)=O)C2 10.1021/jm00077a002
CHEMBL340639 118155 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 566 8 3 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCS(N)(=O)=O)C2 10.1021/jm00077a002
16737618 96935 None 0 Human Binding pIC50 = 6.4 6.4 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL265630 96935 None 0 Human Binding pIC50 = 6.4 6.4 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1053 17 11 14 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
10366192 116756 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL337212 116756 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 444 4 1 3 3.6 CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44351229 116953 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
CHEMBL338324 116953 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@H](O)C2 10.1021/jm00099a020
44352433 117339 None 0 Rat Binding pIC50 = 8.4 8.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 622 10 3 7 1.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)CN)C2 10.1021/jm00077a002
CHEMBL339498 117339 None 0 Rat Binding pIC50 = 8.4 8.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 622 10 3 7 1.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(CCS(C)(=O)=O)NC(=O)CN)C2 10.1021/jm00077a002
10346739 117091 None 0 Rat Binding pIC50 = 8.4 8.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 5 0 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC#N)C1=O)C2 10.1021/jm00077a002
CHEMBL338984 117091 None 0 Rat Binding pIC50 = 8.4 8.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 5 0 5 3.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC#N)C1=O)C2 10.1021/jm00077a002
9893887 47628 None 2 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmc.2020.115546
CHEMBL154668 47628 None 2 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human OXTR expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)CC23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1016/j.bmc.2020.115546
14981575 78903 None 0 Rat Binding pIC50 = 8.3 8.3 - 1
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112896 78903 None 0 Rat Binding pIC50 = 8.3 8.3 - 1
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 582 10 1 7 2.1 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@H](CCS(C)(=O)=O)N(C)C)C3(C)C)CC1 10.1021/jm00031a004
44352492 18977 None 0 Rat Binding pIC50 = 8.3 8.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 1 6 3.0 CN(C)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL128749 18977 None 0 Rat Binding pIC50 = 8.3 8.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 593 9 1 6 3.0 CN(C)C(CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44429298 147542 None 0 Human Binding pIC50 = 7.4 7.4 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393020 147542 None 0 Human Binding pIC50 = 7.4 7.4 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1033 19 10 14 -1.5 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3CCCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44273321 167600 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCN)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL429971 167600 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 542 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCN)C1=O)C2 10.1016/0960-894X(94)00469-V
71449094 78810 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 581 8 3 7 1.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@](O)(CNC(=O)C(N)CS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2112663 78810 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 581 8 3 7 1.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@](O)(CNC(=O)C(N)CS(C)(=O)=O)C2 10.1021/jm00077a002
9797987 118573 None 1 Rat Binding pIC50 = 5.4 5.4 -1 3
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL341490 118573 None 1 Rat Binding pIC50 = 5.4 5.4 -1 3
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL2112655 211703 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCCCN)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10323799 116672 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 502 7 2 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC(=O)O)C2 10.1021/jm00077a002
CHEMBL336742 116672 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 502 7 2 4 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCC(=O)O)C2 10.1021/jm00077a002
44352373 22327 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 8 3 5 3.4 CC(C)C[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL132389 22327 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 8 3 5 3.4 CC(C)C[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
11757440 116993 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CCC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL338503 116993 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 556 7 1 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(CCC(=O)O)C1=O)C2 10.1021/jm00077a002
44352374 18534 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 529 7 3 5 3.0 CC(C)[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL127445 18534 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 529 7 3 5 3.0 CC(C)[C@H](N)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44273034 99102 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.3 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCC(=O)O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL280356 99102 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 557 7 2 6 2.3 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCC(=O)O)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL340204 214091 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cccc3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44352431 18910 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 3 5 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL128417 18910 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 7 3 5 3.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10483039 78528 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
CHEMBL2111851 78528 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 8 2 6 2.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)CCS(C)(=O)=O)C2 10.1021/jm00077a002
10347314 116991 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 8 2 4 4.9 CCC(C)(C)C(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL338499 116991 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 8 2 4 4.9 CCC(C)(C)C(=O)NCC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44352443 118535 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL341311 118535 None 0 Rat Binding pIC50 = 7.4 7.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](N)Cc1c[nH]cn1)C2 10.1021/jm00077a002
44352299 116867 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 416 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
CHEMBL337842 116867 None 0 Rat Binding pIC50 = 6.4 6.4 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 416 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
44351210 117373 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 557 3 0 3 5.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CC1)c1ccccc1C(Br)C3Br)C(=O)C2 10.1021/jm00099a020
CHEMBL339698 117373 None 0 Rat Binding pIC50 = 5.4 5.4 - 0
Compound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissueCompound was evaluated for half-maximal inhibition of binding of [3H]oxytocin to Oxytocin receptor in rat uterine tissue
ChEMBL 557 3 0 3 5.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CC1)c1ccccc1C(Br)C3Br)C(=O)C2 10.1021/jm00099a020
44352124 117116 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 7 2 5 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCC#N)C2 10.1021/jm00077a002
CHEMBL339124 117116 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 7 2 5 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCC#N)C2 10.1021/jm00077a002
44351215 117792 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 477 4 1 3 5.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(c1ccccc1)C2 10.1021/jm00099a020
CHEMBL340153 117792 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 477 4 1 3 5.1 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(c1ccccc1)C2 10.1021/jm00099a020
10321314 117791 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 445 4 2 3 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(N)=O)C2 10.1021/jm00077a002
CHEMBL340150 117791 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 445 4 2 3 3.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(N)=O)C2 10.1021/jm00077a002
10030575 22126 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL132210 22126 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 554 5 2 4 3.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NC1CN3CCC1CC3)C2 10.1021/jm00077a002
44351034 116952 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL338318 116952 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
10046632 115416 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00077a002
CHEMBL334953 115416 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 401 3 1 3 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@H](O)C2 10.1021/jm00077a002
10370147 18861 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 1 5 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL128163 18861 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 1 5 2.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)O)C1=O)C2 10.1021/jm00077a002
10369550 118540 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cncc1CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL341338 118540 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cncc1CC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44352473 117290 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 606 7 2 4 5.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)CC13CC4CC(CC(C4)C1)C3)C2 10.1021/jm00077a002
CHEMBL339464 117290 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 606 7 2 4 5.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)CC13CC4CC(CC(C4)C1)C3)C2 10.1021/jm00077a002
44429303 147543 None 0 Human Binding pIC50 = 6.3 6.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL393021 147543 None 0 Human Binding pIC50 = 6.3 6.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1007 20 11 14 -1.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44352171 20823 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 7 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)C1=CCC(=O)N=C1)C2 10.1021/jm00077a002
CHEMBL130993 20823 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 565 7 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)C1=CCC(=O)N=C1)C2 10.1021/jm00077a002
44352442 163558 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 8 2 5 3.5 CN(C)[C@H](Cc1c[nH]cn1)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL419973 163558 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 8 2 5 3.5 CN(C)[C@H](Cc1c[nH]cn1)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10460610 172733 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 1 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
CHEMBL449399 172733 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 1 7 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(Cc3nn[nH]n3)C1=O)C2 10.1021/jm00077a002
9986160 117434 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 608 7 2 6 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)Nc3ncc[nH]3)C1=O)C2 10.1021/jm00077a002
CHEMBL339768 117434 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 608 7 2 6 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CN(CC(=O)Nc3ncc[nH]3)C1=O)C2 10.1021/jm00077a002
44352347 116870 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 540 6 4 7 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1n[nH]c(N)n1)C2 10.1021/jm00077a002
CHEMBL337853 116870 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 540 6 4 7 2.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)c1n[nH]c(N)n1)C2 10.1021/jm00077a002
11757133 117004 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 2 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
CHEMBL338548 117004 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 543 6 2 5 2.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CC(=O)O)C1=O)C2 10.1021/jm00077a002
44352146 117281 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 513 5 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CNC1=O)C2 10.1021/jm00077a002
CHEMBL339433 117281 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 513 5 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CN1C(=O)CNC1=O)C2 10.1021/jm00077a002
10258572 118163 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC(CC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL340676 118163 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 638 11 4 6 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CC(CC(N)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
44342185 10065 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 456 6 0 8 5.0 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(OC(C)=O)c1O2 10.1016/S0960-894X(01)80905-7
CHEMBL115277 10065 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 456 6 0 8 5.0 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(OC(C)=O)c1O2 10.1016/S0960-894X(01)80905-7
10357626 118478 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 303 2 0 1 3.8 O=C(Cc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL341077 118478 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 303 2 0 1 3.8 O=C(Cc1ccccc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
44429290 87403 None 0 Human Binding pIC50 = 7.3 7.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233328 87403 None 0 Human Binding pIC50 = 7.3 7.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1081 19 10 14 -0.9 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL415417 215648 None 0 Human Binding pIC50 = 4.3 4.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(C)(C)C)C(=O)NCC(N)=O 10.1016/j.ejmech.2006.12.016
172997 2332 None 49 Human Binding pIC50 = 6.3 6.3 - 2
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
2238 2332 None 49 Human Binding pIC50 = 6.3 6.3 - 2
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
CHEMBL49429 2332 None 49 Human Binding pIC50 = 6.3 6.3 - 2
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
DB06666 2332 None 49 Human Binding pIC50 = 6.3 6.3 - 2
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 473 3 1 3 6.1 Fc1ccc(c(c1)C(=O)Nc1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2)C 10.1016/j.bmcl.2007.08.053
10436379 74205 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 510 6 2 4 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1016/0960-894X(94)00469-V
CHEMBL20230 74205 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 510 6 2 4 3.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1c[nH]cn1)C2 10.1016/0960-894X(94)00469-V
10413997 2224 None 5 Rat Binding pIC50 = 7.3 7.3 1 2
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
2246 2224 None 5 Rat Binding pIC50 = 7.3 7.3 1 2
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
CHEMBL338522 2224 None 5 Rat Binding pIC50 = 7.3 7.3 1 2
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 O=C(Cc1cnc[nH]1)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCC2(CC1)CCc1c2cccc1)(C)C 10.1021/jm00077a002
44352413 21471 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
CHEMBL131551 21471 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1cccnc1)C2 10.1021/jm00077a002
10052855 116691 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 534 7 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1ccccc1)C2 10.1021/jm00077a002
CHEMBL336857 116691 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 534 7 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1ccccc1)C2 10.1021/jm00077a002
44352491 118293 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 8 2 5 2.7 C[S+]([O-])CCC(N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL340915 118293 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 8 2 5 2.7 C[S+]([O-])CCC(N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL127056 211128 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCN2C1=O 10.1021/jm00099a019
10046625 168515 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 5 0 4 3.5 CCOC(=O)C1(c2ccccc2)CCN(S(=O)(=O)c2ccc(C)cc2)CC1C 10.1021/jm00099a020
CHEMBL434825 168515 None 0 Rat Binding pIC50 = 5.3 5.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 401 5 0 4 3.5 CCOC(=O)C1(c2ccccc2)CCN(S(=O)(=O)c2ccc(C)cc2)CC1C 10.1021/jm00099a020
44429304 87299 None 0 Human Binding pIC50 = 7.3 7.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL233080 87299 None 0 Human Binding pIC50 = 7.3 7.3 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1062 19 10 14 -0.7 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N3CCCC[C@@H]3C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
10075696 21548 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL131650 21548 None 0 Rat Binding pIC50 = 7.3 7.3 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 530 8 3 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00077a002
44351092 18232 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL127016 18232 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(F)ccc43)CC1)[C@H](O)C2 10.1021/jm00099a020
44351219 117159 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@H](O)C2 10.1021/jm00099a020
CHEMBL339302 117159 None 0 Rat Binding pIC50 = 6.3 6.3 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 419 3 1 3 3.7 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(F)cc43)CC1)[C@H](O)C2 10.1021/jm00099a020
44352392 116920 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
CHEMBL338118 116920 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 567 6 2 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C1CN3CCC1CC3)C2 10.1021/jm00077a002
9984984 116987 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 8 1 3 5.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCCc1ccccc1)C2 10.1021/jm00077a002
CHEMBL338490 116987 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 548 8 1 3 5.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCCc1ccccc1)C2 10.1021/jm00077a002
9974603 18377 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 341 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(CCc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL127117 18377 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 341 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(CCc4ccccc43)CC2)cc1 10.1021/jm00099a020
44352428 117210 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 4 4.0 CC(C)C[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL339366 117210 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 515 7 2 4 4.0 CC(C)C[C@@H](N)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
44350978 17690 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@H]1O)C2(C)C 10.1021/jm00099a020
CHEMBL125847 17690 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@H]1O)C2(C)C 10.1021/jm00099a020
CHEMBL2112248 211694 None 0 Rat Binding pIC50 = 8.2 8.2 1 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
11764606 117428 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 630 9 0 7 3.3 Cn1cnc(CC(=O)N(CCS(C)(=O)=O)[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL339756 117428 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 630 9 0 7 3.3 Cn1cnc(CC(=O)N(CCS(C)(=O)=O)[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
10258045 18876 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 601 11 4 6 1.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CCN)C2 10.1021/jm00077a002
CHEMBL128219 18876 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 601 11 4 6 1.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CCN)C2 10.1021/jm00077a002
10461149 117344 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 596 7 4 8 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CNc3n[nH]c(N)n3)C1=O)C2 10.1021/jm00077a002
CHEMBL339524 117344 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 596 7 4 8 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)NC(CNc3n[nH]c(N)n3)C1=O)C2 10.1021/jm00077a002
10324965 19561 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 1 5 4.1 CC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1cn(C)cn1 10.1021/jm00077a002
CHEMBL129971 19561 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 538 6 1 5 4.1 CC(C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C)c1cn(C)cn1 10.1021/jm00077a002
10480543 116589 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCC(N)C1=O)C2 10.1021/jm00077a002
CHEMBL336195 116589 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 485 4 1 4 3.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1CCC(N)C1=O)C2 10.1021/jm00077a002
44351264 19370 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 4.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](C)(O)C2 10.1021/jm00099a020
CHEMBL129104 19370 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 4.0 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@](C)(O)C2 10.1021/jm00099a020
10021111 17990 None 2 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 355 3 0 3 3.4 COc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
CHEMBL126195 17990 None 2 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 355 3 0 3 3.4 COc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm00099a020
10370127 18878 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CN1CC[C@H](N)C1=O)C2 10.1021/jm00077a002
CHEMBL128228 18878 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 542 6 2 5 2.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CN1CC[C@H](N)C1=O)C2 10.1021/jm00077a002
10460052 22127 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 544 8 2 5 2.3 CN(C)CC(=O)NCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL132211 22127 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 544 8 2 5 2.3 CN(C)CC(=O)NCC(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
10255857 117436 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 4 5.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccs1)C2 10.1021/jm00077a002
CHEMBL339783 117436 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 4 5.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)c1cccs1)C2 10.1021/jm00077a002
44351057 18109 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C1(C=C2)CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
CHEMBL126824 18109 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C1(C=C2)CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
44351155 19454 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C=CC21CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
CHEMBL129581 19454 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 413 3 0 3 4.1 Cc1cccc2c1C=CC21CCN(S(=O)(=O)C[C@]23CCC(CC2=O)C3(C)C)CC1 10.1021/jm00099a020
44351235 116937 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 429 4 1 3 4.3 CC[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL338235 116937 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 429 4 1 3 4.3 CC[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
44273316 98925 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL279022 98925 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 589 7 1 5 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@@H](NCc3ccccc3)C1=O)C2 10.1016/0960-894X(94)00469-V
15011336 19394 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 359 3 0 3 3.1 O=C1CCCCC1CS(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL129246 19394 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 359 3 0 3 3.1 O=C1CCCCC1CS(=O)(=O)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL419793 215701 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@H](CCCCN)NC(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10098332 22455 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cnc(CC(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
CHEMBL132496 22455 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 6 1 5 3.6 Cn1cnc(CC(=O)N[C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)c1 10.1021/jm00077a002
44352189 118566 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 414 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
CHEMBL341470 118566 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 414 3 1 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)/C(=N\O)C2 10.1021/jm00077a002
10414067 168620 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CCCCC1)C2 10.1021/jm00077a002
CHEMBL435398 168620 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 512 5 1 3 5.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CCCCC1)C2 10.1021/jm00077a002
44351192 118128 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 430 3 0 4 2.7 CN1C(=O)C2(CCN(S(=O)(=O)C[C@]34CCC(CC3=O)C4(C)C)CC2)c2ccccc21 10.1021/jm00099a020
CHEMBL340465 118128 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 430 3 0 4 2.7 CN1C(=O)C2(CCN(S(=O)(=O)C[C@]34CCC(CC3=O)C4(C)C)CC2)c2ccccc21 10.1021/jm00099a020
10363767 19545 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](N)C2 10.1021/jm00077a002
CHEMBL129955 19545 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 402 3 1 3 3.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](N)C2 10.1021/jm00077a002
CHEMBL129089 211137 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL338981 214072 None 0 Rat Binding pIC50 = 6.2 6.2 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
124213 110703 None 18 Rat Binding pIC50 = 4.2 4.2 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 372 4 2 6 4.3 COc1c([C@@H](O)CC(C)C)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
CHEMBL325752 110703 None 18 Rat Binding pIC50 = 4.2 4.2 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 372 4 2 6 4.3 COc1c([C@@H](O)CC(C)C)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
10324995 164428 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NCCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL421248 164428 None 0 Rat Binding pIC50 = 7.2 7.2 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 539 7 3 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)NCCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL395290 214944 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44272997 71745 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL19658 71745 None 0 Rat Binding pIC50 = 8.2 8.2 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 499 4 1 5 2.6 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)C[C@H](N)C1=O)C2 10.1016/0960-894X(94)00469-V
44352455 168733 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 701 12 4 8 1.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL436189 168733 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 701 12 4 8 1.9 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)C(CCS(C)(=O)=O)NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
9997556 118508 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 343 2 0 2 3.6 O=S(=O)(c1ccc(F)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL341108 118508 None 0 Rat Binding pIC50 = 5.2 5.2 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 343 2 0 2 3.6 O=S(=O)(c1ccc(F)cc1)N1CCC2(C=Cc3ccccc32)CC1 10.1021/jm00099a020
CHEMBL405289 215014 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
CHEMBL435159 216123 None 0 Human Binding pIC50 = 6.1 6.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
11758421 99722 None 0 Rat Binding pIC50 = 6.1 6.1 - 1
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 609 6 1 8 4.1 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cnc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL284442 99722 None 0 Rat Binding pIC50 = 6.1 6.1 - 1
Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)Compound was tested for displacement of 3[H] oxytocin from rat OT receptor (in vitro)
ChEMBL 609 6 1 8 4.1 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cnc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL395430 214947 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44351004 19445 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL129513 19445 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
44351157 19203 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(Cl)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL128978 19203 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4cc(Cl)ccc43)CC1)C(=O)C2 10.1021/jm00099a020
44351065 118146 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(Cl)cc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL340588 118146 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 433 3 0 3 4.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccc(Cl)cc43)CC1)C(=O)C2 10.1021/jm00099a020
44351251 18292 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00099a020
CHEMBL127049 18292 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00099a020
10026274 21427 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00077a002
CHEMBL131499 21427 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 440 4 1 4 3.8 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC#N)C2 10.1021/jm00077a002
44351204 117371 None 3 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00099a020
CHEMBL339681 117371 None 3 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00099a020
44429300 87053 None 0 Human Binding pIC50 = 5.1 5.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL232501 87053 None 0 Human Binding pIC50 = 5.1 5.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1035 18 11 14 -1.3 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)C(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C(C)(C)C)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
10030443 116825 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL337615 116825 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1ccncc1)C2 10.1021/jm00077a002
CHEMBL2369136 212055 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity towards oxytocin receptorBinding affinity towards oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H]([C@@H](C)c2c(C)cc(OC)cc2C)NC(=O)[C@H](N)C(C)(C)SSC[C@@H]2NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(=O)NCCCC[C@H](C(=O)NCC(N)=O)NC(=O)[C@H]3CCCN3C2=O)NC1=O 10.1021/jm0303103
CHEMBL2112250 211696 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cccc3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44352427 116878 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 637 10 4 6 3.2 CC(C)[C@H](NC(=O)Cc1c[nH]cn1)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL337889 116878 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 637 10 4 6 3.2 CC(C)[C@H](NC(=O)Cc1c[nH]cn1)C(=O)NC[C@@]1(O)C[C@H]2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00077a002
CHEMBL435021 216122 None 2 Rat Binding pIC50 = 8.1 8.1 1 2
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CNCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10437668 78911 None 1 Rat Binding pIC50 = 8.1 8.1 6 2
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
CHEMBL2112903 78911 None 1 Rat Binding pIC50 = 8.1 8.1 6 2
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 554 9 2 7 1.5 Cc1ccccc1N1CCN(S(=O)(=O)C[C@]23CCC(C[C@@H]2NC(=O)[C@@H](N)CCS(C)(=O)=O)C3(C)C)CC1 10.1021/jm00031a004
2249 2227 None 17 Rat Binding pIC50 = 8.1 8.1 1 7
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
9872389 2227 None 17 Rat Binding pIC50 = 8.1 8.1 1 7
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL1253853 2227 None 17 Rat Binding pIC50 = 8.1 8.1 1 7
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
44429295 169053 None 0 Human Binding pIC50 = 7.1 7.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
CHEMBL438849 169053 None 0 Human Binding pIC50 = 7.1 7.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 1110 19 10 14 -0.1 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@@H](C(=O)N3Cc4ccccc4C[C@@H]3C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1016/j.ejmech.2006.12.016
44352114 22071 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 8 3 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCCO)C2 10.1021/jm00077a002
CHEMBL132165 22071 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 517 8 3 5 2.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C(N)CCCO)C2 10.1021/jm00077a002
9981665 118541 None 4 Rat Binding pIC50 = 6.1 6.1 1 6
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00077a002
CHEMBL341339 118541 None 4 Rat Binding pIC50 = 6.1 6.1 1 6
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 459 5 2 4 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CC(=O)O)C2 10.1021/jm00077a002
44352400 18912 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
CHEMBL128423 18912 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 3.7 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
10413998 19055 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL128879 19055 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 510 6 2 4 3.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@H](NC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10341722 10379 None 2 Rat Binding pIC50 = 5.1 5.1 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 414 5 1 7 4.8 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
CHEMBL116226 10379 None 2 Rat Binding pIC50 = 5.1 5.1 - 0
Compound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissueCompound was tested for its ability to inhibit binding of Oxytocin to its Oxytocin receptor in rat uterine tissue
ChEMBL 414 5 1 7 4.8 COc1c([C@H](CC(C)C)OC(C)=O)ccc2c1C(=O)OCc1cc(C)cc(O)c1O2 10.1016/S0960-894X(01)80905-7
16736614 149125 None 0 Human Binding pIC50 = 5.1 5.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
CHEMBL394268 149125 None 0 Human Binding pIC50 = 5.1 5.1 - 1
Displacement of [3H]OT from human OT receptor expressed in HEK cellsDisplacement of [3H]OT from human OT receptor expressed in HEK cells
ChEMBL 975 16 10 13 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H]2Cc3ccccc3CN2C(=O)CCSSC[C@@H](C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.ejmech.2006.12.016
44351033 18086 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 475 4 0 3 5.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)C(c3ccccc3)C1)C(=O)C2 10.1021/jm00099a020
CHEMBL126708 18086 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 475 4 0 3 5.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)C(c3ccccc3)C1)C(=O)C2 10.1021/jm00099a020
71456175 78526 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL2111847 78526 None 0 Rat Binding pIC50 = 5.1 5.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 363 2 0 2 4.4 CC1(C)C2CC[C@]1(CC(=O)N1CCC3(C=Cc4ccccc43)CC1)C(=O)C2 10.1021/jm00099a020
CHEMBL2112654 211702 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
44351248 116975 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 501 6 1 5 4.1 CCOC(=O)C(C)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
CHEMBL338409 116975 None 0 Rat Binding pIC50 = 6.1 6.1 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 501 6 1 5 4.1 CCOC(=O)C(C)[C@@]1(O)CC2CC[C@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)C2(C)C 10.1021/jm00099a020
44273013 99524 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 543 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCO)C1=O)C2 10.1016/0960-894X(94)00469-V
CHEMBL283126 99524 None 0 Rat Binding pIC50 = 8.1 8.1 - 0
Inhibition of binding of [3H]oxytocin to rat uterine oxytocin receptorInhibition of binding of [3H]oxytocin to rat uterine oxytocin receptor
ChEMBL 543 7 2 6 2.2 CC1(C)C2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](N1C(=O)CC(NCCO)C1=O)C2 10.1016/0960-894X(94)00469-V
14981574 78905 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
CHEMBL2112898 78905 None 0 Rat Binding pIC50 = 8.0 8.0 - 0
Displacement of [3H]OT from binding to oxytocin receptor of rat uterusDisplacement of [3H]OT from binding to oxytocin receptor of rat uterus
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1CC2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1021/jm00031a004
10483105 90714 None 1 Rat Binding pIC50 = 8.0 8.0 - 4
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL2391300 90714 None 1 Rat Binding pIC50 = 8.0 8.0 - 4
Inhibition of rat uterus OT receptorInhibition of rat uterus OT receptor
ChEMBL 568 10 2 7 1.8 CN[C@@H](CCS(C)(=O)=O)C(=O)N[C@H]1C[C@H]2CC[C@]1(CS(=O)(=O)N1CCN(c3ccccc3C)CC1)C2(C)C 10.1016/j.bmcl.2012.10.116
44352372 20649 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 558 9 4 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00077a002
CHEMBL130848 20649 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 558 9 4 6 1.6 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CNC(=O)[C@@H](N)CCC(N)=O)C2 10.1021/jm00077a002
44352141 21457 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 7 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](C(=O)[C@H](N)CC(N)=O)C2 10.1021/jm00077a002
CHEMBL131538 21457 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 501 7 2 5 2.5 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](C(=O)[C@H](N)CC(N)=O)C2 10.1021/jm00077a002
10347587 165123 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 8 3 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL422612 165123 None 0 Rat Binding pIC50 = 7.1 7.1 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 552 8 3 5 3.4 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)Cc1c[nH]cn1)C2 10.1021/jm00077a002
10030231 18923 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 1 4 4.5 CC(C)CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
CHEMBL128489 18923 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 541 6 1 4 4.5 CC(C)CC1NC(=O)N([C@H]2C[C@H]3CC[C@]2(CS(=O)(=O)N2CCC4(CCc5ccccc54)CC2)C3(C)C)C1=O 10.1021/jm00077a002
10097994 116332 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 3 4 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CNC(=O)N1)C2 10.1021/jm00077a002
CHEMBL335876 116332 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 514 5 3 4 2.3 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)C1CNC(=O)N1)C2 10.1021/jm00077a002
CHEMBL2112650 211700 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.Concentration required to displace 50% of [3H]oxytocin from rat uterine receptor.
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](C)N(C)C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
10256281 18911 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
CHEMBL128422 18911 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 524 7 2 4 4.0 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)CCc1c[nH]cn1)C2 10.1021/jm00077a002
10414380 116129 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
CHEMBL335634 116129 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 521 6 1 4 4.2 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(CCc4ccccc43)CC1)[C@@H](NC(=O)Cc1ccccn1)C2 10.1021/jm00077a002
10392781 118341 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1cccnc1)C2 10.1021/jm00077a002
CHEMBL340964 118341 None 0 Rat Binding pIC50 = 7.0 7.0 - 0
Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissueInhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue
ChEMBL 549 7 2 5 4.1 CC1(C)[C@@H]2CC[C@@]1(CS(=O)(=O)N1CCC3(C=Cc4ccccc43)CC1)[C@@](O)(CCNC(=O)c1cccnc1)C2 10.1021/jm00077a002
44350979 117879 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@@H]1O)C2(C)C 10.1021/jm00099a020
CHEMBL340237 117879 None 0 Rat Binding pIC50 = 6.0 6.0 - 0
Half-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissueHalf-maximal inhibition of binding of [3H]oxytocin to OT receptor in rat uterine tissue
ChEMBL 415 3 1 3 3.8 C[C@H]1C2CC[C@@](CS(=O)(=O)N3CCC4(C=Cc5ccccc54)CC3)([C@@H]1O)C2(C)C 10.1021/jm00099a020
90663156 106662 None 0 Human Binding pKd = 9.6 9.6 - 1
Dissociation constant value for human OT-receptorDissociation constant value for human OT-receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142545 106662 None 0 Human Binding pKd = 9.6 9.6 - 1
Dissociation constant value for human OT-receptorDissociation constant value for human OT-receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142790 106662 None 0 Human Binding pKd = 9.6 9.6 - 1
Dissociation constant value for human OT-receptorDissociation constant value for human OT-receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
136961688 118657 None 0 Human Binding pKd = 8.9 8.9 14 3
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1206 23 5 13 7.4 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL3416750 118657 None 0 Human Binding pKd = 8.9 8.9 14 3
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1206 23 5 13 7.4 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCNC(=O)CCc2ccc(S(=O)(=O)N(CC(=O)N/N=C3\C(=O)Nc4ccccc43)c3ccc(Cl)cc3)cc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
118753720 120937 None 0 Human Binding pKd = 8.8 8.8 - 1
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1051 28 4 17 6.7 COc1ccc(-n2c(COCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
CHEMBL3416751 120937 None 0 Human Binding pKd = 8.8 8.8 - 1
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1051 28 4 17 6.7 COc1ccc(-n2c(COCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
CHEMBL3559144 120937 None 0 Human Binding pKd = 8.8 8.8 - 1
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1051 28 4 17 6.7 COc1ccc(-n2c(COCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
145947419 167757 None 0 Human Binding pKd = 8.8 8.8 323 2
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1204 30 2 18 7.6 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL3416753 167757 None 0 Human Binding pKd = 8.8 8.8 323 2
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1204 30 2 18 7.6 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL4301807 167757 None 0 Human Binding pKd = 8.8 8.8 323 2
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1204 30 2 18 7.6 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
136961687 118656 None 0 Human Binding pKd = 8.8 8.8 35 3
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1053 21 7 12 6.4 O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm501395b
CHEMBL3416749 118656 None 0 Human Binding pKd = 8.8 8.8 35 3
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1053 21 7 12 6.4 O=C(CCCCCNC(=O)c1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)NCCNC(=O)CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm501395b
145947801 167815 None 0 Human Binding pKd = 8.7 8.7 190 2
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1381 42 2 22 7.7 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL3416754 167815 None 0 Human Binding pKd = 8.7 8.7 190 2
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1381 42 2 22 7.7 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
CHEMBL4302530 167815 None 0 Human Binding pKd = 8.7 8.7 190 2
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1381 42 2 22 7.7 CCN1/C(=C\C=C\C=C\C2=[N+](CC)c3cc(S(=O)(=O)[O-])ccc3C2(C)C)C(C)(CCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCc2nnc(N3CC(Oc4ccc(F)cc4Cl)C3)n2-c2ccc(OC)nc2)c2cc(S(=O)(=O)O)ccc21 10.1021/jm501395b
44324579 97089 None 0 Rat Binding pKd = 8.0 8.0 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 31 15 14 -1.2 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(C)(C)S 10.1021/jm00014a022
CHEMBL266898 97089 None 0 Rat Binding pKd = 8.0 8.0 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 31 15 14 -1.2 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(C)(C)S 10.1021/jm00014a022
10011419 115456 None 0 Rat Binding pKd = 8.0 8.0 1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 115456 None 0 Rat Binding pKd = 8.0 8.0 1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718384 115410 None 0 Rat Binding pKd = 8.0 8.0 7 3
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349465 115410 None 0 Rat Binding pKd = 8.0 8.0 7 3
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
56671727 63258 None 0 Rat Binding pKd = 5.0 5.0 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1101 29 15 14 -2.5 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)[C@@H](C)O 10.1021/jm00014a022
CHEMBL1790762 63258 None 0 Rat Binding pKd = 5.0 5.0 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1101 29 15 14 -2.5 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)[C@@H](C)O 10.1021/jm00014a022
90669116 109780 None 0 Human Binding pKd = 6.9 6.9 2 2
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3229632 109780 None 0 Human Binding pKd = 6.9 6.9 2 2
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
90669116 109780 None 0 Rat Binding pKd = 6.9 6.9 -2 2
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229632 109780 None 0 Rat Binding pKd = 6.9 6.9 -2 2
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
90669121 109785 None 0 Rat Binding pKd = 7.9 7.9 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229637 109785 None 0 Rat Binding pKd = 7.9 7.9 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324578 96641 None 0 Rat Binding pKd = 7.9 7.9 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL263153 96641 None 0 Rat Binding pKd = 7.9 7.9 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
10463677 115413 None 1 Rat Binding pKd = 7.9 7.9 38 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349468 115413 None 1 Rat Binding pKd = 7.9 7.9 38 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90669124 109788 None 0 Rat Binding pKd = 6.9 6.9 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229640 109788 None 0 Rat Binding pKd = 6.9 6.9 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL2370976 212431 None 10 Rat Binding pKd = 7.9 7.9 -2 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL None None None CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
71312201 115451 None 11 Rat Binding pKd = 7.9 7.9 1 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350118 115451 None 11 Rat Binding pKd = 7.9 7.9 1 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
118718751 115454 None 0 Rat Binding pKd = 7.9 7.9 -1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 115454 None 0 Rat Binding pKd = 7.9 7.9 -1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3245748 213717 None 1 Human Binding pKd = 6.9 6.9 -4 3
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3245748 213717 None 1 Rat Binding pKd = 6.9 6.9 -4 3
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
44324625 169140 None 0 Rat Binding pKd = 7.9 7.9 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439482 169140 None 0 Rat Binding pKd = 7.9 7.9 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
118718383 115409 None 0 Rat Binding pKd = 7.8 7.8 16 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 115409 None 0 Rat Binding pKd = 7.8 7.8 16 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
44320759 160869 None 0 Human Binding pKd = 7.8 7.8 8 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1036 22 12 15 -4.4 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
CHEMBL411420 160869 None 0 Human Binding pKd = 7.8 7.8 8 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1036 22 12 15 -4.4 CCOc1ccc(C[C@@H]2NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
90669121 109785 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229637 109785 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1032 15 11 14 -0.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
90669122 109786 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229638 109786 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
90669118 109782 None 0 Rat Binding pKd = 6.8 6.8 -1 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229634 109782 None 0 Rat Binding pKd = 6.8 6.8 -1 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
90669123 109787 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229639 109787 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324596 97303 None 0 Rat Binding pKd = 7.8 7.8 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 97303 None 0 Rat Binding pKd = 7.8 7.8 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
118718748 115450 None 0 Rat Binding pKd = 7.8 7.8 1 2
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 115450 None 0 Rat Binding pKd = 7.8 7.8 1 2
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
44320761 141554 None 0 Human Binding pKd = 6.8 6.8 1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1110 20 13 15 -3.2 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL384292 141554 None 0 Human Binding pKd = 6.8 6.8 1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1110 20 13 15 -3.2 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL3245750 213718 None 0 Human Binding pKd = 6.8 6.8 - 1
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1021/jm00187a002
90669122 109786 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229638 109786 None 0 Rat Binding pKd = 7.8 7.8 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1033 18 10 14 -1.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
44321134 112625 None 0 Human Binding pKd = 7.8 7.8 45 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 963 16 9 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL330022 112625 None 0 Human Binding pKd = 7.8 7.8 45 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 963 16 9 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N(C)CC(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
44294474 97065 None 0 Rat Binding pKd = 7.7 7.7 -1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 97065 None 0 Rat Binding pKd = 7.7 7.7 -1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718386 115412 None 0 Rat Binding pKd = 7.7 7.7 12 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349467 115412 None 0 Rat Binding pKd = 7.7 7.7 12 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90678222 111487 None 0 Rat Binding pKd = 6.7 6.7 - 1
Antagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challengeAntagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challenge
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
CHEMBL3273609 111487 None 0 Rat Binding pKd = 6.7 6.7 - 1
Antagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challengeAntagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challenge
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
90669119 109783 None 0 Rat Binding pKd = 7.7 7.7 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229635 109783 None 0 Rat Binding pKd = 7.7 7.7 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
70693566 78401 None 0 Human Binding pKd = 5.7 5.7 2 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL2110297 78401 None 0 Human Binding pKd = 5.7 5.7 2 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
118753721 120938 None 0 Human Binding pKd = 8.7 8.7 - 1
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1227 40 4 21 6.8 COc1ccc(-n2c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
CHEMBL3416752 120938 None 0 Human Binding pKd = 8.7 8.7 - 1
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1227 40 4 21 6.8 COc1ccc(-n2c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
CHEMBL3559145 120938 None 0 Human Binding pKd = 8.7 8.7 - 1
Binding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assayBinding affinity to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells by TR-FRET assay
ChEMBL 1227 40 4 21 6.8 COc1ccc(-n2c(COCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCCCCNC(=O)c3ccc(-c4c5ccc(=O)cc-5oc5cc(O)ccc45)c(C(=O)O)c3)nnc2N2CC(Oc3ccc(F)cc3Cl)C2)cn1 10.1021/jm501395b
44320718 168997 None 0 Human Binding pKd = 7.7 7.7 1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1139 22 12 15 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00028a008
CHEMBL438387 168997 None 0 Human Binding pKd = 7.7 7.7 1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1139 22 12 15 -2.5 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00028a008
CHEMBL3350121 213924 None 0 Rat Binding pKd = 6.7 6.7 - 1
Compound was evaluated for the oxytocic activity with out Mg2+.Compound was evaluated for the oxytocic activity with out Mg2+.
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718383 115409 None 0 Rat Binding pKd = 7.7 7.7 16 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349464 115409 None 0 Rat Binding pKd = 7.7 7.7 16 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
118718753 115457 None 0 Rat Binding pKd = 7.7 7.7 1 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350126 115457 None 0 Rat Binding pKd = 7.7 7.7 1 3
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
90669123 109787 None 0 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229639 109787 None 0 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1006 16 10 14 -1.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
118718385 115411 None 0 Rat Binding pKd = 7.6 7.6 251 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 115411 None 0 Rat Binding pKd = 7.6 7.6 251 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
10396464 115414 None 0 Rat Binding pKd = 7.6 7.6 8 2
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349469 115414 None 0 Rat Binding pKd = 7.6 7.6 8 2
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90669116 109780 None 0 Rat Binding pKd = 5.6 5.6 -2 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229632 109780 None 0 Rat Binding pKd = 5.6 5.6 -2 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
90669120 109784 None 1 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229636 109784 None 1 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL2372311 212673 None 6 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)CC(C)(C)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00191a019
90669124 109788 None 0 Rat Binding pKd = 6.6 6.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229640 109788 None 0 Rat Binding pKd = 6.6 6.6 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1048 18 11 15 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
118718751 115454 None 0 Rat Binding pKd = 7.6 7.6 -1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350123 115454 None 0 Rat Binding pKd = 7.6 7.6 -1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718386 115412 None 0 Rat Binding pKd = 7.6 7.6 12 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349467 115412 None 0 Rat Binding pKd = 7.6 7.6 12 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 14 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90669117 109781 None 1 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
CHEMBL3229633 109781 None 1 Rat Binding pKd = 7.6 7.6 - 1
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
118718752 115455 None 0 Rat Binding pKd = 7.6 7.6 1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 115455 None 0 Rat Binding pKd = 7.6 7.6 1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
56678404 63350 None 0 Human Binding pKd = 6.6 6.6 -1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1021/jm00028a008
CHEMBL1793955 63350 None 0 Human Binding pKd = 6.6 6.6 -1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC1=O 10.1021/jm00028a008
44321188 162000 None 0 Human Binding pKd = 7.6 7.6 1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1105 22 12 15 -2.7 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
CHEMBL415230 162000 None 0 Human Binding pKd = 7.6 7.6 1 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1105 22 12 15 -2.7 CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC2=O)cc1 10.1021/jm00028a008
90669118 109782 None 0 Rat Binding pKd = 7.6 7.6 -1 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229634 109782 None 0 Rat Binding pKd = 7.6 7.6 -1 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
118718748 115450 None 0 Rat Binding pKd = 7.5 7.5 1 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350116 115450 None 0 Rat Binding pKd = 7.5 7.5 1 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL2370976 212431 None 10 Rat Binding pKd = 7.5 7.5 -2 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL None None None CCOc1ccc(C[C@@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
71312201 115451 None 11 Rat Binding pKd = 8.5 8.5 1 2
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350118 115451 None 11 Rat Binding pKd = 8.5 8.5 1 2
In vitro antioxycic activity with out Mg2+.In vitro antioxycic activity with out Mg2+.
ChEMBL 1074 19 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
90669117 109781 None 1 Rat Binding pKd = 7.5 7.5 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229633 109781 None 1 Rat Binding pKd = 7.5 7.5 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324600 169086 None 0 Rat Binding pKd = 5.5 5.5 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 32 16 14 -2.4 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL439098 169086 None 0 Rat Binding pKd = 5.5 5.5 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1157 32 16 14 -2.4 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL3245748 213717 None 1 Chicken Binding pKd = 7.5 7.5 4 3
Antagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor responseAntagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor response
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00201a017
90669117 109781 None 1 Rat Binding pKd = 7.5 7.5 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00187a002
CHEMBL3229633 109781 None 1 Rat Binding pKd = 7.5 7.5 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00187a002
118718747 115449 None 0 Rat Binding pKd = 7.5 7.5 2 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 115449 None 0 Rat Binding pKd = 7.5 7.5 2 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
90669117 109781 None 1 Rat Binding pKd = 7.5 7.5 - 1
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
CHEMBL3229633 109781 None 1 Rat Binding pKd = 7.5 7.5 - 1
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00200a007
CHEMBL3229641 213695 None 0 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL None None None COc1ccc(C[C@@H]2NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00191a019
118718753 115457 None 0 Rat Binding pKd = 7.4 7.4 1 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350126 115457 None 0 Rat Binding pKd = 7.4 7.4 1 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1074 18 11 15 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
70693557 78387 None 0 Human Binding pKd = 6.4 6.4 6 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL2110163 78387 None 0 Human Binding pKd = 6.4 6.4 6 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1018 18 12 14 -4.5 CC[C@H](C)[C@H]1NC(=O)[C@@]2(CCc3ccccc3C2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
90669120 109784 None 1 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic responseAntagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic response
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3229636 109784 None 1 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic responseAntagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic response
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
90669120 109784 None 1 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229636 109784 None 1 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
90669120 109784 None 1 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229636 109784 None 1 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysisAntagonist activity at oxytocin receptor in rat uterus by average effective molar concentration based analysis
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
118718749 115452 None 0 Rat Binding pKd = 7.4 7.4 -1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 115452 None 0 Rat Binding pKd = 7.4 7.4 -1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
44373715 155791 None 0 Human Binding pKd = 7.4 7.4 131 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1031 20 13 14 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL405165 155791 None 0 Human Binding pKd = 7.4 7.4 131 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1031 20 13 14 -4.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
118718384 115410 None 0 Rat Binding pKd = 7.4 7.4 7 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349465 115410 None 0 Rat Binding pKd = 7.4 7.4 7 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 18 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)N(C)C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
44324574 96922 None 0 Rat Binding pKd = 5.4 5.4 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1114 30 15 14 -3.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL265490 96922 None 0 Rat Binding pKd = 5.4 5.4 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1114 30 15 14 -3.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL2370617 212346 None 0 Rat Binding pKd = 8.4 8.4 1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL None None None CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
CHEMBL2370617 212346 None 0 Rat Binding pKd = 8.3 8.3 1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL None None None CCOc1ccc(C[C@H]2NC(=O)CC3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm00010a020
90669119 109783 None 0 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229635 109783 None 0 Rat Binding pKd = 7.4 7.4 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1020 17 11 14 -0.9 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
10011419 115456 None 0 Rat Binding pKd = 7.4 7.4 1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350125 115456 None 0 Rat Binding pKd = 7.4 7.4 1 3
In vitro activity for the anti-oxytocic activity with out Mg2+.In vitro activity for the anti-oxytocic activity with out Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
44324601 141946 None 0 Rat Binding pKd = 8.3 8.3 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL386547 141946 None 0 Rat Binding pKd = 8.3 8.3 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44294474 97065 None 0 Rat Binding pKd = 8.3 8.3 -1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL266643 97065 None 0 Rat Binding pKd = 8.3 8.3 -1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1092 17 11 13 -1.0 CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm00010a020
118718747 115449 None 0 Rat Binding pKd = 8.3 8.3 2 2
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
CHEMBL3350115 115449 None 0 Rat Binding pKd = 8.3 8.3 2 2
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1126 19 13 14 -2.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00010a020
10396464 115414 None 0 Rat Binding pKd = 8.3 8.3 8 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349469 115414 None 0 Rat Binding pKd = 8.3 8.3 8 2
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1154 19 12 16 -0.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
10463677 115413 None 1 Rat Binding pKd = 8.2 8.2 38 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349468 115413 None 1 Rat Binding pKd = 8.2 8.2 38 3
In vitro anti-oxytocic activity with 0.5 mM Mg2+.In vitro anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 991 15 10 14 -0.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(OC)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90673598 110565 None 0 Chicken Binding pKd = 7.3 7.3 - 1
Antagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor responseAntagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor response
ChEMBL 957 17 12 12 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)NCCCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00201a017
CHEMBL3249128 110565 None 0 Chicken Binding pKd = 7.3 7.3 - 1
Antagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor responseAntagonist activity at oxytocin receptor in conscious chicken assessed as inhibition of oxytocin-induced vaspdepressor response
ChEMBL 957 17 12 12 -3.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)NCCCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00201a017
90669118 109782 None 0 Human Binding pKd = 7.2 7.2 1 2
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3229634 109782 None 0 Human Binding pKd = 7.2 7.2 1 2
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1047 19 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
118718750 115453 None 0 Rat Binding pKd = 7.2 7.2 -8 2
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 115453 None 0 Rat Binding pKd = 7.2 7.2 -8 2
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
118718752 115455 None 0 Rat Binding pKd = 7.2 7.2 1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350124 115455 None 0 Rat Binding pKd = 7.2 7.2 1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL2371240 212485 None 0 Human Binding pKd = 4.2 4.2 - 1
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H]2c3[nH]c4ccccc4c3CCN2C(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
44324577 96496 None 0 Rat Binding pKd = 5.2 5.2 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1128 31 15 14 -2.6 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL262157 96496 None 0 Rat Binding pKd = 5.2 5.2 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1128 31 15 14 -2.6 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL3350121 213924 None 0 Rat Binding pKd = 5.2 5.2 - 1
Compound was evaluated for the oxytocic activity with 0.5 mM Mg2+.Compound was evaluated for the oxytocic activity with 0.5 mM Mg2+.
ChEMBL None None None NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm00010a020
90669117 109781 None 1 Rat Binding pKd = 6.2 6.2 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
CHEMBL3229633 109781 None 1 Rat Binding pKd = 6.2 6.2 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 992 15 11 14 -1.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00191a019
44324597 97302 None 0 Rat Binding pKd = 5.2 5.2 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268778 97302 None 0 Rat Binding pKd = 5.2 5.2 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@@H](C)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44373714 96771 None 0 Human Binding pKd = 8.2 8.2 -1 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1148 32 14 16 -3.1 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)oc2cc(OC)ccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O 10.1016/s0960-894x(99)00041-4
CHEMBL264208 96771 None 0 Human Binding pKd = 8.2 8.2 -1 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 1148 32 14 16 -3.1 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)c1cc(=O)oc2cc(OC)ccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O 10.1016/s0960-894x(99)00041-4
44321189 98291 None 0 Human Binding pKd = 8.2 8.2 - 1
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1017 20 14 14 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL274397 98291 None 0 Human Binding pKd = 8.2 8.2 - 1
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1017 20 14 14 -4.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSSC[C@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
118718749 115452 None 0 Rat Binding pKd = 8.2 8.2 -1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350119 115452 None 0 Rat Binding pKd = 8.2 8.2 -1 3
In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.In vitro activity was determined for the anti-oxytocic activity with 0.5 mM Mg2+.
ChEMBL 1136 18 11 14 -0.5 CCN1C(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
2042 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
2174 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
2176 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
439302 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
439302.0 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
CHEMBL395429 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
DB00107 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None None 10.1016/s0960-894x(99)00041-4
2042 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
2174 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
2176 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
439302 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
439302.0 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
CHEMBL395429 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
DB00107 2983 None 40 Human Binding pKd = 8.2 8.2 1 8
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL None None None None 10.1021/jm00028a008
90678222 111487 None 0 Rat Binding pKd = 5.2 5.2 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
CHEMBL3273609 111487 None 0 Rat Binding pKd = 5.2 5.2 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of synthetic lysine vasopressin-induced pressor response
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
44321206 96856 None 0 Human Binding pKd = 8.2 8.2 13 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1094 20 12 14 -2.9 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
CHEMBL265017 96856 None 0 Human Binding pKd = 8.2 8.2 13 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1094 20 12 14 -2.9 CN(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C(=O)[C@@H]1CSSC2(CCCCC2)CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm00028a008
118718750 115453 None 0 Rat Binding pKd = 8.1 8.1 -8 2
In vitro activity for the anti-oxytocic activity with out Mg2+In vitro activity for the anti-oxytocic activity with out Mg2+
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
CHEMBL3350120 115453 None 0 Rat Binding pKd = 8.1 8.1 -8 2
In vitro activity for the anti-oxytocic activity with out Mg2+In vitro activity for the anti-oxytocic activity with out Mg2+
ChEMBL 1151 19 12 15 -2.3 CN1C(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]1Cc1ccc(O)cc1 10.1021/jm00010a020
90669120 109784 None 1 Rat Binding pKd = 7.2 7.2 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229636 109784 None 1 Rat Binding pKd = 7.2 7.2 - 1
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition in presence of 0.5 mM Mg2+
ChEMBL 1059 17 11 14 -0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3245755 213719 None 0 Rat Binding pKd = 7.1 7.1 - 1
Antagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic responseAntagonist activity at oxytocin receptor in isolated rat uterus assessed as inhibition of oxytocin-induced oxytocic response
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
90669116 109780 None 0 Rat Binding pKd = 7.1 7.1 -2 2
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
CHEMBL3229632 109780 None 0 Rat Binding pKd = 7.1 7.1 -2 2
Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+Antagonist activity at oxytocin receptor in rat uterus by Schild's method in absence of Mg2+
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00200a007
90669116 109780 None 0 Rat Binding pKd = 7.1 7.1 -2 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
CHEMBL3229632 109780 None 0 Rat Binding pKd = 7.1 7.1 -2 2
Antagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin additionAntagonist activity at oxytocin receptor in rat uterus pretreated with diethylstilbestrol compound treated 1 min prior to oxytocin addition
ChEMBL 1019 17 11 14 -1.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(C)(C)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00191a019
44324596 97303 None 0 Rat Binding pKd = 5.1 5.1 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
CHEMBL268779 97303 None 0 Rat Binding pKd = 5.1 5.1 - 1
Biological activity against Oxytocin receptor in ratBiological activity against Oxytocin receptor in rat
ChEMBL 1129 31 15 14 -2.0 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CC1(S)CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O 10.1021/jm00014a022
44373744 51188 None 0 Human Binding pKd = 8.1 8.1 52 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 993 20 12 14 -4.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
CHEMBL157988 51188 None 0 Human Binding pKd = 8.1 8.1 52 2
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL 993 20 12 14 -4.2 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
44321133 161929 None 0 Human Binding pKd = 8.1 8.1 38 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL414582 161929 None 0 Human Binding pKd = 8.1 8.1 38 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 1060 20 12 14 -3.1 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
44320760 208843 None 0 Human Binding pKd = 8.1 8.1 52 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 992 20 12 14 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
CHEMBL87636 208843 None 0 Human Binding pKd = 8.1 8.1 52 2
Inhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membraneInhibition of radioligand [3H]OT binding to oxytocin receptor (OT) in guinea pig myometrium membrane
ChEMBL 992 20 12 14 -4.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00028a008
90672304 110496 None 0 Rat Binding pKd = 7.1 7.1 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1203 19 11 14 0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3245753 110496 None 0 Rat Binding pKd = 7.1 7.1 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1203 19 11 14 0.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL2371240 212485 None 0 Human Binding pKd = 5.1 5.1 - 1
Compound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptorCompound was evaluated for its dissociation constant (Kd) to guinea pig myometrial Oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H]2c3[nH]c4ccccc4c3CCN2C(=O)CCSSC[C@H](C(=O)N(C)CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/s0960-894x(99)00041-4
90672303 110495 None 0 Rat Binding pKd = 7.1 7.1 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1147 17 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
CHEMBL3245752 110495 None 0 Rat Binding pKd = 7.1 7.1 - 1
Antagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor in rat assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1147 17 11 14 -1.0 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cc(Br)c(O)c(Br)c2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00187a002
118718385 115411 None 0 Rat Binding pKd = 8.0 8.0 251 2
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
CHEMBL3349466 115411 None 0 Rat Binding pKd = 8.0 8.0 251 2
In vitro anti-oxytocic activity with out Mg2+.In vitro anti-oxytocic activity with out Mg2+.
ChEMBL 1000 14 11 13 0.2 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2cc3ccccc3[nH]2)NC(=O)CC2(CCCCC2)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN)C(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC1=O 10.1021/jm00010a020
90672302 110494 None 0 Human Binding pKd = 7.0 7.0 - 1
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1033 18 10 13 0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1021/jm00187a002
CHEMBL3245751 110494 None 0 Human Binding pKd = 7.0 7.0 - 1
Antagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic responseAntagonist activity at oxytocin receptor (unknown origin) assessed as inhibition of agonist-induced oxytocic response
ChEMBL 1033 18 10 13 0.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC(CC)(CC)SSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC1=O 10.1021/jm00187a002
CHEMBL3273606 213751 None 0 Rat Binding pKd = 6.0 6.0 - 1
Antagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challengeAntagonist activity at oxytocin receptor in rat uterus assessed as inhibition of synthetic oxytocin-induced response treated 1.5 to 2 mins prior to oxytocin challenge
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSSCC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm00224a010
56950588 75368 None 0 Human Binding pKi = 10.6 10.6 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 7 1 5 2.8 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037514 75368 None 0 Human Binding pKi = 10.6 10.6 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 7 1 5 2.8 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
11554957 75370 None 0 Human Binding pKi = 10.5 10.5 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 490 7 1 4 3.4 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037516 75370 None 0 Human Binding pKi = 10.5 10.5 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 490 7 1 4 3.4 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
11570070 75371 None 0 Human Binding pKi = 10.5 10.5 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 532 7 1 5 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037517 75371 None 0 Human Binding pKi = 10.5 10.5 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 532 7 1 5 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
11605341 75361 None 0 Human Binding pKi = 10.4 10.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cnc(C)cc1C 10.1021/jm201287w
CHEMBL2037507 75361 None 0 Human Binding pKi = 10.4 10.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cnc(C)cc1C 10.1021/jm201287w
57722466 75362 None 0 Human Binding pKi = 10.3 10.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cnc(C)cc1C 10.1021/jm201287w
CHEMBL2037508 75362 None 0 Human Binding pKi = 10.3 10.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cnc(C)cc1C 10.1021/jm201287w
11547430 75367 None 0 Human Binding pKi = 10.3 10.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 1 4 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037513 75367 None 0 Human Binding pKi = 10.3 10.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 1 4 3.1 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
11691437 75369 None 0 Human Binding pKi = 10.3 10.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 2 4 3.0 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037515 75369 None 0 Human Binding pKi = 10.3 10.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 7 2 4 3.0 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
56950040 75350 None 0 Human Binding pKi = 10.2 10.2 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 5 1 4 3.1 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
CHEMBL2037496 75350 None 0 Human Binding pKi = 10.2 10.2 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 5 1 4 3.1 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
11669836 75360 None 0 Human Binding pKi = 10.2 10.2 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cnc(C)cc1C 10.1021/jm201287w
CHEMBL2037506 75360 None 0 Human Binding pKi = 10.2 10.2 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cnc(C)cc1C 10.1021/jm201287w
56950041 75351 None 0 Human Binding pKi = 10.1 10.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 5 1 5 2.8 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
CHEMBL2037497 75351 None 0 Human Binding pKi = 10.1 10.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 5 1 5 2.8 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)(C)C)cn1 10.1021/jm201287w
11719871 75364 None 0 Human Binding pKi = 10.1 10.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037510 75364 None 0 Human Binding pKi = 10.1 10.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1C 10.1021/jm201287w
11465834 138509 None 0 Human Binding pKi = 10.1 10.1 23 4
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm201287w
CHEMBL377414 138509 None 0 Human Binding pKi = 10.1 10.1 23 4
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm201287w
56675150 63246 None 0 Human Binding pKi = 10.1 10.1 85 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1382 21 14 19 -1.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc(C3=C4C=CC(N(C)C)=CC4OC4=CC(=[N+](C)C)C=CC43)c(C(=O)O)c2)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790723 63246 None 0 Human Binding pKi = 10.1 10.1 85 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1382 21 14 19 -1.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc(C3=C4C=CC(N(C)C)=CC4OC4=CC(=[N+](C)C)C=CC43)c(C(=O)O)c2)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
11421025 155197 None 0 Human Binding pKi = 10 10.0 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 519 7 2 4 4.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)o1 10.1016/j.bmcl.2007.11.008
CHEMBL401960 155197 None 0 Human Binding pKi = 10 10.0 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 519 7 2 4 4.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(C(F)(F)F)o1 10.1016/j.bmcl.2007.11.008
11576272 75366 None 0 Human Binding pKi = 10 10.0 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 7 2 4 2.7 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037512 75366 None 0 Human Binding pKi = 10 10.0 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 7 2 4 2.7 CCC(CC)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1 10.1021/jm201287w
11598736 78098 None 0 Human Binding pKi = 9.9 9.9 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 513 8 2 4 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)CCO)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL210029 78098 None 0 Human Binding pKi = 9.9 9.9 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 513 8 2 4 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)CCO)c1ccc(F)cc1F 10.1021/jm060073e
11634973 75365 None 15 Human Binding pKi = 9.9 9.9 31622 2
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037511 75365 None 15 Human Binding pKi = 9.9 9.9 31622 2
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1C 10.1021/jm201287w
44456151 95691 None 0 Human Binding pKi = 9.8 9.8 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 520 7 2 5 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1coc(C(F)(F)F)n1 10.1016/j.bmcl.2007.11.008
CHEMBL257916 95691 None 0 Human Binding pKi = 9.8 9.8 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 520 7 2 5 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1coc(C(F)(F)F)n1 10.1016/j.bmcl.2007.11.008
56950167 75355 None 0 Human Binding pKi = 9.8 9.8 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037501 75355 None 0 Human Binding pKi = 9.8 9.8 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
56657868 63241 None 0 Human Binding pKi = 9.8 9.8 69 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1297 16 15 21 -0.8 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790719 63241 None 0 Human Binding pKi = 9.8 9.8 69 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1297 16 15 21 -0.8 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
56671720 63243 None 0 Human Binding pKi = 9.7 9.7 67 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1324 18 15 21 -0.9 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790720 63243 None 0 Human Binding pKi = 9.7 9.7 67 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1324 18 15 21 -0.9 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
56950311 75353 None 0 Human Binding pKi = 9.7 9.7 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037499 75353 None 0 Human Binding pKi = 9.7 9.7 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
56678446 63234 None 0 Human Binding pKi = 9.7 9.7 18 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1125 16 13 16 -0.3 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790712 63234 None 0 Human Binding pKi = 9.7 9.7 18 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1125 16 13 16 -0.3 CC[C@@H](C)[C@H]1NC(=O)[C@@](C)(c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN)C(=O)N[C@H](C(N)=O)c2ccc(O)cc2)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@@H](C)O)NC1=O 10.1021/jm010526+
118734326 118659 None 0 Human Binding pKi = 9.7 9.7 - 1
Competitive binding to human oxytocin receptor by radioligand binding assayCompetitive binding to human oxytocin receptor by radioligand binding assay
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
CHEMBL3416758 118659 None 0 Human Binding pKi = 9.7 9.7 - 1
Competitive binding to human oxytocin receptor by radioligand binding assayCompetitive binding to human oxytocin receptor by radioligand binding assay
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
56664849 63244 None 0 Human Binding pKi = 9.6 9.6 426 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1308 18 14 20 0.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790721 63244 None 0 Human Binding pKi = 9.6 9.6 426 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1308 18 14 20 0.2 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
56949758 75341 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 520 7 1 6 2.1 COc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037487 75341 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 520 7 1 6 2.1 COc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
56949760 75343 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 491 7 1 5 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(N(C)C)nc1 10.1021/jm201287w
CHEMBL2037489 75343 None 0 Human Binding pKi = 9.6 9.6 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 491 7 1 5 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(N(C)C)nc1 10.1021/jm201287w
56664848 63240 None 0 Human Binding pKi = 9.5 9.5 199 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1322 19 14 20 0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790718 63240 None 0 Human Binding pKi = 9.5 9.5 199 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1322 19 14 20 0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
53316559 56354 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630522 56354 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se]SC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
90663156 106662 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142545 106662 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142790 106662 None 0 Human Binding pKi = 9.5 9.5 - 1
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1377 36 13 17 0.6 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
56950039 75344 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 533 7 1 6 2.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(N(C)C)nc1 10.1021/jm201287w
CHEMBL2037490 75344 None 0 Human Binding pKi = 9.5 9.5 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 533 7 1 6 2.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(N(C)C)nc1 10.1021/jm201287w
56671723 63248 None 0 Human Binding pKi = 9.5 9.5 53 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1311 17 15 21 -0.4 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790729 63248 None 0 Human Binding pKi = 9.5 9.5 53 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1311 17 15 21 -0.4 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
449224 169078 None 10 Human Binding pKi = 9.5 9.5 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
CHEMBL439044 169078 None 10 Human Binding pKi = 9.5 9.5 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL 991 17 11 14 -2.5 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
56657867 63239 None 0 Human Binding pKi = 9.5 9.5 40 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1338 19 15 21 -0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
CHEMBL1790717 63239 None 0 Human Binding pKi = 9.5 9.5 40 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1338 19 15 21 -0.5 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)C(O)CSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O 10.1021/jm010526+
44456352 158208 None 0 Human Binding pKi = 9.4 9.4 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 468 6 1 5 2.7 Cc1nc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cs1 10.1016/j.bmcl.2007.11.008
CHEMBL408691 158208 None 0 Human Binding pKi = 9.4 9.4 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 468 6 1 5 2.7 Cc1nc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cs1 10.1016/j.bmcl.2007.11.008
11662784 139386 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 469 6 2 3 2.9 CNC(=O)[C@@H](c1ccc(F)cc1F)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm060073e
CHEMBL379192 139386 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 469 6 2 3 2.9 CNC(=O)[C@@H](c1ccc(F)cc1F)N1C(=O)[C@@H](C2Cc3ccccc3C2)NC(=O)[C@H]1CC(C)C 10.1021/jm060073e
56949757 75340 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 7 1 5 2.4 COc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037486 75340 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 7 1 5 2.4 COc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
56949906 75346 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037492 75346 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 Cc1ccc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
11705315 75363 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
CHEMBL2037509 75363 None 0 Human Binding pKi = 9.4 9.4 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1ccc(C)nc1C 10.1021/jm201287w
56657866 63233 None 0 Human Binding pKi = 9.4 9.4 75 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1281 16 14 20 0.3 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@H](C)O)NC1=O 10.1021/jm010526+
CHEMBL1790711 63233 None 0 Human Binding pKi = 9.4 9.4 75 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1281 16 14 20 0.3 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H]([C@H](C)O)NC1=O 10.1021/jm010526+
2042 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
2174 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
2176 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
439302 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
439302.0 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
CHEMBL395429 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
DB00107 2983 None 40 Human Binding pKi = 9.4 9.4 1 8
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2016.05.062
118734326 118659 None 0 Human Binding pKi = 9.4 9.4 - 1
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
CHEMBL3416758 118659 None 0 Human Binding pKi = 9.4 9.4 - 1
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 2-(5-(3-(1-(5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4-(6-methoxypyridinium-3-yl)-4H-1,2,4-triazol-3-yl)-15-oxo-2,5,8,11-tetraoxa-14-azaoctadecan-18-yl)-1-ethyl-3-methyl-5-sulfoindolin-2-ylidene)penta-1,3-dienyl)-1-ethyl-3,3-dimethyl-3H-indolium-6-sulfonate 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
10461270 3678 None 12 Human Binding pKi = 9.3 9.3 3 5
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 3678 None 12 Human Binding pKi = 9.3 9.3 3 5
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 3678 None 12 Human Binding pKi = 9.3 9.3 3 5
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
44279520 100084 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 7 1 10 2.9 O=C(Cn1ccc(N2CCOCC2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL286895 100084 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 7 1 10 2.9 O=C(Cn1ccc(N2CCOCC2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11590596 169019 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 455 6 2 3 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(N)=O)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL438609 169019 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 455 6 2 3 2.6 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(N)=O)c1ccc(F)cc1F 10.1021/jm060073e
56949907 75347 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 488 6 1 4 3.2 Cc1ccc([C@H](C(=O)N2CCCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037493 75347 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 488 6 1 4 3.2 Cc1ccc([C@H](C(=O)N2CCCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
56950043 75354 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037500 75354 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 504 6 1 5 2.4 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(C)nc1 10.1021/jm201287w
155536940 172351 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4474284 172351 None 0 Human Binding pKi = 9.3 9.3 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1074 20 12 15 -2.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
2042 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
2174 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
2176 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
439302 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
439302.0 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
CHEMBL395429 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
DB00107 2983 None 40 Human Binding pKi = 9.2 9.2 1 8
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None None 10.1021/acs.jmedchem.8b01691
18700180 94872 None 0 Rat Binding pKi = 9.2 9.2 1 2
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25353 94872 None 0 Rat Binding pKi = 9.2 9.2 1 2
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
90663155 106661 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1363 35 14 17 0.3 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
CHEMBL3142789 106661 None 0 Human Binding pKi = 9.2 9.2 - 1
Binding affinity towards OT receptor in CHO cells expressing the human OT receptorBinding affinity towards OT receptor in CHO cells expressing the human OT receptor
ChEMBL 1363 35 14 17 0.3 CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CC1(SCCC(N)=O)CCCCC1)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc1ccc(N=[N+]=[N-])c(I)c1)C(N)=O)[C@@H](C)O 10.1021/jm010125u
11340891 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
8403 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
CHEMBL429736 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
DB11818 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
11590614 79749 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 456 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)O)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL211556 79749 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 456 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)O)c1ccc(F)cc1F 10.1021/jm060073e
11295207 138489 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 511 6 2 4 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CC(O)C1)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377315 138489 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 511 6 2 4 2.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CC(O)C1)c1ccc(F)cc1F 10.1021/jm060073e
11465834 138509 None 0 Human Binding pKi = 9.2 9.2 23 4
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 138509 None 0 Human Binding pKi = 9.2 9.2 23 4
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
11569527 139243 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 495 6 1 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCC1)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL378718 139243 None 0 Human Binding pKi = 9.2 9.2 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 495 6 1 3 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCC1)c1ccc(F)cc1F 10.1021/jm060073e
11340891 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
8403 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL429736 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
DB11818 3321 None 28 Human Binding pKi = 9.2 9.2 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
135413562 2205 None 13 Human Binding pKi = 9.2 9.2 1 5
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 2205 None 13 Human Binding pKi = 9.2 9.2 1 5
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 2205 None 13 Human Binding pKi = 9.2 9.2 1 5
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
135413562 2205 None 13 Human Binding pKi = 9.2 9.2 1 5
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
2194 2205 None 13 Human Binding pKi = 9.2 9.2 1 5
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
CHEMBL445816 2205 None 13 Human Binding pKi = 9.2 9.2 1 5
Displacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
44297449 169363 None 0 Rat Binding pKi = 9.2 9.2 -1 3
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL441195 169363 None 0 Rat Binding pKi = 9.2 9.2 -1 3
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1315 37 15 16 -2.2 CN(C(=O)Cc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
118734326 118659 None 0 Human Binding pKi = 9.2 9.2 - 1
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
CHEMBL3416758 118659 None 0 Human Binding pKi = 9.2 9.2 - 1
Competitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetateCompetitive binding to SNAP-tagged oxytocin receptor (unknown origin) expressed in HEK293 cells incubated for 1 hr at RT followed by 4 hrs at 4 degC by TR-FRET assay in presence of 5-(3-(22-(3-carboxy-4-(3-oxo-3H-xanthen-9-yl)phenyl)-15,22-dioxo-2,5,8,11-tetraoxa-14,21-diazadocosyl)-5-(3-(2-chloro-4-fluorophenoxy)azetidin-1-yl)-4H-1,2,4-triazol-4-yl)-2-methoxypyridinium 2,2,2-trifluoroacetate
ChEMBL 1203 19 13 17 -1.3 COc1ccc(C[C@@H]2NC(=O)C(N)C3(CCCCC3)SSC[C@@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)N[C@@H](Cc3ccc(O)cc3)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](Cc3ccccc3)NC2=O)cc1 10.1021/jm501395b
135413562 2205 None 13 Rat Binding pKi = 9.2 9.2 -1 5
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
2194 2205 None 13 Rat Binding pKi = 9.2 9.2 -1 5
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
CHEMBL445816 2205 None 13 Rat Binding pKi = 9.2 9.2 -1 5
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm050645f
135413562 2205 None 13 Rat Binding pKi = 9.2 9.2 -1 5
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
2194 2205 None 13 Rat Binding pKi = 9.2 9.2 -1 5
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
CHEMBL445816 2205 None 13 Rat Binding pKi = 9.2 9.2 -1 5
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 624 14 3 7 1.1 CN(CCCNC(=O)CCc1ccc(cc1)S(=O)(=O)N(c1ccc(cc1)Cl)CC(=O)NNC1=c2ccccc2=NC1=O)C 10.1021/jm901812z
1103817 17011 None 9 Rat Binding pKi = 9.2 9.2 3 4
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
CHEMBL1254117 17011 None 9 Rat Binding pKi = 9.2 9.2 3 4
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 492 8 2 6 3.1 CCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(C)cc2)cc1 10.1021/jm901812z
CHEMBL2112249 211695 None 2 Rat Binding pKi = 9.2 9.2 8 2
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00099a019
9938406 93370 None 1 Rat Binding pKi = 9.2 9.2 1 6
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24526 93370 None 1 Rat Binding pKi = 9.2 9.2 1 6
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
53317550 56355 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630523 56355 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1026 17 12 14 -3.8 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CS[Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
2042 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
2174 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
2176 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
439302 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
439302.0 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
CHEMBL395429 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
DB00107 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity to OTR (unknown origin)Binding affinity to OTR (unknown origin)
ChEMBL None None None None 10.1021/jm501395b
2042 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
2174 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
2176 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
439302 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
439302.0 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
CHEMBL395429 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
DB00107 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Competitive binding to oxytocin receptor (unknown origin) by radioligand binding assayCompetitive binding to oxytocin receptor (unknown origin) by radioligand binding assay
ChEMBL None None None None 10.1021/jm501395b
2042 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
2174 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
2176 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
439302 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
439302.0 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
CHEMBL395429 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
DB00107 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
44456194 95408 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 478 7 1 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1coc(C2CC2)n1 10.1016/j.bmcl.2007.11.008
CHEMBL256692 95408 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 478 7 1 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1coc(C2CC2)n1 10.1016/j.bmcl.2007.11.008
44455964 97609 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 529 7 2 4 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)o1 10.1016/j.bmcl.2007.11.008
CHEMBL270624 97609 None 0 Human Binding pKi = 9.1 9.1 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 529 7 2 4 3.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)o1 10.1016/j.bmcl.2007.11.008
25212177 174933 None 7 Human Binding pKi = 9.1 9.1 7 4
Displacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL456263 174933 None 7 Human Binding pKi = 9.1 9.1 7 4
Displacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of 3H-oxytocin from human recombinant oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
56950170 75358 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cc(C)cnc1C 10.1021/jm201287w
CHEMBL2037504 75358 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 476 6 1 4 3.0 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1cc(C)cnc1C 10.1021/jm201287w
56950171 75359 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cc(C)cnc1C 10.1021/jm201287w
CHEMBL2037505 75359 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 518 6 1 5 2.8 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1cc(C)cnc1C 10.1021/jm201287w
2042 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
2174 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
2176 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
439302 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
439302.0 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
CHEMBL395429 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
DB00107 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL None None None None 10.1021/jm010526+
2042 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
2174 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
2176 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
439302 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
439302.0 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
CHEMBL395429 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
DB00107 2983 None 40 Human Binding pKi = 9.1 9.1 1 8
Displacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysisDisplacement of [Tyrosyl-2,6-3H]-Oxytocin from recombinant human oxytocin receptor expressed in CHO-DUKX-A2 cells after 180 mins by liquid scintillation counting analysis
ChEMBL None None None None 10.1016/j.ejmech.2015.11.050
10627984 206062 None 0 Human Binding pKi = 9.1 9.1 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 646 8 0 7 5.5 CCc1c(CN2CCC(Oc3cc(OC)c(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)cc3F)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL66985 206062 None 0 Human Binding pKi = 9.1 9.1 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 646 8 0 7 5.5 CCc1c(CN2CCC(Oc3cc(OC)c(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)cc3F)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
10723001 102397 None 0 Human Binding pKi = 9.1 9.1 3 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL303700 102397 None 0 Human Binding pKi = 9.1 9.1 3 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
18700180 94872 None 0 Human Binding pKi = 9.1 9.1 -1 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL25353 94872 None 0 Human Binding pKi = 9.1 9.1 -1 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 533 6 0 6 4.2 O=C(Cc1ccc(N2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
2042 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
2174 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
2176 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
439302 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
439302.0 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
CHEMBL395429 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
DB00107 2983 None 40 Rat Binding pKi = 9.1 9.1 -1 8
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL None None None None 10.1021/jm00171a003
135476004 79092 None 0 Human Binding pKi = 9.1 9.1 8 3
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1039/C5MD00566C
CHEMBL2113185 79092 None 0 Human Binding pKi = 9.1 9.1 8 3
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1039/C5MD00566C
57346808 216130 None 2 Rat Binding pKi = 9.1 9.1 - 1
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
CHEMBL435716 216130 None 2 Rat Binding pKi = 9.1 9.1 - 1
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm9607156
135491819 79091 None 0 Human Binding pKi = 9.1 9.1 104 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 12 4 7 2.4 O=C(CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1)NCCCO 10.1021/jm050645f
CHEMBL2113181 79091 None 0 Human Binding pKi = 9.1 9.1 104 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 12 4 7 2.4 O=C(CCc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1)NCCCO 10.1021/jm050645f
135476004 79092 None 0 Human Binding pKi = 9.1 9.1 8 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
CHEMBL2113185 79092 None 0 Human Binding pKi = 9.1 9.1 8 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 10 2 8 2.7 O=C(CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCN2CCOCC2)cc1)N/N=C1\C(=O)Nc2ccccc21 10.1021/jm050645f
155527198 171281 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4458988 171281 None 0 Human Binding pKi = 9.1 9.1 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1056 20 12 14 -2.7 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3814744 214750 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
2181 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
2182 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
27991 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
27991.0 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
CHEMBL1429 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
CHEMBL264448 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
DB00035 1331 None 29 Rat Binding pKi = 9.0 9.0 -1 8
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
10555563 102165 None 0 Human Binding pKi = 9 9.0 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL302297 102165 None 0 Human Binding pKi = 9 9.0 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 600 7 0 7 4.8 COc1cc(OC2CCN(Cc3c(C)cc[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10579886 103665 None 0 Human Binding pKi = 9 9.0 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 632 7 0 7 5.2 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL308673 103665 None 0 Human Binding pKi = 9 9.0 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 632 7 0 7 5.2 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
15840423 93251 None 0 Human Binding pKi = 9 9.0 1 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24456 93251 None 0 Human Binding pKi = 9 9.0 1 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
11340891 3321 None 28 Human Binding pKi = 9 9.0 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
8403 3321 None 28 Human Binding pKi = 9 9.0 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL429736 3321 None 28 Human Binding pKi = 9 9.0 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
DB11818 3321 None 28 Human Binding pKi = 9 9.0 891 2
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 CC[C@@H]([C@@H]1C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)N1CCOCC1)c1coc(n1)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
11511019 78058 None 0 Human Binding pKi = 9 9.0 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 7 2 4 3.3 Cc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)o1 10.1016/j.bmcl.2007.11.008
CHEMBL209864 78058 None 0 Human Binding pKi = 9 9.0 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 7 2 4 3.3 Cc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)o1 10.1016/j.bmcl.2007.11.008
44456383 95617 None 0 Human Binding pKi = 9 9.0 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1cc(Br)cs1 10.1016/j.bmcl.2007.11.008
CHEMBL257660 95617 None 0 Human Binding pKi = 9 9.0 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1cc(Br)cs1 10.1016/j.bmcl.2007.11.008
44279572 102811 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 617 7 1 8 4.7 O=C(Cn1ccc(-c2ccccc2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL30510 102811 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 617 7 1 8 4.7 O=C(Cn1ccc(-c2ccccc2)nc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11488952 77613 None 0 Human Binding pKi = 9 9.0 31 3
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
CHEMBL208787 77613 None 0 Human Binding pKi = 9 9.0 31 3
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 501 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc2occc2c1 10.1021/jm060073e
56950042 75352 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
CHEMBL2037498 75352 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)nc1 10.1021/jm201287w
56950168 75356 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 6 1 4 1.9 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)[n+]([O-])c1 10.1021/jm201287w
CHEMBL2037502 75356 None 0 Human Binding pKi = 9 9.0 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 478 6 1 4 1.9 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(C)[n+]([O-])c1 10.1021/jm201287w
44428107 10319 None 0 Human Binding pKi = 9.0 9.0 -11 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
91935616 10319 None 0 Human Binding pKi = 9.0 9.0 -11 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
CHEMBL1161978 10319 None 0 Human Binding pKi = 9.0 9.0 -11 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 2058 46 18 25 6.0 CC1CC(C)(C)Nc2c1cc1c(c2S(=O)(=O)O)OC2C(=C1c1c(Cl)c(SCC(=O)NCCCCCC(=O)N(C(=O)[C@H]3CCN(C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](Cc4ccc(O)cc4)N(C)C(=O)CCc4ccc(O)cc4)C3)[C@@H](CCCCN)C(N)=O)c(Cl)c(Cl)c1C(=O)O)CC1C(=NC(C)(C)CC1C)C2S(=O)(=O)O 10.1021/jm061404q
CHEMBL3813894 214742 None 0 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)N(C)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
135493119 79100 None 0 Human Binding pKi = 9.0 9.0 4 3
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113201 79100 None 0 Human Binding pKi = 9.0 9.0 4 3
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
56665480 63228 None 0 Rat Binding pKi = 9.0 9.0 91 2
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 754 6 2 8 3.5 CC[C@@H](C)[C@@H]1/N=C(\S)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
CHEMBL1790544 63228 None 0 Rat Binding pKi = 9.0 9.0 91 2
Binding affinity against oxytocin receptor in rat uterusBinding affinity against oxytocin receptor in rat uterus
ChEMBL 754 6 2 8 3.5 CC[C@@H](C)[C@@H]1/N=C(\S)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCC=NN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00171a003
10531717 103014 None 0 Human Binding pKi = 9.0 9.0 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 604 7 0 7 4.6 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL306416 103014 None 0 Human Binding pKi = 9.0 9.0 4 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 604 7 0 7 4.6 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
135493119 79100 None 0 Human Binding pKi = 9.0 9.0 4 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113201 79100 None 0 Human Binding pKi = 9.0 9.0 4 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 569 11 2 7 3.3 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
76073634 115920 None 5 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354594 115920 None 5 Human Binding pKi = 9.0 9.0 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1041 20 11 13 -1.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
44275447 96476 None 0 Human Binding pKi = 9.0 9.0 -1 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1111 32 13 13 -3.6 CN(C(=O)Cc1ccccc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
CHEMBL262035 96476 None 0 Human Binding pKi = 9.0 9.0 -1 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1111 32 13 13 -3.6 CN(C(=O)Cc1ccccc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(N)=O 10.1021/jm9804782
2168 3976 None 29 Rat Binding pKi = 8.9 8.9 -6 9
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
2810 3976 None 29 Rat Binding pKi = 8.9 8.9 -6 9
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
644077 3976 None 29 Rat Binding pKi = 8.9 8.9 -6 9
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
644077.0 3976 None 29 Rat Binding pKi = 8.9 8.9 -6 9
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
CHEMBL373742 3976 None 29 Rat Binding pKi = 8.9 8.9 -6 9
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
DB00067 3976 None 29 Rat Binding pKi = 8.9 8.9 -6 9
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm060928n
10556286 206794 None 0 Human Binding pKi = 8.9 8.9 10 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL71540 206794 None 0 Human Binding pKi = 8.9 8.9 10 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
15840423 93251 None 0 Rat Binding pKi = 8.9 8.9 -1 2
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24456 93251 None 0 Rat Binding pKi = 8.9 8.9 -1 2
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 601 9 0 6 5.6 O=C(Cc1ccc(OC2CCN(CC3CC3)CC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
2042 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2174 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
2176 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
439302 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
439302.0 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
CHEMBL395429 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
DB00107 2983 None 40 Human Binding pKi = 8.9 8.9 1 8
Displacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting methodDisplacement of [3H]OT from human mammary gland oxytocin receptor expressed in HEK293 cell membrane after 1 hr by scintillation counting method
ChEMBL None None None None 10.1016/j.bmc.2018.03.019
44275525 195356 None 0 Human Binding pKi = 8.9 8.9 -16 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
91931055 195356 None 0 Human Binding pKi = 8.9 8.9 -16 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
CHEMBL540192 195356 None 0 Human Binding pKi = 8.9 8.9 -16 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1525 36 12 20 1.8 CN(C)c1ccc2c(c1)Oc1cc(N(C)C)ccc1C21OC(=O)c2cc(C(=O)N(C(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H](Cc3ccc(O)cc3)N(C)C(=O)CCc3ccc(O)cc3)[C@@H](CCCCN)C(N)=O)ccc21 10.1021/jm9804782
2239 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
6918854 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
CHEMBL196478 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1016/j.bmcl.2007.11.008
44456109 95345 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 482 8 2 6 1.6 Cc1nc([C@H](C(=O)N(C)CCO)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL256391 95345 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 482 8 2 6 1.6 Cc1nc([C@H](C(=O)N(C)CCO)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44456004 97808 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 479 7 2 4 3.6 Cc1cc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)oc1C 10.1016/j.bmcl.2007.11.008
CHEMBL271657 97808 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 479 7 2 4 3.6 Cc1cc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)oc1C 10.1016/j.bmcl.2007.11.008
44456229 155187 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 466 7 2 5 2.7 Cc1nc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL401910 155187 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 466 7 2 5 2.7 Cc1nc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44279607 99917 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 595 6 1 10 3.0 Cn1ncc2c(=O)n(CC(=O)NCc3cc4cc(C(=O)N5CCC(N6C(=O)OCc7ccccc76)CC5)ccc4o3)cnc21 10.1016/s0960-894x(02)00160-9
CHEMBL285820 99917 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 595 6 1 10 3.0 Cn1ncc2c(=O)n(CC(=O)NCc3cc4cc(C(=O)N5CCC(N6C(=O)OCc7ccccc76)CC5)ccc4o3)cnc21 10.1016/s0960-894x(02)00160-9
2239 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
6918854 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
CHEMBL196478 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Displacement of [3H]-oxytocin from human oxytocin receptorDisplacement of [3H]-oxytocin from human oxytocin receptor
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm901812z
2239 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm060073e
6918854 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm060073e
CHEMBL196478 1077 None 0 Human Binding pKi = 8.9 8.9 501 3
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 497 7 2 3 3.7 CC(C[C@@H]1C(=O)N[C@@H](C(=O)N1[C@H](c1ccc(cc1F)F)C(=O)NC(C)C)C1Cc2c(C1)cccc2)C 10.1021/jm060073e
11685100 79628 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 525 6 1 4 3.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL211443 79628 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 525 6 1 4 3.0 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N1CCOCC1)c1ccc(F)cc1F 10.1021/jm060073e
56950169 75357 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cc(C)cnc1C 10.1021/jm201287w
CHEMBL2037503 75357 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 2 4 2.6 CC[C@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC)c1cc(C)cnc1C 10.1021/jm201287w
42611262 180665 None 0 Human Binding pKi = 8.9 8.9 31 4
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL475395 180665 None 0 Human Binding pKi = 8.9 8.9 31 4
Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assayDisplacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells by filtration binding assay
ChEMBL 349 6 0 2 4.7 Cc1cc(C(=O)N(CC2CC2)CC2CCCO2)ccc1-c1ccccc1 10.1016/j.bmcl.2008.11.064
CHEMBL2112248 211694 None 0 Human Binding pKi = 8.9 8.9 -1 2
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant womenCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from nonlabor pregnant women
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL2112248 211694 None 0 Rat Binding pKi = 8.9 8.9 1 2
Compound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant ratsCompound was evaluated for OT receptor affinity by displacement of [3H]OT from binding sites in uterine tissue taken from pregnant rats
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2c[nH]cn2)NC(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCC=NN2C1=O 10.1021/jm00099a019
CHEMBL3814633 214749 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
10699322 206054 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL66931 206054 None 0 Human Binding pKi = 8.9 8.9 - 1
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 640 7 0 7 5.2 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3C(F)(F)F)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
9938406 93370 None 1 Human Binding pKi = 8.9 8.9 -1 6
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL24526 93370 None 1 Human Binding pKi = 8.9 8.9 -1 6
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 589 7 0 6 4.7 CC(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)c(OCC(F)(F)F)c2)CC1 10.1016/s0960-894x(99)00181-x
18700187 98898 None 0 Human Binding pKi = 8.9 8.9 1 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 577 9 0 7 4.0 O=C(Cc1ccc(OCCN2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
CHEMBL278818 98898 None 0 Human Binding pKi = 8.9 8.9 1 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 577 9 0 7 4.0 O=C(Cc1ccc(OCCN2CCOCC2)cc1OCC(F)(F)F)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(99)00181-x
118720268 115905 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL3354579 115905 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 991 21 12 14 -3.6 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
155565903 175847 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
CHEMBL4583231 175847 None 0 Human Binding pKi = 8.9 8.9 - 1
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL 1024 21 13 16 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N(CCCO)CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/acs.jmedchem.8b01691
44297525 96862 None 0 Rat Binding pKi = 8.9 8.9 -10 3
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
CHEMBL265048 96862 None 0 Rat Binding pKi = 8.9 8.9 -10 3
Tested for inhibition constant at OT receptor of rat mammary glandsTested for inhibition constant at OT receptor of rat mammary glands
ChEMBL 1329 38 15 16 -1.8 CN(C(=O)CCc1cccc(N=[N+]=[N-])c1)[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O 10.1021/jm00038a013
10817776 206285 None 0 Human Binding pKi = 8.8 8.8 5 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 628 8 0 7 5.3 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
CHEMBL68480 206285 None 0 Human Binding pKi = 8.8 8.8 5 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 628 8 0 7 5.3 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)c(C)cc(C)[n+]1[O-] 10.1021/jm9800797
73346893 89388 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL2369425 89388 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 989 17 12 14 -3.3 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](N)CCSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
44456070 155419 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 464 6 1 5 2.4 Cc1nc([C@H](C(=O)N2CCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL403149 155419 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 464 6 1 5 2.4 Cc1nc([C@H](C(=O)N2CCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44581267 174928 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 505 9 0 7 4.9 COc1ccc(OC)c(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)c1 10.1016/j.bmcl.2008.11.018
CHEMBL456254 174928 None 0 Human Binding pKi = 8.8 8.8 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 505 9 0 7 4.9 COc1ccc(OC)c(S(=O)(=O)N(Cc2ccc(-c3ccccc3C)cn2)c2ccc(OC)nc2)c1 10.1016/j.bmcl.2008.11.018
44413575 166416 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 546 8 2 5 3.2 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N2CCOCC2)cc1 10.1021/jm060073e
CHEMBL427227 166416 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 546 8 2 5 3.2 CC[C@@H](C)[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(N2CCOCC2)cc1 10.1021/jm060073e
11519207 133623 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL371008 133623 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
56949905 75345 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
CHEMBL2037491 75345 None 0 Human Binding pKi = 8.8 8.8 - 1
Displacement of [3H]oxytocin from human oxytocin receptorDisplacement of [3H]oxytocin from human oxytocin receptor
ChEMBL 462 6 1 4 2.7 Cc1ccc([C@H](C(=O)N(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cn1 10.1021/jm201287w
135399831 79093 None 0 Human Binding pKi = 8.8 8.8 1 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113189 79093 None 0 Human Binding pKi = 8.8 8.8 1 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 597 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)NC(=O)c3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
10461270 3678 None 12 Rat Binding pKi = 8.8 8.8 -3 5
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
2201 3678 None 12 Rat Binding pKi = 8.8 8.8 -3 5
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL1615640 3678 None 12 Rat Binding pKi = 8.8 8.8 -3 5
Displacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cellsDisplacement of [3H]-oxytocin from rat oxytocin receptor expressed in CHO cells
ChEMBL 603 9 0 5 6.9 CCN(C(=O)c1ccc(c(c1)[C@@]1(C)c2cc(Cl)ccc2N(C1=O)Cc1ccc(cc1OC)OC)Cl)Cc1cccnc1 10.1021/jm901812z
CHEMBL2372927 212774 None 0 Rat Binding pKi = 8.8 8.8 199 2
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H]2CCCCN2C(=O)[C@@H]2CCCCN2C1=O 10.1021/jm00169a001
44275524 161387 None 0 Human Binding pKi = 8.8 8.8 -9 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
91931053 161387 None 0 Human Binding pKi = 8.8 8.8 -9 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
CHEMBL412210 161387 None 0 Human Binding pKi = 8.8 8.8 -9 4
The inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptorThe inhibition constant (Ki(nM)) by displacement of [125I]- HO-LVA radiolabeled ligand using membranes of CHO cells of human Oxytocin receptor
ChEMBL 1471 34 14 20 1.1 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N(C(=O)c1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21)[C@@H](CCCCN)C(N)=O 10.1021/jm9804782
2168 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
2810 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
644077 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
644077.0 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
CHEMBL373742 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
DB00067 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL None None None None 10.1021/jm3006146
2042 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
2174 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
2176 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
439302 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
439302.0 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
CHEMBL395429 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
DB00107 2983 None 40 Rat Binding pKi = 8.8 8.8 -1 8
Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocinBinding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin
ChEMBL None None None None 10.1021/jm9607156
10675476 206339 None 0 Human Binding pKi = 8.8 8.8 5 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68800 206339 None 0 Human Binding pKi = 8.8 8.8 5 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 630 6 0 7 5.2 COc1cc(OC2CCN([C@H]3CCCc4c3ccc[n+]4[O-])CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
2168 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
2810 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
644077 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
644077.0 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
CHEMBL373742 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
DB00067 3976 None 29 Human Binding pKi = 8.8 8.8 -18 9
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL None None None None 10.1021/jm1016208
56675151 63247 None 0 Human Binding pKi = 8.7 8.7 14 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1295 17 14 20 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790728 63247 None 0 Human Binding pKi = 8.7 8.7 14 3
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1295 17 14 20 0.7 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)NCN)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
11169 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
131676677 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
165708555 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
165708555.0 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
16681432 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
16681432.0 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
495 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
CHEMBL3301668 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
DB01282 797 None 33 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hrDisplacement of [3H]OT from recombinant human OTR expressed in HEK293 cell membranes measured after 1 hr
ChEMBL None None None CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C 10.1021/acs.jmedchem.8b01691
44428109 10320 None 0 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
91935618 10320 None 0 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
CHEMBL1161979 10320 None 0 Human Binding pKi = 8.7 8.7 1 2
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 1629 38 18 23 -0.0 CN(C(=O)CCc1ccc(O)cc1)[C@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CC[C@H](C(=O)N(C(=O)c2ccc(-c3c4ccc(=N)c(S(=O)(=O)O)c-4oc4c(S(=O)(=O)O)c(N)ccc34)c(C(=O)O)c2)[C@@H](CCCCN)C(N)=O)C1 10.1021/jm061404q
11260438 97687 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
CHEMBL271039 97687 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 494 6 1 6 2.0 Cc1nc([C@H](C(=O)N2CCOCC2)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)co1 10.1016/j.bmcl.2007.11.008
44456424 159784 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)s1 10.1016/j.bmcl.2007.11.008
CHEMBL410420 159784 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 545 7 2 4 4.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(Br)s1 10.1016/j.bmcl.2007.11.008
44279908 99639 None 0 Human Binding pKi = 8.7 8.7 794 2
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 585 8 1 9 3.5 CCOc1ccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c(=O)n1 10.1016/s0960-894x(02)00160-9
CHEMBL283894 99639 None 0 Human Binding pKi = 8.7 8.7 794 2
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 585 8 1 9 3.5 CCOc1ccn(CC(=O)NCc2cc3cc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)ccc3o2)c(=O)n1 10.1016/s0960-894x(02)00160-9
10416272 104795 None 5 Human Binding pKi = 8.7 8.7 630 2
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL31065 104795 None 5 Human Binding pKi = 8.7 8.7 630 2
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
11685194 135325 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 532 7 3 4 3.8 CC(=O)Nc1ccc([C@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372554 135325 None 0 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 532 7 3 4 3.8 CC(=O)Nc1ccc([C@H](C(=O)NC(C)(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
21886866 135339 None 18 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 135 0 1 2 1.1 c1ccc2c(c1)CNCO2 10.1021/jm050557v
CHEMBL372615 135339 None 18 Human Binding pKi = 8.7 8.7 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 135 0 1 2 1.1 c1ccc2c(c1)CNCO2 10.1021/jm050557v
2252 2230 None 35 Human Binding pKi = 8 8.0 -1 5
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00159-2
6918320 2230 None 35 Human Binding pKi = 8 8.0 -1 5
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00159-2
CHEMBL24781 2230 None 35 Human Binding pKi = 8 8.0 -1 5
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 507 5 0 6 3.8 COc1cc(ccc1C(=O)N1CCC(CC1)N1C(=O)OCc2c1cccc2)OC1CCN(CC1)C(=O)C 10.1016/s0960-894x(02)00159-2
44279637 111495 None 0 Human Binding pKi = 8 8.0 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 550 5 0 6 4.1 Cc1cc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc2ccn(C[C@H]3CCCN3S(C)(=O)=O)c12 10.1016/s0960-894x(02)00159-2
CHEMBL32745 111495 None 0 Human Binding pKi = 8 8.0 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 550 5 0 6 4.1 Cc1cc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)cc2ccn(C[C@H]3CCCN3S(C)(=O)=O)c12 10.1016/s0960-894x(02)00159-2
44308876 206350 None 0 Human Binding pKi = 8 8.0 2 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68914 206350 None 0 Human Binding pKi = 8 8.0 2 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 556 7 0 7 4.9 COc1cc(OC2CCN(Cc3cccnc3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
44581687 175703 None 0 Human Binding pKi = 8 8.0 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 445 7 0 5 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccccc2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL457998 175703 None 0 Human Binding pKi = 8 8.0 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 445 7 0 5 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2ccccc2)cn1 10.1016/j.bmcl.2008.11.018
44581240 189833 None 0 Human Binding pKi = 8 8.0 6 3
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL515660 189833 None 0 Human Binding pKi = 8 8.0 6 3
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 486 8 0 7 4.4 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3C#N)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44279573 99194 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 625 6 1 8 4.6 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1nc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2s1 10.1016/s0960-894x(02)00160-9
CHEMBL281081 99194 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 625 6 1 8 4.6 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1nc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2s1 10.1016/s0960-894x(02)00160-9
44279846 99622 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 648 6 0 7 6.4 O=C(c1ccc2oc(CN3CCCC[C@H]3Cn3cc(C(F)(F)F)ccc3=O)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL283676 99622 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 648 6 0 7 6.4 O=C(c1ccc2oc(CN3CCCC[C@H]3Cn3cc(C(F)(F)F)ccc3=O)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
44280354 171262 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 628 5 0 7 6.5 O=C(c1ccc2oc(-c3cccc(Cn4cc(C(F)(F)F)ccc4=O)n3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
CHEMBL445875 171262 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 628 5 0 7 6.5 O=C(c1ccc2oc(-c3cccc(Cn4cc(C(F)(F)F)ccc4=O)n3)cc2c1)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00160-9
135520376 79108 None 0 Human Binding pKi = 8 8.0 138 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113209 79108 None 0 Human Binding pKi = 8 8.0 138 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
44404012 70444 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
CHEMBL194584 70444 None 0 Human Binding pKi = 8 8.0 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
70685417 73675 None 0 Human Binding pKi = 8 8.0 79 3
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
CHEMBL2017867 73675 None 0 Human Binding pKi = 8 8.0 79 3
Displacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation countingDisplacement of [3H]oxytocin from human oxytocin receptor after 1.5 hrs by liquid scintillation counting
ChEMBL 707 9 0 6 4.3 CS(=O)(=O)N1CCC(Oc2ccc(CC(=O)N3CCC(N4C(=O)CCc5ccccc54)CC3)c(OC/C=C/I)c2)CC1 10.1016/j.bmc.2012.02.019
11465834 138509 None 0 Rat Binding pKi = 8 8.0 -23 4
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL377414 138509 None 0 Rat Binding pKi = 8 8.0 -23 4
Displacement of [3H]oxytocin from rat OTRDisplacement of [3H]oxytocin from rat OTR
ChEMBL 483 6 1 3 3.3 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)N(C)C)c1ccc(F)cc1F 10.1021/jm060073e
135520376 79108 None 0 Human Binding pKi = 8 8.0 138 2
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
CHEMBL2113209 79108 None 0 Human Binding pKi = 8 8.0 138 2
Inhibition of oxytocin receptor (unknown origin)Inhibition of oxytocin receptor (unknown origin)
ChEMBL 526 9 2 6 3.8 CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1039/C5MD00566C
67839485 164296 None 0 Human Binding pKi = 8.0 8.0 -4 3
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 327 2 0 1 5.3 O=C(c1ccc(-c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL4210854 164296 None 0 Human Binding pKi = 8.0 8.0 -4 3
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 327 2 0 1 5.3 O=C(c1ccc(-c2ccccc2)cc1)N1CCCCc2ccccc21 10.1021/acs.jmedchem.8b00697
CHEMBL3813722 214738 None 0 Human Binding pKi = 8.0 8.0 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1016/j.bmc.2016.05.062
44279688 100182 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5c(F)cccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL287628 100182 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 626 6 1 7 4.8 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5c(F)cccc54)CC3)ccc2o1 10.1016/s0960-894x(02)00160-9
44279997 102881 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2o1 10.1016/s0960-894x(02)00160-9
CHEMBL30550 102881 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of 3[H]oxytocin from human oxytocin receptorDisplacement of 3[H]oxytocin from human oxytocin receptor
ChEMBL 608 6 1 7 4.7 O=C(Cn1cc(C(F)(F)F)ccc1=O)NCc1cc2ccc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)cc2o1 10.1016/s0960-894x(02)00160-9
1134581 9896 None 6 Human Binding pKi = 7 7.0 3 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
CHEMBL114302 9896 None 6 Human Binding pKi = 7 7.0 3 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 444 7 1 4 4.5 COc1ccc(N(CC(=O)Nc2cccc(Cl)c2C)S(=O)(=O)c2ccccc2)cc1 10.1021/jm050645f
44404027 72148 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
CHEMBL197833 72148 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 539 8 2 5 2.8 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm050557v
11619939 166443 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
CHEMBL427353 166443 None 0 Human Binding pKi = 7 7.0 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 479 7 2 3 3.5 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@H](C(=O)NC(C)C)c1ccc(F)cc1 10.1021/jm050557v
44275026 91621 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 488 7 2 4 3.3 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24074 91621 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 488 7 2 4 3.3 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
44274724 93511 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 522 7 2 4 4.0 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc(Cl)c(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24605 93511 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 522 7 2 4 4.0 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2ccc(Cl)c(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
44274675 93699 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 572 12 2 5 4.5 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24678 93699 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 572 12 2 5 4.5 CC(=O)CCCC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCCc2cccc(Cl)c2)C1=O 10.1016/s0960-894x(01)00202-5
44274994 93964 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 504 7 2 4 3.8 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc3ccccc23)C1=O 10.1016/s0960-894x(01)00202-5
CHEMBL24816 93964 None 0 Human Binding pKi = 7 7.0 - 1
Inhibition of binding of [3H]oxytocin with human oxytocin receptorInhibition of binding of [3H]oxytocin with human oxytocin receptor
ChEMBL 504 7 2 4 3.8 CC(=O)NC1N=C(c2ccccc2)c2ccccc2N(CC(=O)NCCc2cccc3ccccc23)C1=O 10.1016/s0960-894x(01)00202-5
9797987 118573 None 1 Human Binding pKi = 6 6.0 1 3
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
CHEMBL341490 118573 None 1 Human Binding pKi = 6 6.0 1 3
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 339 2 0 2 3.7 Cc1ccc(S(=O)(=O)N2CCC3(C=Cc4ccccc43)CC2)cc1 10.1021/jm901812z
56682530 63230 None 0 Human Binding pKi = 7.0 7.0 -245 4
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL1790575 63230 None 0 Human Binding pKi = 7.0 7.0 -245 4
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1053 18 12 14 -2.6 CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@@H](CC(N)=O)NC1=O 10.1021/jm030611c
CHEMBL2369841 212165 None 0 Human Binding pKi = 6.0 6.0 -301 4
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm030611c
135510027 141157 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 524 7 2 5 6.4 Cc1ccc(N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)S(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1 10.1021/jm050645f
CHEMBL382515 141157 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 524 7 2 5 6.4 Cc1ccc(N(CC(=O)/N=N/c2c(O)[nH]c3ccccc23)S(=O)(=O)c2ccc(-c3ccccc3)cc2)cc1 10.1021/jm050645f
145976648 163938 None 0 Human Binding pKi = 7.0 7.0 -1 3
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 293 3 0 1 4.6 CCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
CHEMBL4206482 163938 None 0 Human Binding pKi = 7.0 7.0 -1 3
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 293 3 0 1 4.6 CCCc1ccc(C(=O)N2CCCCc3ccccc32)cc1 10.1021/acs.jmedchem.8b00697
44419039 137483 None 0 Human Binding pKi = 6.0 6.0 -8511 8
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
CHEMBL375324 137483 None 0 Human Binding pKi = 6.0 6.0 -8511 8
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL 1096 20 14 15 -4.6 NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
135489430 79095 None 0 Human Binding pKi = 7.0 7.0 11 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 627 12 2 9 3.1 COC(=O)c1cccc2c1NC(=O)/C2=N\NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCCN(C)C)cc1 10.1021/jm050645f
CHEMBL2113195 79095 None 0 Human Binding pKi = 7.0 7.0 11 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 627 12 2 9 3.1 COC(=O)c1cccc2c1NC(=O)/C2=N\NC(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c1ccc(OCCCN(C)C)cc1 10.1021/jm050645f
10411308 203691 None 0 Human Binding pKi = 7.0 7.0 -39 3
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
CHEMBL603708 203691 None 0 Human Binding pKi = 7.0 7.0 -39 3
Displacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assayDisplacement of [3H]-AVP from human OXR receptor expressed in CHO cell membranes by radioligand binding assay
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/acs.jmedchem.8b00697
10411308 203691 None 0 Human Binding pKi = 7.0 7.0 -39 3
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
CHEMBL603708 203691 None 0 Human Binding pKi = 7.0 7.0 -39 3
Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 minsDisplacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm3006146
10411308 203691 None 0 Human Binding pKi = 7.0 7.0 -39 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL603708 203691 None 0 Human Binding pKi = 7.0 7.0 -39 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 446 4 1 2 6.6 O=C(Nc1ccc(C(=O)N2CCCCc3ccccc32)cc1)c1ccccc1-c1ccccc1 10.1021/jm901084f
10507277 206440 None 0 Human Binding pKi = 8.0 8.0 2 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.2 COc1cc(OC2CCN(Cc3cccnc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69520 206440 None 0 Human Binding pKi = 8.0 8.0 2 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 570 7 0 7 5.2 COc1cc(OC2CCN(Cc3cccnc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10793202 206443 None 0 Human Binding pKi = 8.0 8.0 2 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 572 7 0 7 4.1 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL69539 206443 None 0 Human Binding pKi = 8.0 8.0 2 2
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 572 7 0 7 4.1 COc1cc(OC2CCN(Cc3ccc[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10507800 205962 None 0 Rat Binding pKi = 8.0 8.0 -5 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 8 0 7 4.7 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
CHEMBL66240 205962 None 0 Rat Binding pKi = 8.0 8.0 -5 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 600 8 0 7 4.7 CCc1c(CN2CCC(Oc3ccc(C(=O)N4CCC(N5C(=O)OCc6ccccc65)CC4)c(OC)c3)CC2)ccc[n+]1[O-] 10.1021/jm9800797
2213 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
3008 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
5311010 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
5311010.0 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
68613 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
68613.0 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
CHEMBL378642 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
CHEMBL382301 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
DB09059 518 None 30 Human Binding pKi = 8.0 8.0 -46 5
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL None None None None 10.1016/j.bmcl.2007.11.008
53320505 56356 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
CHEMBL1630524 56356 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL 1074 17 12 13 -4.4 CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)C[Se][Se]C[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O 10.1021/jm100989w
135513039 79104 None 0 Human Binding pKi = 7.0 7.0 63 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 473 6 2 6 2.5 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2ccc(C#N)cc2)cc1 10.1021/jm050645f
CHEMBL2113205 79104 None 0 Human Binding pKi = 7.0 7.0 63 2
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 473 6 2 6 2.5 Cc1ccc(N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)S(=O)(=O)c2ccc(C#N)cc2)cc1 10.1021/jm050645f
135916059 203546 None 0 Human Binding pKi = 7.0 7.0 -16 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 513 4 2 5 6.6 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1NC(=O)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL602872 203546 None 0 Human Binding pKi = 7.0 7.0 -16 3
Displacement of [3H]AVP from human oxytocin receptor expressed in CHO cellsDisplacement of [3H]AVP from human oxytocin receptor expressed in CHO cells
ChEMBL 513 4 2 5 6.6 Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1NC(=O)c1ccccc1-c1ccccc1 10.1021/jm901084f
CHEMBL3814126 214744 None 0 Human Binding pKi = 7.0 7.0 - 1
Displacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting methodDisplacement of [3H]8-arginine-vasopressin from human oxytocin receptor expressed in CHO cell membrane incubated for 1 hr by liquid scintillation counting method
ChEMBL None None None CC[C@H](C)[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N1C 10.1016/j.bmc.2016.05.062
135530164 79099 None 0 Human Binding pKi = 6.9 6.9 1 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113200 79099 None 0 Human Binding pKi = 6.9 6.9 1 3
Displacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from human oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 570 11 2 8 2.7 CN(C)CCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccncc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
54581533 62408 None 0 Human Binding pKi = 6.9 6.9 -57 3
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 636 9 0 9 5.2 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN(C)C)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
CHEMBL1779418 62408 None 0 Human Binding pKi = 6.9 6.9 -57 3
Displacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation countingDisplacement of radiolabeled oxytocin from human oxytocin receptor expressed in CHO cells by scintillation counting
ChEMBL 636 9 0 9 5.2 COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3cc(CN(C)C)ccc3OC)(N3CCC[C@H]3c3ncco3)c3cc(Cl)ccc32)cc1 10.1016/j.bmcl.2011.03.012
10005688 5073 None 0 Rat Binding pKi = 7.9 7.9 -2 2
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 487 6 0 6 5.0 COc1cc(OC(C)c2cccnc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
CHEMBL105406 5073 None 0 Rat Binding pKi = 7.9 7.9 -2 2
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 487 6 0 6 5.0 COc1cc(OC(C)c2cccnc2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(98)00568-x
10841081 102363 None 0 Rat Binding pKi = 7.9 7.9 -3 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL303487 102363 None 0 Rat Binding pKi = 7.9 7.9 -3 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10651439 102959 None 0 Rat Binding pKi = 7.9 7.9 -2 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 614 7 0 7 5.1 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL306010 102959 None 0 Rat Binding pKi = 7.9 7.9 -2 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 614 7 0 7 5.1 COc1cc(OC2CCN(Cc3c(C)cc(C)[n+]([O-])c3C)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
135414531 79107 None 0 Rat Binding pKi = 7.9 7.9 -3 3
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
CHEMBL2113208 79107 None 0 Rat Binding pKi = 7.9 7.9 -3 3
Displacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cellsDisplacement of [125I]OVTA antagonist from rat oxytocin receptor expressed in HEK293-EBNA cells
ChEMBL 586 13 2 8 3.1 COCCOCCOc1ccc(S(=O)(=O)N(CC(=O)N/N=C2\C(=O)Nc3ccccc32)c2ccc(Cl)cc2)cc1 10.1021/jm050645f
2168 3976 None 29 Human Binding pKi = 7.9 7.9 -18 9
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
2810 3976 None 29 Human Binding pKi = 7.9 7.9 -18 9
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
644077 3976 None 29 Human Binding pKi = 7.9 7.9 -18 9
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
644077.0 3976 None 29 Human Binding pKi = 7.9 7.9 -18 9
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
CHEMBL373742 3976 None 29 Human Binding pKi = 7.9 7.9 -18 9
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
DB00067 3976 None 29 Human Binding pKi = 7.9 7.9 -18 9
Displacement of [3H]OT from oxytocin receptor expressed in COS1 cellsDisplacement of [3H]OT from oxytocin receptor expressed in COS1 cells
ChEMBL None None None None 10.1021/jm100989w
44456072 97770 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 6 2 4 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccoc1 10.1016/j.bmcl.2007.11.008
CHEMBL271456 97770 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human oxytocin receptorBinding affinity to human oxytocin receptor
ChEMBL 465 6 2 4 3.4 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](C(=O)NC(C)(C)C)c1ccoc1 10.1016/j.bmcl.2007.11.008
25212177 174933 None 7 Human Binding pKi = 7.9 7.9 7 4
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL456263 174933 None 7 Human Binding pKi = 7.9 7.9 7 4
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 463 7 0 7 3.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)c(C)n2)cn1 10.1016/j.bmcl.2008.11.018
44581241 175990 None 0 Human Binding pKi = 7.9 7.9 3 3
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL458634 175990 None 0 Human Binding pKi = 7.9 7.9 3 3
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 495 8 0 6 5.2 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3Cl)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44581719 175997 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 451 7 0 6 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccs2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL458654 175997 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 451 7 0 6 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccs2)cn1 10.1016/j.bmcl.2008.11.018
44581720 176085 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 523 8 0 7 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccc(S(C)(=O)=O)c2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL458872 176085 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 523 8 0 7 4.3 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cccc(S(C)(=O)=O)c2)cn1 10.1016/j.bmcl.2008.11.018
44581718 189633 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 480 7 0 7 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2sc(C)nc2C)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL514123 189633 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 480 7 0 7 4.9 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2sc(C)nc2C)cn1 10.1016/j.bmcl.2008.11.018
25212178 189870 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 449 7 0 7 3.6 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)cn2)cn1 10.1016/j.bmcl.2008.11.018
CHEMBL515975 189870 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 449 7 0 7 3.6 COc1ccc(N(Cc2ccc(-c3ccccc3C)cn2)S(=O)(=O)c2cn(C)cn2)cn1 10.1016/j.bmcl.2008.11.018
11495934 78071 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 442 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](CO)c1ccc(F)cc1F 10.1021/jm060073e
CHEMBL209917 78071 None 0 Human Binding pKi = 7.9 7.9 - 1
Displacement of [3H]oxytocin from human OTRDisplacement of [3H]oxytocin from human OTR
ChEMBL 442 6 2 3 3.2 CC(C)C[C@@H]1C(=O)N[C@H](C2Cc3ccccc3C2)C(=O)N1[C@@H](CO)c1ccc(F)cc1F 10.1021/jm060073e
54581307 61204 None 0 Human Binding pKi = 7.9 7.9 -9 4
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1097 21 12 15 -1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
CHEMBL1765666 61204 None 0 Human Binding pKi = 7.9 7.9 -9 4
Displacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 minsDisplacement of [3H]AVP from human oxytocin receptor expressed CHO cells after 60 mins
ChEMBL 1097 21 12 15 -1.4 CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCNC(=O)CCN)C(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm1016208
44275618 97792 None 0 Rat Binding pKi = 6.9 6.9 -1 2
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
CHEMBL27157 97792 None 0 Rat Binding pKi = 6.9 6.9 -1 2
Binding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterineBinding affinity against oxytocin receptor (rOTr) in DES pretreated rat uterine
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(98)00568-x
44275618 97792 None 0 Rat Binding pKi = 6.9 6.9 -1 2
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
CHEMBL27157 97792 None 0 Rat Binding pKi = 6.9 6.9 -1 2
Binding affinity for rat uterine oxytocin receptor (rOTr)Binding affinity for rat uterine oxytocin receptor (rOTr)
ChEMBL 396 4 0 5 3.5 COc1ccc(C(=O)N2CCC(N3C(=O)OCc4ccccc43)CC2)c(OC)c1 10.1016/s0960-894x(99)00181-x
16109439 137329 None 0 Rat Binding pKi = 5.9 5.9 -120 5
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL375187 137329 None 0 Rat Binding pKi = 5.9 5.9 -120 5
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1023 15 11 14 -1.7 NC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC2CCCCC2)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1021/jm060928n
CHEMBL2372932 212776 None 0 Rat Binding pKi = 4.9 4.9 - 1
Inhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptorInhibition of [3H]- oxytocin binding to rat uterine Oxytocin receptor
ChEMBL None None None C[C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCCN2C(=O)[C@H]2CCCCN2C1=O 10.1021/jm00169a001
3537 4004 None 22 Human Binding pKi = 6.9 6.9 -3 3
Binding affinity to OTR receptor (unknown origin)Binding affinity to OTR receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
5311500 4004 None 22 Human Binding pKi = 6.9 6.9 -3 3
Binding affinity to OTR receptor (unknown origin)Binding affinity to OTR receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
CHEMBL363910 4004 None 22 Human Binding pKi = 6.9 6.9 -3 3
Binding affinity to OTR receptor (unknown origin)Binding affinity to OTR receptor (unknown origin)
ChEMBL 402 2 0 4 4.8 Cc1ccn(n1)c1ccc(c(c1)Cl)C(=O)N1Cc2cccn2Cc2c1cccc2 10.1021/acs.jmedchem.8b00697
16109442 137484 None 0 Rat Binding pKi = 6.9 6.9 -208 4
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 20 14 15 -3.3 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
CHEMBL375325 137484 None 0 Rat Binding pKi = 6.9 6.9 -208 4
Displacement of [3H]AVP from rat OT receptor expressed in CHO cellsDisplacement of [3H]AVP from rat OT receptor expressed in CHO cells
ChEMBL 1068 20 14 15 -3.3 N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O 10.1021/jm060928n
44279330 100132 None 0 Human Binding pKi = 6.9 6.9 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 0 4 3.9 Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL287293 100132 None 0 Human Binding pKi = 6.9 6.9 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 0 4 3.9 Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
44278983 108466 None 0 Human Binding pKi = 6.9 6.9 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 434 3 0 6 4.3 Cc1nc(-c2ccncc2)sc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
CHEMBL31986 108466 None 0 Human Binding pKi = 6.9 6.9 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 434 3 0 6 4.3 Cc1nc(-c2ccncc2)sc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1016/s0960-894x(02)00159-2
44279329 111493 None 0 Human Binding pKi = 6.9 6.9 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 1 3 4.2 Cc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2[nH]1 10.1016/s0960-894x(02)00159-2
CHEMBL32740 111493 None 0 Human Binding pKi = 6.9 6.9 - 1
Ability to displace [3H]oxytocin from human OT receptor (hOT)Ability to displace [3H]oxytocin from human OT receptor (hOT)
ChEMBL 389 2 1 3 4.2 Cc1cc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc2[nH]1 10.1016/s0960-894x(02)00159-2
44581685 175701 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 461 8 0 6 4.6 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
CHEMBL457997 175701 None 0 Human Binding pKi = 6.9 6.9 - 1
Binding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assayBinding affinity to human recombinant oxytocin receptor expressed in CHO cells by fluorescence polarization assay
ChEMBL 461 8 0 6 4.6 COc1ccc(S(=O)(=O)N(Cc2ccc(-c3ccccc3)cn2)c2ccc(OC)nc2)cc1 10.1016/j.bmcl.2008.11.018
44279580 100103 None 0 Human Binding pKi = 6.9 6.9 - 1
Compound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptorCompound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptor
ChEMBL 536 5 0 6 3.8 CS(=O)(=O)N1CCC[C@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
CHEMBL287042 100103 None 0 Human Binding pKi = 6.9 6.9 - 1
Compound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptorCompound was tested for its ability to displace [3H]oxytocin from human Oxytocin receptor
ChEMBL 536 5 0 6 3.8 CS(=O)(=O)N1CCC[C@H]1Cn1ccc2cc(C(=O)N3CCC(N4C(=O)OCc5ccccc54)CC3)ccc21 10.1016/s0960-894x(02)00159-2
11577215 135341 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL372619 135341 None 0 Human Binding pKi = 6.9 6.9 - 1
Displacement of [3H]oxytocin from human Oxytocin receptorDisplacement of [3H]oxytocin from human Oxytocin receptor
ChEMBL 518 8 3 4 3.4 CC(=O)Nc1ccc([C@@H](C(=O)NC(C)C)N2C(=O)[C@@H](C3Cc4ccccc4C3)NC(=O)[C@H]2CC(C)C)cc1 10.1021/jm050557v
CHEMBL2369842 212166 None 0 Human Binding pKi = 6.9 6.9 -8 4
Binding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptorsBinding affinity against human oxytocin receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors
ChEMBL None None None NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(N)=O)C(=O)N1 10.1021/jm030611c
56671721 63245 None 0 Human Binding pKi = 6.9 6.9 5 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1321 15 13 19 3.0 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
CHEMBL1790722 63245 None 0 Human Binding pKi = 6.9 6.9 5 2
Binding affinity for human oxytocin receptorBinding affinity for human oxytocin receptor
ChEMBL 1321 15 13 19 3.0 CC[C@@H](C)[C@H]1NC(=O)[C@H](c2ccc(O)cc2)NC(=O)CC2(CCCCC2)SSC[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@@H](CCCNC(=O)c2ccc3c(c2)C2(OC3=O)c3ccc(O)cc3Oc3cc(O)ccc32)C(=O)O)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](C(C)O)NC1=O 10.1021/jm010526+
10507580 206331 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3cc(C)c[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL68752 206331 None 0 Human Binding pKi = 7.9 7.9 - 1
Binding affinity for cloned human oxytocin receptor (OT-R)Binding affinity for cloned human oxytocin receptor (OT-R)
ChEMBL 586 7 0 7 4.4 COc1cc(OC2CCN(Cc3cc(C)c[n+]([O-])c3)CC2)ccc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
10556286 206794 None 0 Rat Binding pKi = 7.9 7.9 -10 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
CHEMBL71540 206794 None 0 Rat Binding pKi = 7.9 7.9 -10 2
Binding affinity for rat oxytocin receptor (OT-R)Binding affinity for rat oxytocin receptor (OT-R)
ChEMBL 658 7 0 7 5.3 COc1cc(OC2CCN(Cc3c[n+]([O-])ccc3C(F)(F)F)CC2)c(F)cc1C(=O)N1CCC(N2C(=O)OCc3ccccc32)CC1 10.1021/jm9800797
2249 2227 None 17 Human Binding pKi = 7.9 7.9 -2 7
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
9872389 2227 None 17 Human Binding pKi = 7.9 7.9 -2 7
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
CHEMBL1253853 2227 None 17 Human Binding pKi = 7.9 7.9 -2 7
Binding affinity to human OT receptorBinding affinity to human OT receptor
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1016/j.bmcl.2012.10.116
2249 2227 None 17 Human Binding pKi = 7.9 7.9 -2 7
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1(CC2)CS(=O)(=O)N1CCN(CC1)c1ccccc1C)(C)C 10.1021/jm901812z
9872389 2227 None 17 Human Binding pKi = 7.9 7.9 -2 7
Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissueDisplacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue
ChEMBL 554 9 2 7 1.5 O=C([C@H](CCS(=O)(=O)C)N)N[C@H]1C[C@@H]2C([C@]1